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Abstract 
Shigella sonnei is rapidly emerging as the primary agent of bacillary dysentery, or 
shigellosis, in many developing countries, replacing the historically more prevalent species, 
S. flexneri, in these regions. There have been various theories proposed to explain this 
phenomenon, including environmental changes and increased antimicrobial use, though the 
precise reasons for this shift are still uncertain. Here I present four studies investigating key 
ecological and genetic differences between S. sonnei and S. flexneri from a region that has 
undergone this pattern of species replacement, Vietnam. This work combines experimental 
and bioinformatics techniques with the aim of identifying the extent that differences in 
disinfectant sensitivity, chromosomal antimicrobial resistance profiles and gene content will 
contribute to the successful spread of S. sonnei over S. flexneri. 
Firstly, I conducted in vitro experimental work to characterise differences between species 
with respect to resistance to chlorine disinfection and tolerance to the detergent SDS. The 
mechanisms by which the bacteria respond to this treatment, in particular the role of efflux 
pumps, were then explored to determine whether any informative variation in these systems 
will explain any differences in disinfectant sensitivity. The availability of high quality whole 
genome sequences for ~150 of each Shigella species allowed for robust bioinformatics work 
to describe genomic variation between species. These sequences are used to detect key 
resistance mutations in each species and look for associated fitness compensating 
mutations. Finally, the complete genome sequence of all coding regions in each strain was 
de novo assembled to look for species-level gene content variation that might contribute to 
functional differences between S. sonnei and S. flexneri. The results of these studies show 
that there are clear biological differences between S. sonnei and S. flexneri, though more 
work is necessary to fully elucidate the reasons for the species replacement in developing 
countries. 
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Chapter 1 
General Introduction 
1.1 Bacterial Pathogens  
Infectious disease epidemiology 
Bacteria are among the most diverse and abundant organisms on Earth, with the sum of 
bacteria living on a single human individual outnumbering human cells 10 to 11. Many 
bacterial species are human pathogens, with a number of important diseases caused by 
microbial agents, including tuberculosis, meningitis and pneumonia. As a consequence, 
bacterial infections continue to cause a great number of deaths every year in humans. 
Discovering treatments for these diseases and preventing their transmission is of the upmost 
importance for global health.  
At the beginning of the 20th century many bacterial diseases were almost untreatable, 
contributing to low life expectancies and high infant mortality rates2. With the success of 
antibiotics around the mid-century, as well as a general improvement in human health and 
the scientific understanding of the biology of these organisms, the threat from such 
infections was declining in the developed world, though they remained a cause for concern 
in developing countries, notably with diarrheal diseases in children2. The end of the 20th 
century brought global cases of newly emerging microbial infections and the re-emergence 
of many diseases that were thought to have been eradicated in the developed world, such 
as tuberculosis, cholera and infections from Streptococcus aureus3,4. The awareness that 
infectious diseases have been increasing globally and understanding the reasons for the rise 
in the number of cases has led to an emphasis on research to address this growing concern. 
Major threats to human populations also include viral and fungal diseases such as human 
Immunodeficiency virus (HIV) and Aspergillosis, though for the purposes of this report I will 
be concentrating only on the transmission of bacterial pathogens. The main factors that 
influence the present-day transmission of bacterial pathogens are shown in Figure 1.  
A rise in human migration and recreational travel has changed the accessibility of 
susceptible individuals to certain diseases, as the chance increases of transmission of novel 
bacterial infections that would not have been able to pass between previously disparate 
groups. There can also be different genetic and social risk factors associated with disease 
transmission that may be influencing the prevalence of particular infections in a more 
connected and diverse populace5. 
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Figure 1. Factors influencing the emergence and spread of human infectious bacterial 
diseases. Illustration taken from Cohen2. 
 
 
Human population demographics, notably in developed nations, are transforming due to 
societal and behavioural changes. Many of these countries have an aging population as 
people wait longer to have children and as advances in healthcare leads to higher average 
life expectancies. This can increase the number of individuals who are susceptible to 
particular illnesses through weakening immune systems with age or can increase the 
transmission and reactivation of chronic or latent infections as individuals have a greater 
chance of harbouring a disease for a longer time2,6.  
The risk of bacterial disease transmission has also increased through exposure to particular 
infections with changes in human behaviour, such as the increase in people living in close 
proximity in densely populated cities, dietary changes and changes in sexual behaviours. 
The increases in HIV both in men who have sex with men (MSM) and heterosexual 
populations has been linked to high risk sexual behaviours7,8. The rate of these behaviours 
has increased in the developed world from the mid 20th century with the sexual revolution, 
and through greater economic disparity in many less developed regions, such as sub-
Saharan Africa, where there are reports of higher numbers of sexual partners due to 
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increases in the numbers of sex workers and through pronouncement of unsafe social 
behaviours, with women particularly at risk9. There is evidence for co-incidence of HIV and 
many bacterial diseases, for instance tuberculosis, where HIV positive patients are more 
likely to contract the disease with a faster progression of symptoms10. An increase in sexual 
risk behaviours can also directly increase the frequency of sexually-transmitted bacterial 
infections such as gonorrhoea and chlamydia, which can cause severe disease and infertility 
if not adequately treated. 
Dietary changes have also had an impact on bacterial disease transmission, with a 
revolution in eating habits and food preparation habits in many countries. Particularly in the 
developed world, people will eat a wider range of food from non-local sources that may be 
more likely to carry novel pathogens from their point of origin11. There is also a greater 
number of people eating outside of the home, and this has been linked to an increase in the 
transmission of food-borne pathogens12. Additionally, it has long been known that there is an 
association between the risk of contracting zoonotic diseases and agriculture through close 
contact between host and pathogen. The intensification of farming practices to feed a 
growing populace and a shortage of arable land in many areas due to climate change and 
overpopulation has led to large-scale farms of genetically homogenous livestock where 
disease can spread rapidly, with an increased risk of transmission into other taxa. This in 
turn has increased the frequency of zoonosis emergence and re-emergence in both human 
and animal populations13,14.  
In addition to contributing to an increase in zoonotic diseases described above, change to 
the natural environment and climate has contributed to the emergence or increased 
incidence of many other human pathogens15. Warmer climates and the rising of annual 
rainfall and sea temperatures have all been linked to an increase in a number of bacterial 
infections, particularly diarrheal and food-borne diseases16. As an example, Vibrio diseases 
from contaminated water or seafood have been shown to be increasing worldwide in both 
humans and aquatic mammals through rising sea surface temperatures (SST). Rising SST 
causes changes to bacterial growth as well as altering interactions with other organisms that 
can act as a vehicle for transmission to humans, such as oysters17. In addition, climate 
change can lead to increased reproduction in some bacterial pathogens, such as some 
salmonellas, and changes to microflora composition as average temperatures rise18. 
Forecasting the diseases that will emerge in particular regions and the risk posed to human 
populations depends on a multitude of factors including the optimum temperature range and 
adaptability of a pathogen15. Modelling potential changes to bacterial species compositions 
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in the face of a changing natural environment will be vital for the effective management of 
infectious diseases. 
Finally, advances in technology and medical care have been responsible for increasing the 
chance of host survival with both infectious and chronic diseases, though these treatments 
can leave people more vulnerable to further infection. A combination of lengthier stays in 
hospital, extended and varied courses of treatment and potential inadequacies in controlling 
contamination have created environments where pathogens can be transmitted readily 
between susceptible individuals, as well as leading to longer infections that allow time for 
microbial adaptations for increased virulence. There is evidence of severe outbreaks of 
bacterial infections that have undergone mutation to alter their pathogenicity in these 
hospital settings, famously with the evolution of Methicillin-resistant Staphylococcus aureus 
(MRSA)19. Advancement in the treatment of infectious disease has also heralded the dawn 
of the era of widespread antibiotic use and subsequent acquisition of antimicrobial 
resistance in bacteria. This has had one of the most profound effects on pathogen 
transmission and this subject will be discussed in detail in section 1.2. 
Mechanisms of pathogenicity 
Bacterial pathogens have evolved variety of mechanisms to evade host detection or elicit a 
cellular response to increase their virulence (Figure 2). These strategies will damage the 
host directly or help the organism to battle against a host immune response, with many 
bacteria using a combination of these mechanisms to cause disease. Species such as 
Streptococcus pneumoniae can produce large polysaccharide capsules that surround the 
bacteria and provides protection against phagocytosis by preventing the host immune 
response from recognising the pathogen antibodies as a foreign invader20. The cell wall of 
both Gram-negative and Gram-positive bacteria contains components (lipopolysaccharides, 
LPS, and teichoic acid respectively) that are toxic to the host and can cause septic shock 
when released upon cell death and lysis. Bacteria can also secrete four categories of 
exotoxins, (1) two subunit A-B toxins, (2) proteolytic toxins that break down host proteins, (3) 
membrane-disrupting pore forming toxins, and (4) other toxins that can modify the host 
structure or disrupt signalling pathways21,22. Shiga and Shiga-like toxins found in Shigella 
species are examples of the two sub-unit A-B toxins23. 
The ability to avoid host clearance by adhering to surfaces is also an important mechanism 
to increase virulence. A host will employ a number of mechanical strategies to clear 
infections such as coughing, sneezing and increasing blood flow, and some bacteria  
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Figure 2. An illustration showing some common bacterial virulence factors. 
 
produce either fibrous and non-fibrous protein (fimbriae) or polysaccharide adherence 
factors to attach themselves to host surfaces including skin, the mucosal lining of the 
nasopharynx, urogenital area and oral cavity, and deeper tissues such as the gut epithelia21. 
Not only does this adherence enable the pathogen to evade host clearance, but this close 
contact allows the pathogen to invade the host and continue the infectious cycle21. Some 
bacteria, including Streptococcus aureus, will access the host through extracellular invasion 
where enzymes that degrade host tissues are released and allow the pathogen to infect the 
host whilst remaining external to the cell24. Intracellular invasion allows the pathogen to live 
within the host cell and co-opt host resources for survival and growth25. Many bacterial 
species can live both within and outside of cells (facultative intracellular parasites), including 
several Mycobacterium species and Salmonella typhi, whilst others (obligate intracellular 
parasites) survive exclusively in an intracellular lifestyle, such as Chlamydia species and 
Mycobacterium leprae26. 
Understanding the mechanisms by which microbes can evade host detection and cause 
disease is important for developing effective treatments. Evidence has shown that the loss 
and gain of genes has been integral in the evolution of pathogenesis in bacteria27, and with 
the horizontal gene transfer (HGT) of complete genes and large genetic elements, bacterial 
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strains are able to rapidly acquire new virulence plasmids and mechanisms to compete 
against host defences. The ongoing battle between host and pathogen to develop 
antagonistic strategies, along with the ubiquity of HGT for transferring large amounts of 
genetic information readily between microbial populations, has brought about perhaps the 
greatest threat that bacterial pathogens pose to human populations in modern times; the 
acquisition of antibiotic resistance. 
 
1.2 Antibiotic Resistance and Compensatory Mutation 
The use of antibiotics as an effective treatment for bacterial disease has markedly improved 
human health for the past century and rendered some infections that were almost always 
fatal, such as meningitis, treatable in all but the most serious cases28. Unfortunately, the 
misuse and often overuse of these drugs has led to a reduction in their efficacy due to the 
increased frequency of bacteria evolving antibiotic resistance. Coupled with the fact that few 
novel antibiotics are currently in development29, a future where previously treatable 
infections such as typhoid and cholera are major global concerns is a very real possibility. 
Understanding the evolutionary principles underlying the acquisition and spread of 
resistance is one of the most important challenges facing scientists today.  
Numerous studies have shown that antibiotic-resistant bacteria were present at low levels 
before the introduction of antimicrobial drugs, with evidence of naturally occurring resistance 
conferring competitive advantage over antibiotic producing bacteria30. It is clear though that 
the increased selection pressure of widespread antibiotic drug therapy has accelerated the 
spread of resistance genes amongst bacterial populations through adaptive evolution.  
A growing concern in recent times is the emergence of multidrug resistance (MDR) in 
bacteria, where an organism has evolved resistance to more than one antibiotic. Often, in 
the simplest cases of resistance, a bacterial pathogen will acquire resistance to first-line 
antibiotics, typically one that is the primary treatment for a given infection as it has the best 
risk-benefit profile when taking into account the cost of production and safety of the drug. If a 
patient carries an infection that does not respond adequately to these first line drugs, often 
due to resistance in the bacteria, further courses of antibiotics that have a lesser risk-benefit 
profile may be administered, referred to as second- and third-line drugs. Given the adaptive 
nature of the evolution of resistance31, the increased use of these second- and third-line 
drugs in cases where the infectious agent is first-line antibiotic resistant can lead to 
Chapter 1. General introduction 
 13 
sequential resistance to these antibiotics over time, and thus the pathogen will be 
considered MDR. 
Last-line antibiotics are so called as they are often the drugs of last resort and administered 
only when all other therapies have been ineffective or when only one antibiotic treatment 
exists for a particular pathogen. Clinicians are often averse to issuing these treatments due 
to the rate at which bacteria are acquiring resistance; indeed, there are now cases where 
pathogens have evolved resistance to drugs classified as last-line, such as recent evidence 
plasmid-mediated colistin resistance in Escherichia coli from China32. Pharmaceutical 
companies have become reluctant to fund the development of new antibiotics for a number 
of reasons including low profitability, in part owing to numerous cases of bacteria acquiring 
resistance, and this has been a major factor in the paucity of new antibiotics entering the 
market. As a result, there have been no new antibiotics for over 20 years and, more 
worryingly, the last class of antibiotics developed to treat Gram-negative bacteria, 
fluoroquinolones, coming more than 40 years ago33. 
It has become increasingly important for evolutionary biologists and microbiologists to 
research the mechanisms by which antibiotic resistance can be acquired and fixed in 
populations. Resistance genes occur either through spontaneous de novo mutation within 
the chromosomal genome or by HGT from other bacterial species (Figure 3). The most 
common resistance mutations will correspond to alterations in the target site of the antibiotic, 
increases in drug efflux, and gene amplification34. 
The rate at which these genes evolve and spread is influenced by the interaction between 
the selective force exerted by the antibiotic, the rate of supply of these mutations and the 
fitness effects of carrying the resistance gene, both in the presence and absence of the 
antibiotic31. Evidence has shown that number of chromosomal mutations conferring antibiotic 
resistance will have a deleterious effect on fitness, with reduced bacterial growth typically 
observed35 as loci where mutations occur may also be involved in vital metabolic functions36, 
and with these true de novo mutations a population has not passed enough time to evolve 
strategies to reduce these costs. To a lesser extent there can be also be costs associated 
with harbouring plasmid-mediated resistance through the acquisition and maintenance of 
these genetic elements. These costs are often lower though as often an organism can 
already carry adaptations to account for plasmid carriage37 or, as the resistance has evolved 
previously in another host, there may already have been selection acting on this genetic 
element to mitigate associated fitness costs38. Importantly though, plasmids can carry a 
number of simultaneous resistance genes to a variety of antimicrobial 
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Figure 3. Illustration of three mechanisms leading to horizontal gene transfer (HGT) in bacteria. 
(a) Bacterial transformation occurs when DNA is released through cell lysis of the donor cell and taken 
up by the recipient, where it can then be integrated into a chromosome or existing plasmid. (b) Bacterial 
transduction is when a recipient cell acquires genetic information from a donor cell through a 
bacteriophage vector, also called lysogeny. (c) Bacterial conjugation is the sharing of genetic 
information, notably plasmids and transposons, through direct contact or a mating bridge between two 
bacterial cells. Illustration taken from Furuya and Lowry39. 
 
families and it has been shown that there are higher fitness costs associated with the 
acquisition of plasmids harbouring more resistance genes, though not with increasing 
plasmid size, suggesting that resistance genes on these elements carry a greater cost than 
other genetic elements38. 
Theoretical models suggest that, in cases of increasing antibiotic resistance in populations, 
reducing antibiotic use would enable susceptible strains to outcompete the resistant strains 
as the selective advantage of resistance would be diminished and, over time, the deleterious 
resistance gene will be lost from the population, or be reversed back to wild-type40. More 
recently it has been shown though that this theory may be complicated by the evolution of 
compensatory mutations, with evidence suggesting that these mutations are more likely to 
occur than reversions36. These genes, whilst deleterious on their own, can increase the 
fitness of resistant bacteria to that of susceptible strains resulting in stabilization of 
resistance genes in the population. This can also increase the rate of resistance genes 
a	|	Transforma on	occurs	when	naked	DNA	is	released	on	lysis	of	an	organism	and	is	taken	up	by	another	organism.	The	an bio c-resistance	gene	can	be	
integrated	into	the	chromosome	or	plasmid	of	the	recipient	cell.	b	|	In	transduc on,	an bio c-resistance	genes	are	transferred	from	one	bacterium	to	
another	by	means	of	bac eriophag s	and	can	be	integrated	into	the	chromos me	of	the	recipient	cell	(lysogeny).	c	|	Conjuga on	occurs	by	direct	contact	
between	two	bacteria:	plasmids	form	a	ma ng	bridge	across	the	bacteria	and	DNA	is	exchanged,	which	can	result	in	acquisi on	of	an bio c-resistance	genes	
by	the	recipient	cell.	Transposons	are	sequences	of	DNA	that	carry	their	own	recombina on	enzymes	that	allow	for	transposi on	from	one	loca on	to	
another;	transposons	can	also	carry	an bio c-resistance	genes.	
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spreading through the population when antibiotics are present as organisms with both 
resistant and compensatory mutations will be at a greater selective advantage over 
susceptible strains without any of the associated fitness costs41. 
There have been several examples where compensatory mutations have been identified in 
pathogens, such as with streptomycin resistance in a number of organisms including 
Mycobacterium tuberculosis and Escherichia coli41. Mutations in the gene encoding for the 
ribosomal protein S12 (rpsL) can confer resistance to streptomycin but also greatly reduces 
the efficacy of translation. In vitro studies have shown that when rpsL mutants are grown in 
streptomycin-free cultures the resistance genes remain in the population and secondary 
mutations in ribosomal proteins S4, S5 and L19 can occur42. These mutations are postulated 
to compensate the associated costs of resistance, and the relative fitness of mutant 
populations will return to close to that of wild-type strains.  
The mechanisms by which compensatory mutations reduce the fitness costs associated with 
resistance genes can be somewhat varied. Perhaps the most common is the restoration of a 
lost or compromised function by intragenic and intergenic mutations. Intragenic 
compensations within the same gene as the deleterious mutation will restore the read frame 
of the original gene where the resistance mutation is either an insertion or deletion. These 
have been identified in bacteria resistant to various antibiotics including streptomycin, β-
lactams and rifampicin36. Compensatory mutations can also be in the form of intergenic 
mutations in other areas of the genome to the resistance gene such as with streptomycin 
resistance in E. coli described previously42.  
A further compensatory mechanism is to bypass the altered genomic function by replacing it 
with an alternative pathway. This has been demonstrated in isoniazid-resistant M. 
tuberculosis with a mutation in the katG gene43. This mutation will also incur a fitness cost to 
the organism by reducing the activity of the catalase-peroxide enzyme, important in the 
oxidative stress response. Secondary mutations in the ahpC gene will stimulate the 
overproduction of alkyl hydroperoxidase, which will compensate for the reduction in KatG 
catalase. Finally, where the cost to fitness is due to a defect in a transcribed enzyme, 
secondary mutations that promote the overproduction of this enzyme itself can compensate 
for the reduced function at uncompensated levels. In many cases though there is a complex 
interaction involving multiple mechanisms, and there is also evidence of epistatic fitness 
effects with different combinations of resistance and compensatory genes44,45. 
1.3 The Genus Shigella  
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History and classification 
The first description of the pathogen responsible for causing bacillary dysentery was in 1898 
by Kiyoshi Shiga upon the discovery of Bacillus dysenteriae, later renamed Shigella 
dysenteriae, from a severe outbreak in Japan46. In the 1950’s this species was placed into a 
new genus, eponymously named Shigella, compromising four species based upon 
serological and biochemical characteristics; S. dysenteriae, S. boydii, S. flexneri and S. 
sonnei. These species, or serogroups, are further subdivided into serotypes based on the O 
antigen of a lipopolysaccharide outer membrane of the cell wall, serogroup A (S. 
dysenteriae, 12 serotypes), serogroup B (S. flexneri, 6 serotypes), serogroup C (S. boydii, 
16 serotypes), and serogroup D (S. sonnei, 1 serotype)47. S. flexneri and S. sonnei are the 
two most common species isolated globally, whilst S. boydii appears to be restricted to the 
Indian sub-continent47; S. dysenteriae is rarely found today but has historically been 
responsible for severe outbreaks in developing regions48–50. Of these groups, serogroup D, 
S. sonnei, is the most physiologically distinct and can be distinguished by key biochemical 
and genetic characteristics, including lactose fermentation and differences in the utilization 
of a range of substrates51.  
Pathology and virulence 
Shigella species are pathogenic Gram-negative bacteria that can cause bacillary dysentery, 
or shigellosis, in humans. Clinical symptoms of Shigella infections can range from mild 
diarrhoea to very severe, bloody dysentery and can cause death in some cases, mainly in 
young children. They are highly transmissible pathogens, with one study with human 
volunteers finding that some strains of Shigella can cause active infections with exposure to 
as few as 10 bacteria52. Infections are spread through the faecal-oral route though there is 
evidence of environmental and sexual transmission, including high incidences of infection in 
HIV positive patients49. The most severe infections are due to the inflammation of the gut 
epithelia leading to the destruction of the colonic mucosa53. The mechanism of epithelial 
entry is controlled by two gene loci on the pINV invasion plasmid carried by all Shigella 
strains; the type III secretion system (TTSS) mxi-spa locus47 and the ipa locus that encodes 
three genes for actin polymerization at the site of entry and cytoskeleton rearrangement 
modulation53. The disease is treated with a variety of antibiotics that varies depending on the 
serogroup and availability of drugs in the infected population, though many previously 
common therapies such as ampicillin, sulphonamides and fluoroquinolones are now 
becoming less efficient due to the ability of the pathogen to rapidly gain antimicrobial 
resistance both through chromosomal mutations and plasmid acquisition by HGT49. 
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Evolutionary origin 
The evolutionary relationship between Shigella and Escherichia coli and the designation of 
Shigella as a separate taxonomic group is contentious, with Shigella falling as a paraphyletic 
group or as monophyletic subclades within E. coli in a number of studies23,47,51,54,55. Prior to 
the use of genetics to compare organisms, Shigella species were known to be very closely 
related to E. coli based on shared physiological characteristics but were originally assigned 
a distinct classification as they were pathogenic and able to survive in a wide variety of 
environments, whereas E. coli was regarded as a relatively harmless commensal bacteria55. 
With the discovery of pathogenic E. coli in 1944, now known as Enteroinvasive E. coli 
(EIEC), and later characterisation of another five strains of disease causing E. coli, of which 
one includes the common strain O157:H7 that also produces a Shiga-like toxin found in S. 
dysenteriae56, this consensus had to be revised. With advances in molecular genetics 
techniques for discerning associations between species many studies sought to determine 
the true phylogenetic relationship between Shigella and E. coli, and reconstruct the 
evolutionary origin of Shigella serogroups. 
Initially, studies looking at the genetic divergence through DNA re-association between 
strains of Shigella and E. coli found high levels of reciprocal binding between the species 
and advocated that Shigella species be reassigned to the Escherichia genus57,58. More 
sophisticated techniques followed that compared the sequence similarity of chromosomal 
housekeeping genes23,51 and orthologous sequences59 to reconstruct the phylogenetic tree 
of E. coli/Shigella, and found that Shigella serogroups were positioned in clusters within E. 
coli23 or formed a single pathovar of E. coli with EIEC51,60. These results cast doubt on the 
legitimacy of Shigella as a separate species and instead advocated a close evolutionary 
relationship with E. coli and the designation of Shigella strains as specialized E. coli that 
have acquired virulence independently in multiple lineages 55.  
The availability of whole genome sequencing (WGS) allowed for extensions on these 
methods to include all shared (core) genes rather than a subset of housekeeping genes. 
Again, when reconstructing the evolutionary relationship between Shigella species and a 
range of pathogenic and commensal E. coli with these core alignments, Shigella were 
placed within E. coli, with S. dysenteriae in particular clustering within the pathogenic E. 
coli61,62 (Figure 4A). Furthering the application of whole genome data, work by Sims and 
Kim55 sought to resolve the E. coli/Shigella relationship by comparing strains using an 
alignment-free feature frequency profile (FFP) to consider all genomic features not limited to 
core genes. They found conflicting results when comparing the trees obtained through all 
possible features and filtered for only core, shared features. In the all feature phylogeny 
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Shigella formed a single monophyletic clade whereas when only core features were used 
there were two related subclades, with S. dysenteriae again being placed in a separate 
cluster outside of the other Shigella species55. In contrast to the indication of a multiple origin 
hypothesis for Shigella evolution, a study by Zuo et al63 using a WGS gene protein product 
approach (CVTree) to compare the genomes of Shigella and E. coli found evidence for a 
single Shigella clade, suggesting that rather than Shigella falling within the E. coli species, it 
could be considered a highly related group within the Escherichia genus that has evolved 
from a single ancestor (Figure 4B).  
The history of the major invasion plasmid in Shigella, pINV, a pivotal step in the evolution of 
pathogenesis, is also not fully resolved, with studies suggesting both a single acquisition in 
an E. coli ancestor prior to speciation and multiple convergent events across Shigella 
lineages. Work by Lan et al64 supports the multiple origin hypothesis of Shigella serogroups 
and the repeated acquisition of the virulence plasmid, including in the EIEC, of which there 
are in fact two forms, pINV A and pINV B, that contain largely homologous genes but with 
distinct differences. Escobar-Paramo et al54 did not detect these different forms of the 
plasmid though when comparing three virulence genes (ipaB, ipaD and icsA) in strains of 
Shigella and EIEC, supporting the model of a single origin of pINV in these groups from a 
single E. coli strain. A different hypothesis was put forward by Yang et al65 who suggested 
that the virulence plasmid was obtained at multiple times across Shigella/EIEC lineages from 
a diverse ancestral pool of plasmids rather than just the two forms postulated by Lan et a64. 
Clearly the exact relationship between Shigella and E. coli and the evolution of virulence in 
Shigella is still uncertain, with evidence both for the single event radiation of Shigella/EIEC 
from a single ancestor as well as a multiple origin hypothesis with subsequent convergent 
evolution of virulence among Shigella/EIEC lineages. Similarly, the designation of Shigella 
as a distinct species from E. coli, particularly from EIEC, is contentious and many studies 
now support the classification of Shigella as a separate genus solely for historical reasons; 
though with advances in molecular genetic techniques and the availability of more whole 
genome sequences this matter may yet be resolved.
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              (A) 
(B) 
Figure 4. Conflicting phylogenetic trees reconstructing the evolutionary relationship between 
Shigella species and E. coli. (A) Adapted from Zhou et al62, a maximum likelihood tree of 19 E. coli 
and 7 Shigella strains built from 2,034 core genes, showing Shigella species to form two clades within 
E. coli.     (B) From Zuo et al63, CVTree approach to construct trees based on whole genome, alignment 
free comparison of protein sequences of Shigella species and E. coli. K = length of peptide chains. This 
approach finds Shigella and E. coli to be separate, sister clades.
Shigella sonnei, 
S. boydii and S. 
flexneri clade 
S. dysenteriae 
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1.4 Shigella in Vietnam 
Shigellosis is a major public health concern in much of Asia, with the number of annual 
infections estimated at 125 million in this region alone, resulting in 14,000 deaths66. 
Historically, the most commonly isolated species from infections in Asia, including Vietnam, 
was S. flexneri, with this species the predominant agent of shigellosis in many developing 
countries. The less genetically diverse S. sonnei, whilst also found globally, was primarily 
isolated in more developed countries, for example Israel and USA, where it accounts for 
over 70% of all clinical presentations of bacillary dysentary67. There is evidence that the 
dominant serotype of S. flexneri can fluctuate over time and geography due to a changing 
temporal environments68. More recently though, there have been documented accounts of 
S. sonnei infections increasing in relative proportion in many countries where S. flexneri was 
previously the most common agent, such as Vietnam67, China69 and Brazil70, with a 
simultaneous decrease in clinical presentations of S. flexneri. The reason for this shift in 
dominance is unclear, though there is a clear correlation with rapid development in these 
regions, coupled with improving sanitation and antimicrobial use, discussed further in section 
1.5. Identifying the most commonly occurring serotype of Shigella is particularly important for 
the effective treatment and management of the spread of the disease as there can be 
variation in antibiotic resistance profiles and virulence between serotypes. 
Vinh et al67 first described the shifting pattern of species dominance in southern Vietnam 
after work by Seidlein et al71 suggested that this pattern was being observed in other 
countries of Asia. They found that over a 14-year period there was a marked shift in the 
dominant species (from S. flexneri to S. sonnei) found in clinical isolates from patients with 
dysentery, along with a change in resistance profiles of the strains that were circulating 
(Figure 5). Such was the dramatic increase in the number of S. sonnei infections in this 
study period that the proportion rose from 29% to 78% of total shigellosis presentations. Also 
within this period, there was an overall increase in the number of strains showing resistance 
to a range of commonly used antimicrobials, with over 80% resistant to three or more of the 
seven tested antibiotics towards the end of the study compared to 63% in the first period of 
study. Resistance to nalidixic acid increased significantly in this time period and though 
rarely recommended for use as an antimicrobial directly, resistance to this compound is the 
same mechanism conferring resistance to fluoroquinolones, which are often one of the first 
line treatments of shigellosis. Interestingly, the severity of the disease was also greater in 
the last period of the study, with an increased number of patients reporting watery diarrhoea, 
pains and convulsion. These are symptoms associated with severe infections and, 
conversely, are more likely brought on from S. flexneri or S. dysenteriae than S. sonnei.  
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Figure 5. The relative proportion of Shigella species in Vietnam between 1995 and 2008. 
Data were collected on childhood Infections over three periods in southern Vietnam. Shigella 
sonnei are coloured red, Shigella flexneri grey and other Shigella species in black. 
 
 
Following this report detailing the shifting pattern of shigellosis infections in Vietnam, a study 
by Holt et al72 then looked to reconstruct the phylogenetic and epidemiological history of S. 
sonnei in the region to determine key events that may have led to the expansion of the 
organism. Using whole genome sequencing of clinical strains of S. sonnei over 15 years, the 
team were able to reconstruct a likely most common recent ancestor (MCRA) within the 
1980’s that had been introduced to Ho Chi Minh City from Europe. The subsequent spread 
of the pathogen through the region is proposed to have likely been due to clonal expansion 
through four selective sweeps that have coincided with decreased genetic variation within 
the population but with an increase in virulence and antibiotic resistance. This suggests that 
these bottlenecks in genetic diversity were driven by increased selective pressure on the 
population and the resultant fixation of key mutations from more successful S. sonnei clonal 
sub-populations. The data collected in this study also indicate that by 2010 the proportion of 
shigellosis infections caused by S. sonnei is up to 99% in southern Vietnam.  
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The majority of the strains sequenced in this study were found to be resistant to more than 
one antimicrobial and it has been hypothesized that the MCRA was already multidrug 
resistant (MDR) at its introduction. As with the Vinh et al67 report, resistance to 
fluoroquinolones was very high within the population along with resistance to a number of 
other antimicrobials, either through chromosomal mutations or plasmid acquisition. In 
particular, plasmid acquisition appears to be an important driver in the establishment of S. 
sonnei in the region, with the horizontal acquisition of the plasmid-borne colicin system from 
other enteric bacteria facilitating the inflammation within the human gut in S. sonnei 
infections and allowing the organisms to out-compete other microbiota. The fixation of this 
plasmid also coincided with the first genetic bottleneck in the population. In addition, 
resistance to third-generation cephalosporins (plasmid-mediated) and fluoroquinolones 
(chromosomal) was fixed in subsequent bottlenecks within a short time73, demonstrating the 
rate at which bacterial populations can acquire multiple resistance mechanisms that may 
confer a competitive advantage and accelerate the spread of a pathogen. 
 
1.5 The Shifting Dominance of Shigella Species in Developing Countries 
The pattern of species replacement observed in Vietnam and many developing countries 
suggests there may be important genetic and epidemiological distinctions between S. sonnei 
and S. flexneri that influence each species’ survival and transmission in different 
environments. As stated previously, S. sonnei has historically been the most common cause 
of shigellosis in more developed regions, such as the USA74–76, Europe77–79 and Israeli 
cities80, and the increase in incidence in lower-income countries has corresponded with an 
improvement in water quality and sanitation, as well as antimicrobial use. This would 
suggest that S. sonnei strains emerging in these regions have a competitive advantage over 
S. flexneri. It may be that the genetic and phenotypic features of the strains that are entering 
these regions are more optimally suited to surviving in these changing conditions, such as 
already MDR S. sonnei emerging in Vietnam, or that S. sonnei are characteristically better at 
adapting to any change in the environment, such as a greater ability to take up antibiotic 
resistance genes from other bacteria. 
Indeed, it appears from the previous work conducted by in Vietnam, an increase in antibiotic 
resistance is a key feature in Shigella populations in this region, and in particular in the 
emerging clonal strains of S. sonnei. A paper by Holt et al describes the emergence of S. 
sonnei infections globally, with all contemporary infections caused by a few clonal lineages 
that have expanded globally81. Of these, lineage III is the most abundant in Vietnam and the 
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rest of Asia69,81,82, and these strains harbour plasmid-borne resistance to a wide range of 
antibiotics including streptomycin, tetracycline and sulphonamides72. In addition, localized 
adaptation since the clonal S. sonnei expansion within various locations in Vietnam brought 
about distinct CTX-M plasmids encoding extended-spectrum beta-lactamases (ESBLs) that 
confer resistance to a range of antibiotics including penicillin and cephalosporins, 
demonstrating ongoing recombination in S. sonnei in the region. This evidence that S. 
sonnei are able to readily acquire new resistance genes through HGT from other enteric and 
environmental bacteria suggests this species is able to acquire advantageous adaptive traits 
in response to selective pressures. Furthermore, there is evidence that increased levels of 
gut inflammation can facilitate conjugation and transfer of plasmid elements between 
pathogenic and commensal bacteria within the host. S. flexneri has been shown to inhibit the 
inflammatory response during infection in order to avoid the host detection and this may 
reduce the efficacy of HGT in S. flexneri, though inflammatory differences between S. sonnei 
and S. flexneri infections have not yet been investigated. 
The frequency of mutations conferring resistance in Shigella species also appears to vary 
between species, both in de novo point mutations and the integration of genomic elements 
and plasmids. Work characterizing the resistance profiles of MDR S. sonnei and S. flexneri 
in Chilean children found some differences between the distribution of specific genetic 
determinants of both trimethoprim and ampicillin resistance in each species83, with S. sonnei 
more frequently possessing the blaTEM gene for ampicillin resistance on a conjugative 
plasmid while the bloOXA chromosomal gene was the most prevalent in S. flexneri. This 
chromosomal ampicillin-resistance gene was also found in Japanese S. flexneri isolates, as 
well as a varying range of integron gene cassettes between species that conferred 
resistance to an assortment of antibiotics82. In addition, there have been further studies that 
have found differences in the range of resistance profiles and genetic determinants between 
local Shigella populations in a number of countries68,71,84 (Figure 6). These disparities may 
reflect differences in the evolutionary history of the populations, though there is evidence 
that S. sonnei appears to readily acquire a wide range of resistance to antimicrobials 
through plasmid conjugation that are not found in S. flexneri. At the current time there have 
been no studies to determine whether these plasmids can be transferred between Shigella 
species. Differences in antibiotic resistance profiles and the ability to acquire new genes 
when subject to selective pressures may present a competitive advantage for S. sonnei and 
contribute to the global spread of this species due to the widespread use of antimicrobials. 
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Figure 6. Antibiotic resistance in S. sonnei and S. flexneri infections isolated in Kolkata, India, 
1995-2000. Graph taken from Dutta et al68. 
 
 
The increasing use of antibiotics and accompanying resistance is likely to be major feature 
influencing the emergence of S. sonnei as the primary cause of shigellosis in industrializing 
regions, though there are additional factors that have been postulated as contributing to the 
spread of S. sonnei and the replacement of S. flexneri in developing countries. Firstly, there 
may be a natural host immunization to S. sonnei through contact with another member of the 
Enterobacteriaece, Plesiomonas shigelloides, with both species sharing a major surface O-
antigen that is required for the penetration of human gut epithelial cells85. This primarily 
aquatic organism is commonly found in areas with poor water quality and sanitation and can 
also cause bouts of diarrhea86. It is thought that in areas where P. shigelloides is present, in 
particular the serotype O17, exposure to this organism will impart passive immunity to S. 
sonnei. As countries move towards industrialization with an improvement in sanitation, P. 
shigelloides incidence will decrease87 along with the local host immunity to both species 
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carrying the specific O antigen and S. sonnei infections will rise88, reflecting the global trend 
observed in developing countries. 
Recent work looking at the role of the common amoeba Acanthamoeba as an environmental 
host of pathogenic bacteria has proposed another mechanism by which the proportion of S. 
sonnei infections has increased in developing countries. Acanthamoeba are very commonly 
found in water supplies globally, both in industrialized and lower developed countries89, and 
have been shown to have the ability to engulf a range of pathogenic bacteria, including 
Shigella species66,90, protecting the encased organisms from environmental stresses and 
changes91. This mechanism is thought to be analogous to the survival of enteric bacteria in 
macrophages within the mammalian host92, with these amoebae additionally acting as a 
potential site of gene transfer among the encapsulated microbiota93. Two papers by Saeed 
et al present evidence that S. sonnei, S. flexneri and S. dysenteriae were actively integrated 
into Acanthamoeba castellanii cysts and survived for up to three weeks94,95. The growth of 
each species was compared, with notable differences between S. sonnei and S. flexneri 
when taken up by A. castellanii. S. sonnei was readily maintained by the amoeba in 
temperatures up to 30oC and growth rates were even higher than in the free living bacterial 
population95. On the other hand, at higher temperatures S. flexneri reduces the growth and 
survival of A. castellanii and was less likely to be integrated by the amoeba95, possibly due 
to the activation of genes involved in cellular invasion by S. flexneri that causes cell death96. 
This suggests that Acanthamoeba act as an effective source of protection for S. sonnei, 
though not S. flexneri, by encapsulating the bacteria and shielding it from antimicrobials and 
chemical agents97. This may be an important factor in the survival of S. sonnei populations in 
developed countries where antibiotic use and sanitation is widespread, and contributed to 
the emergence of S. sonnei in industrializing regions as these practices are increasing.  
In addition, as these countries have moved towards improvements in sanitation and the 
treatment of drinking water there will be an increased use of commercial and industrial 
disinfectants98. A greater tolerance to these chemicals, as well as key differences in the 
persistence of particular populations or species in these changing environments, may also 
be contributing to the spread of S. sonnei, though this phenomenon has not been previously 
investigated.  
Evidence of explicit differences between S. sonnei and S. flexneri has been found in two 
recent studies, highlighting potential environmental and evolutionary differences between 
species. Work detailing the global evolutionary history of S. flexneri found that this species 
can be classified into seven phylogenetic groups, with distinct geographic and virulence 
patterns that are not influenced by antimicrobial resistance acquisition99. This is in contrast 
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to S. sonnei, which shows a highly clonal evolutionary history influenced by acquisition of 
resistance mutations81. Further differences between S. sonnei and S. flexneri has been 
found by looking at the retention and function of the major virulence plasmid, pINV, in these 
species. The pINV plasmid was found to be less stable in S. sonnei than S. flexneri due to 
the absence of a toxin-antitoxin system, GmvAT, which contributes to the retention of this 
plasmid in S. flexneri, particularly at environmental temperatures. The loss of major 
phenotypic traits, such as virulence and antibiotic resistance, encoded on this plasmid 
suggests that S. sonnei is less adapted to survival outside of a host and will be likely to be 
transmitted solely by person-to-person contact. 
In conclusion, it is clear that an improvement in water quality and an increase in antibiotic 
use have coincided with the replacement of S. flexneri with S. sonnei in developing 
countries. There is evidence for key genetic and epidemiological differences between 
Shigella species that may have contributed to this observed pattern, with S. sonnei 
potentially acquiring a wider range of antimicrobial resistance through the ability to integrate 
genetic elements. In addition, passive immunity to S. sonnei may be decreasing in 
developing countries as P. shigelloides populations declining, and survival of S. sonnei may 
be increased through environmental protection by encapsulation by A. castellanii. The 
combination of these factors appears to be important in increasing the global incidence of S. 
sonnei infections, though there needs to be more work done on genetic and ecological 
differences between populations of each species to further understand the underlying 
reasons for this shift. 
1.6 Thesis Outline 
This thesis comprises projects using both whole genome sequence (WGS) data and in vitro 
experimental approaches to study bacterial genomics and ecology. The main focus of this 
work is to identify ecological and genetic differences that may have contributed to the recent 
trend of the replacement of Shigella flexneri with Shigella sonnei as the primary etiological 
agent of bacillary dysentery in Vietnam, a pattern that has been observed in many 
developing countries.  
To begin, chapter two describes experimental work examining the survival and growth of S. 
sonnei and S. flexneri in cultures containing varying concentrations of calcium hypochlorite 
and sodium dodecyl sulphate (SDS), two components of chemical disinfectants. The 
rationale behind these experiments is to determine whether there is any difference in 
resistance of each species to these chemicals, which may contribute to differential 
persistence and potential to spread infection in the environment. The increased use of 
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cleaning products containing these chemicals in developing countries98 suggests that these 
biocides could be an important selective pressure on bacterial pathogen populations, and 
any differences in resistance may play an important role in their spread. 
Following on from the work presented in chapter three is a further experimental section 
focusing on the role of efflux pumps in calcium hypochlorite resistance in Shigella, as well as 
investigating any links to antibiotic resistance phenotypes. There has been support for the 
importance of efflux pumps in both resistance to antibiotics and chemical antimicrobials, 
including chlorine100, and thus it can be postulated that strains resistant to antibiotics may 
also show a greater resistance to disinfectants.  
In chapter four I present work aiming to identify and characterize key chromosomal antibiotic 
resistance mutations in clinical isolates of S. sonnei and S. flexneri from Vietnam. 
Additionally, SNPs that are present in resistant isolates only and those that have evolved 
independently (homoplasy) will be identified to look for evidence of compensatory mutations. 
As described in section 1.2, previous studies have shown that the evolution of compensatory 
mutations can be an important factor in the selection and spread of antibiotic resistance 
genes. Strains harbouring these resistance genes may have a selective advantage over 
susceptible bacteria in an environment that contains the specific antibiotic, though these 
gene modifications can lower the relative fitness, and survival, when the antibiotic is absent. 
Evidence suggests compensatory mutations can restore fitness levels of resistant bacteria to 
around that of wild type susceptible strains in antibiotic-free environments, which will 
increase their selective advantage and potential for propagation. Experimental work from 
colleagues at the Oxford University Clinical Research Unit (OUCRU) in Ho Chi Minh City, 
Vietnam has suggested that compensatory mechanisms may be present in Vietnamese 
populations of S. sonnei, particularly with those carrying fluoroquinolone resistance through 
gyrA mutations, and thus I will attempt to identify any putative candidates for compensatory 
mutations and determine any differences between the Shigella species. 
Chapter five takes the clinical isolates of Vietnamese S. sonnei and S. flexneri used in 
chapter four and with de novo assembly of the raw sequence data builds a representative 
pan genome for each species. This describes the full genomic content of the Shigella 
species in this study, including genes that are shared by all isolates and those found in 
varying proportions within the population. This method will include local genome content 
variation that would not be captured through the more commonly used assembly method of 
aligning raw sequence reads against a reference strain, which may be relatively distant 
genetically. Of particular interest are genes that are present at high frequencies in one 
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species but not another that may determine key phenotypic differences between the species 
and impact the spread of the pathogens, including ecology and virulence. 
Finally, chapter six is a general discussion of the previous four original data chapters and 
how the findings of these projects go towards answering the key aims of the thesis. 
In addition, there is a short technical chapter within the supplementary materials describing 
the inception and purpose of the R function, vcfProcess, for transforming and filtering variant 
caller output files, such as with GATK or Samtools, in the VCF format, specifically when 
working on genomes of haploid organisms. The challenge faced when using these variant-
calling software on haploid data are two-fold; 1) the software has been predominately 
designed for diploid data and 2) the output format (.vcf) is not a compatible format to be 
used as input files for many downstream phylogenetic or population genetic analysis 
programs. This tool will allow the user to identify and remove heterozygous calls and filter 
called variant sites based on quality and position in the genome before producing output files 
in formats that can be readily used with downstream analysis programs. 
The work presented here examines ecological, antibiotic resistance and genetic differences 
between S. sonnei and S. flexneri that may influence the recent observed pattern of species 
replacement in developing countries. The aim is to determine how these factors contribute to 
the increased spread of a particular species or strain, and if the changing environment in 
these regions may have contributed to the shift in the primary cause of shigellosis infections.  
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Chapter 2 
Chlorine and detergent resistance Shigella sonnei and 
Shigella flexneri 
2.1 Abstract 
The disinfection of microbial pathogens with industrial and commercial cleaning 
products is often the first line of defence against the spread of disease. Shigella is an 
important human pathogen that is spread through faecal-oral transmission, with 
evidence of outbreaks from environmental sources. Recently in developing countries, 
there has been a shift in the dominant species of Shigella isolated in patients, from S. 
flexneri to S. sonnei. Differential sensitivity to disinfectants between these species 
has been proposed to contribute to this species replacement.   
In this chapter, I present in vitro experimental work examining resistance Vietnamese 
S. sonnei and S. flexneri to two common components of antibacterial products, 
calcium hypochlorite (producing free chlorine) and the detergent, sodium dodecyl 
sulphate (SDS), through individual inactivation and pairwise competition assays. 
Results indicated that Vietnamese S. sonnei was able to survive in higher 
concentrations of calcium hypochlorite than Vietnamese S. flexneri, and these 
differences were likely due to local adaptation of the microbial populations as these 
differences were not observed in European isolates of each species. Competitive 
growth assays between the Vietnamese strains also revealed evidence of an 
antagonistic action on the growth of S. flexneri by S. sonnei in the presence of 
calcium hypochlorite. SDS appeared to have little to no direct antimicrobial effect on 
bacterial growth.  
The results of these experiments suggest that Vietnamese S. sonnei are able to 
survive higher concentrations of chlorine-based disinfection than Vietnamese S. 
flexneri. With the increasing sanitation and use of cleaning products in developing 
countries, these differences in sensitivity to disinfectants may be contributing to the 
replacement of S. flexneri with S. sonnei in these regions.             
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2.2 Introduction 
Shigella is a genus of Gram-negative pathogenic bacteria causing bacillary dysentery 
(shigellosis) in humans, reportedly accounting for over 165 million infections that 
result in around 1 million deaths each year1. Recently there has been evidence of a 
shift in the primary etiological agent of shigellosis in many developing countries, with 
infections caused by Shigella sonnei rapidly replacing S. flexneri in economically 
developing countries such as Malaysia, China and Vietnam over the last 30 years2–4. 
Understanding the genetic and phenotypic factors that contribute to the spread of 
these pathogens is vital for preventing infection and implementing effective 
management strategies. 
While Shigella is predominately spread through faecal-oral transmission5, there is 
evidence that the bacteria can survive for a significant time in contaminated water 
and food6–9, as well as being deposited on fomites10. There have been examples of 
Shigella outbreaks that have been traced back to external sources, including 
contaminated tomatoes11, hand washing facilities in a microbiology laboratory12, and 
through recreational swimming in a lake13. Most research on infectious diseases is 
focused on treatment, such as the efficacy of antibiotics However, understanding the 
epidemiology of transmission of Shigella may inform effective interventions to 
prevent the spread of the pathogen before infection.  
Through survival on a host and external deposition in the environment, the bacteria 
will be in contact with disinfectants frequently used as antimicrobial agents. Chemical 
chlorination is a commonly used treatment for disinfecting reclaimed wastewater and 
drinking water supplies, as well as swimming pools14,15. At high concentrations 
chlorine will almost certainly kill most microbes, though due to the potential toxic 
nature of the compounds to humans they are often used in lower concentrations 
when treating drinking water and food. At these levels there is the potential for the 
bacteria to survive and develop resistance to these compounds16. Owing to a number 
of documented cases of bacterial disease transmission from sources that would likely 
have been treated with chlorine compounds, studies have attempted to quantify 
bacterial survival and growth in the presence of chlorine. There is evidence that 
chlorine disinfectant resistance is affected by attachment to surfaces, biofilm 
formation, nutrient availability and type of chlorine compound17–19. There is also 
variation in chlorine resistance between bacterial species, with Gram-negative 
microbes showing a greater sensitivity to chlorine treatments than Gram-positive 
species16. The availability of organic matter can also effect the antimicrobial efficacy 
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of chlorine as the levels of free chlorine in a solution will reduce with oxidation of 
these organic compounds16,20. 
Although there is an abundant use of chlorine compounds in disinfectant products, 
their antimicrobial activity is not yet fully understood, with few recent studies 
attempting to describe potential mechanisms. Chlorine is added to water supplies for 
disinfectant purposes in the form of soluble compounds (such as calcium 
hypochlorite, Ca(ClO)2) or gaseous chlorine (ClO2). In an aqueous solution there are 
two forms of chlorine, referred to collectively as free chlorine, un-ionised 
hypochlorous acid (HClO) and hypochlorite ions (ClO-)21. Calcium hypochlorite is the 
most commonly used compound for chlorination of water as it is very stable and 
easily dissolved, and there is evidence of antimicrobial properties when in 
solution22,23. The reaction of calcium hypochlorite and water is: 
(1) Ca(ClO)2 + 2H2O —> 2HClO + Ca2++ + 2OH-  
calcium hypochlorite + water —> hypochlorous acid + calcium + hydroxide 
It has been proposed that the mechanism by which chlorine kills microorganisms is 
through interactions with the cellular envelope, namely the disruption of the cell wall 
and damage to components of the cellular membrane16,24. The particular role of the 
cell wall in chlorine inactivation is not yet fully resolved, though it has been suggested 
that due to the strong oxidative properties of chlorine, when bound to the bacteria, 
free chlorine will target specific components of the cell wall and compromise the 
integrity25. Subsequent interaction with the cell membrane will cause changes to the 
permeability and the release of important constituents from within the cell in both 
gram-negative and gram-positive bacteria, though there is less reported membrane 
damage to Gram-positive species, likely due to chlorine having a greater effect on 
the outer membrane, present only in Gram-negative bacteria16,26.  This change in 
permeability can alter transport pathways across the membrane and affect metabolic 
processes within the cell21, such as ATP production, which can ultimately lead to cell 
death27. It has also been shown that chlorine compounds such, as hypochlorites, can 
directly react with nucleotides28,29. 
Sodium dodecyl sulphate (SDS), an anionic surfactant, is one of the most commonly 
used agents in a variety of household and industrial detergents, as well as personal 
hygiene products30. It is primarily used due to its foaming ability as well as its 
biodegradability by a number of soil and aquatic bacteria31,32. Direct antimicrobial 
activity by SDS is uncertain, with the surfactant often combined with a toxic or 
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antibiotic compound in cleaning products such as a cationic detergent. However, 
there is evidence that SDS can have some direct effect on biofilm formation33 and, 
importantly, induce shock response proteins in enteric pathogens34,35. As the human 
intestinal tract is high in bile salts, which can act as an antimicrobial much the same 
as chemical detergents36, resistance to SDS can also effect the sensitivity to these 
compounds through similar response mechanisms35. The ubiquity of SDS use in 
cleaning products and the evidence for accumulation in the environment30 suggests 
that the ability to persist and grow in high concentrations of SDS can influence the 
survival and transmission of pathogens . 
Though there has been previous work looking at the action of chlorine and 
detergents on Shigella and related enteric bacteria, to date there have been no 
studies looking specifically at differences in chlorine and SDS tolerance between 
species of Shigella, and particularly at differences in sub-lethal doses of these 
chemical disinfectants. Differential persistence and growth in the presence of these 
common cleaning agents may influence the effectiveness of these antimicrobial 
treatments, and thus if a species is able to survive for longer or against greater 
concentrations in the environment, the chance of opportunistic infection by that 
pathogen might increase. Through improvements in water quality and sanitation in 
many developing countries37, there is an increased use of chemical antimicrobials 
and these can exert selective pressure on pathogenic bacterial populations, with 
evidence of disinfectant use influencing both species survival19,38, virulence17 and 
antibiotic resistance acquisition14.  
The primary objective of the experimental work presented here is to examine the 
resistance of Shigella sonnei and Shigella flexneri to chlorine (in the form of calcium 
hypochlorite) and SDS by measuring bacterial survival against varying 
concentrations of these disinfectants. In particular, the experiments aim to reveal 
whether the tested biocides will have a significantly different efficacy against 
Vietnamese populations of these pathogens, which has been hypothesised to 
contribute to the observed species replacement in this region previously described39. 
Three clinical isolates of S. sonnei and S. flexneri from Vietnamese collections were 
tested for resistance to disinfectants through calcium hypochlorite and SDS 
inactivation assays. Additionally, these experiments were conducted with three 
historical strains of both S. flexneri and S. sonnei from Europe and three strains of 
European enteropathogenic E. coli (EPEC) to determine whether any potential 
differential survival between Vietnamese strains of S. sonnei and S. flexneri was due 
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to local, recent adaptation in these Asian populations, with the European Shigella 
and EPEC strains representing proxies for the likely ancestral phenotypes. Finally, 
the three Vietnamese strains of S. sonnei and S. flexneri were grown together in all-
against-all co-cultures with solutions containing varying sub-lethal concentrations of 
calcium hypochlorite and SDS to determine the competitive fitness of each species 
under these conditions. 
 
2.3 Materials and methods 
Bacterial strains  
Clinical strains of S. sonnei, S. flexneri and EPEC E. coli taken from laboratory 
collections were used in this study. Vietnamese Shigella strains (S. sonnei DE1208, 
MS004 and EG430, and S. flexneri DE0350, MS0052 and EG419) were obtained 
from the Oxford University Clinical Research Unit (OUCRU) in Ho Chi Minh City, 
Vietnam. European samples (S. sonnei strains 25410, 88-83, 43-74; S. flexneri 
strains 9-63, 12-66, 262-78; and enteropathogenic E. coli (EPEC) strains 12823, 
13866 and 27592) were acquired from the group of Professor Francois-Xavier Weill 
in the Institute Pasteur, Paris. Further details of each strain is given in Table 1. 
Vietnamese isolates were selected as reprehensive strains within the region, with all 
S. sonnei samples part of the global lineage III and S. flexneri belonging to the 
serotype 2a type. European Shigella and EPEC strains were chosen where WGS 
data and phenotypic information was also available for further genomic analysis. 
Inocula preparation 
Stock cultures of bacteria strains were maintained in frozen liquid LB broth 
supplemented with 10% (v/v) glycerol at -80oC. To prepare inocula cultures for trials, 
a small amount of the frozen bacterial stock was transferred via sterile loop to solid 
LB agar plates and incubated at 37oC overnight. A single colony was then picked and 
transferred to 20ml of M9 minimum media (Sigma-Aldrich, Dorset UK) supplemented 
with 12.5mg/l nicotinic acid and 20mg/l tryptophan40 and grown overnight in a 
shaking incubator (37oC, 250 rpm). Cultures were then diluted with M9 media to 
around 0.5 OD600nm (around 6-7 x 106 cells/ml) and grown for a further two hours to 
achieve log phase growth of bacteria. Initial cell concentrations were recorded 
through bacterial population counts and cultures used to inoculate test media. 
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Species Strain Abbreviation Origin Other strain 
information 
Available antibiotic 
resistance phenotype  
Shigella 
flexneri 12-66 S.f12-66 Europe Serotype 2a Pan-susceptible 
Shigella 
flexneri 262-78 S.f262-78 Europe Serotype 1a Pan-susceptible 
Shigella 
flexneri 9-63 S.f9-63 Europe Serotype 2a 
Streptomycin, 
Spectinomycin, 
Sulfonamides 
Shigella 
flexneri MS0052 S.f-MS Vietnam Serotype 2a Pan-susceptible 
Shigella 
flexneri DE0350 S.f-DE Vietnam Serotype 2a Fluoroquinolones 
Shigella 
flexneri EG419 S.f-EG Vietnam Serotype 2a Fluoroquinolones 
Shigella 
sonnei 54210 S.s54210 Europe Lineage III Pan-susceptible 
Shigella 
sonnei 88-83 S.s88-83 Europe Lineage III Pan-susceptible 
Shigella 
sonnei 43-74 S.s43-74 Europe Lineage I Pan-susceptible 
Shigella 
sonnei MS004 S.sMS Vietnam Lineage III Pan-susceptible 
Shigella 
sonnei DE1208 S.sDE Vietnam Lineage III Pan-susceptible 
Shigella 
sonnei EG0430 S. sEG Vietnam Lineage III 
Fluoroquinolones, 
Cephalosporins 
Escherichia 
coli 12823 E.c12 Europe EPEC 
Amoxicillin, Sulfonamides, 
Chloramphenicol, 
Tetracycline 
Escherichia 
coli 13866 E.c13 Europe EPEC Amoxicillin, Sulfonamides 
Escherichia 
coli 27592 E.c27 Europe EPEC Amoxicillin, Sulfonamides 
 
Table 1.  Strains used in this study. Antibiotic susceptibility phenotypes were determined 
by available metadata sent with the strains from MIC experiments.  
 
 
Chapter 2. Chlorine and detergent resistance in Shigella 
 
 42 
Bacterial population counts  
Initial cell concentration and bacterial survival within each tested condition was 
determined through plate counts of colony forming units (CFU/ml) in serial dilutions 
from 100 to 10-5 at specified time points. 10μl triplicates for each dilution were plated 
onto solid LB agar plates (supplemented with 0.125% Congo red (Sigma-Aldrich, 
Dorset UK) for virulence plasmid retention41) and incubated for 24-48 hours at 37oC. 
The resulting colonies were counted by eye at appropriate dilutions, with the mean of 
the triplicate readings multiplied to the correct power to estimate the average colony 
count in each tested condition. 
Test media preparation 
Bacterial survival was tested in the presence of varying concentrations of calcium 
hypochlorite and sodium dodecyl sulphate (SDS). Tests with calcium hypochlorite 
were conducted by adding a measured weight of pure calcium hypochlorite 
(Ca(ClO)2) (Sigma-Aldrich, Dorset UK) to a set volume of liquid M9 minimum media 
to make a total of 8ml of solution before inoculation with the bacteria. The pH of the 
M9 media had been measured and adjusted to pH 6 by adding small amounts of 
dilute hydrochloric acid (HCl) as the calcium hypochlorite will raise the pH of the 
solution when added. Calcium hypochlorite was chosen as it has higher available 
chlorine content when in solution and is the most commonly used compound for 
water chlorination42. SDS (>99% reagent, Sigma-Aldrich, Dorset UK) was added as 
an aqueous solution in appropriate volumes and solutions made up to the final pre-
inocula test volume of 8ml with M9 minimum media at a pH of 7. All liquid reagents 
and solutions were maintained at a temperature of 37oC.  
Inactivation experiments 
Resistance to calcium hypochlorite and SDS was investigated by carrying out 
inactivation assays on all Vietnamese and European Shigella and European E. coli 
strains. All strains were tested in triplicate. For each separate assay, 8ml of test 
media was prepared in 15ml centrifuge tubes as described above to concentrations 
of 0, 2.5, 5, 10 and 20 mg/l of calcium hypochlorite and 0, 15, 22.5 and 30 % SDS in 
M9 minimum media. Each test media was then inoculated with 2ml of the bacterial 
strain inoculum to achieve an initial total cell count of ~106-7 CFU/ml. Each tube was 
incubated whilst shaking vigorously (37oC, 250rpm) for 5, 15 and 30 minutes. 
Calcium hypochlorite solutions were neutralised by adding 100l of 0.1M sodium 
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thiosulphate (Na2S2O3) (Sigma-Aldrich, Dorset UK) to each chlorinated solution to 
bind to and neutralise the available free chlorine. SDS solutions were neutralised by 
washing, with three cycles of centrifugation and resuspension in PBS buffer solution. 
At each recorded time point the experiment tubes were transferred from incubation to 
the centrifuge and spun on a medium speed (5000 RPM or 1677 x g) for 3 mins. The 
supernatant was discarded and the pellet re-suspended in 10ml of phosphate-
buffered saline (PBS; 1 mM KH2PO4, 0.27 mM KCl, 13.7 mM NaCl, pH 7.4; Sigma-
Aldrich, Dorset UK) at room temperature. The centrifugation and PBS washing stage 
was repeated and the final pellet re-suspended in 10 ml M9 minimum media before 
plating for bacterial population counts. 
In vitro competition assays 
Competitive growth experiments were conducted with each of the three Vietnamese 
strains of S. sonnei against each Vietnamese strain of S. flexneri in the presence of 
sub-lethal concentrations of calcium hypochlorite (0, 1.5, 2.5, and 5 mg/l Ca(OCl)2) 
and SDS detergent (0, 15, and 22.5 % SDS). As with the inactivation experiments, 
8ml of each test media was prepared in 15ml centrifuge tubes with 1ml of S. sonnei 
and 1ml of S. flexneri inocula added to give a total concentration of ~106-7 CFU/ml of 
bacteria. The media were then placed in a shaking incubator (37oC, 250rpm) for 24 
hours before neutralization of the free chlorine or SDS using the same methods 
described in the inactivation experiments. Survival counts were estimated in CFU/ml 
with the bacterial population count technique. To differentiate between colonies of 
either species, colonies were grown on LB plates supplemented with 20mg/ml X-gal 
(Sigma-Aldrich, Dorset UK) and 0.1M IPTG (Bayer AG, Wuppertal, Germany) to 
perform blue/white screening. S. sonnei strains possess the ability to ferment lactose 
(slowly) through an active lacZ operon whereas S. flexneri do not possess a copy of 
the lacZ gene43. Plate counts were conducted after 48 hours to allow for the slow 
fermentation of lactose by S. sonnei. 
Statistical analysis  
Average CFU/ml counts obtained from experiments on individual strains were 
combined for each species and location group to give the mean survival counts. 
These values were then used to calculate the survival fraction of the starting 
population count to plot graphs using Microsoft Excel of the fraction of surviving 
bacteria after disinfection given a particular concentration or contact time, and to 
model inactivation kinetics and conduct further statistical analyses in R44. Where 
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there was no observable bacterial growth on plates, the population count was set to 
the highest undetectable value (N = 10 CFU/ml) for statistical modelling.  
Inactivation kinetics  
Chlorine disinfection of bacteria is often considered to follow a pseudo-first-order 
kinetic model of inactivation, Chick’s Law, which describes the survival of 
microorganisms after treatment as a function of contact time45.  
𝑙𝑛
𝑁 
𝑁𝑜
=  −𝑘𝑡 
N = Number of bacteria at time t 
No = Initial number of bacteria  
t = Contact time  
k = Rate constant of disinfection 
 
Chick’s law of inactivation was later expanded by H.E. Watson to relate k to the 
concentration of disinfectant (C) at a dilution n (almost always 1). This model has the 
assumptions that there is a constant rate of chlorination, temperature and pH over 
time, and that the mode of disinfection is single-hit and single-site. This is known as 
the Chick-Watson model46. 
𝑙𝑛
𝑁
𝑁𝑜
=  −𝑘𝐶𝑛𝑡 
N = Number of bacteria at time t 
No = Initial number of bacteria  
t = Contact time  
Cn = Concentration of disinfection at dilution n 
k = Chick-Watson coefficient of specific lethality (rate constant of disinfection) 
 
CT values (Cnt) are often used as a comparison of the chlorine dosage required for 
inactivation of a given order of magnitude (i.e. log-2, log-3, ...) of microorganisms 
(CT99%, CT99.9%, …) as a product of the contact time and concentration.  In these 
experiments, a constant rate of calcium hypochlorite concentration was assumed for 
up to 30 minutes of contact time for simplification of the analysis, with Cn remaining 
constant for each calcium hypochlorite concentration tested. It has been reported  
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Figure 1. Survival of Shigella species and EPEC against concentration of calcium 
hypochlorite. The log survival fraction (N/No) is shown at each recorded time point (A) 5 
minutes, (B) 15 minutes, and (C) 30 minutes. Error bars denote the standard error at each 
recorded point. 
 
that, although the amount of free chlorine in as solution will reduce in this time, it will 
do so linearly47, thus, whilst there may be an overestimation of the absolute CT 
values in this study, comparison of these values between species groups is valid. 
 
2.4 Results 
Inactivation by calcium hypochlorite 
To investigate the effect of chlorine on the survival of Vietnamese and European S. 
sonnei and S. flexneri, and European enteropathogenic E. coli (EPEC), inactivation 
experiments were carried out by adding live, log-phase cultures of each species to 
calcium hypochlorite solutions ranging in concentrations from 2.5 to 20 mg/l, with 
bacterial cell colony counts taken at 5, 15 and 30 minutes. Experiments were 
stopped at 30 minutes as, at this time, the levels of free chlorine in the system from 
the added calcium hypochlorite has been shown not to reduce significantly. The log  
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Figure 2. Survival of Shigella species and EPEC against contact time in minutes in 
calcium hypochlorite. The log survival fraction (N/No) is shown for each tested concentration 
of calcium hypochlorite (A) 2.5 mg/l, (B) 5 mg/l, (C) 10 mg/l, and (D) 20 mg/l. Error bars 
denote the standard error at each recorded point. 
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survival fraction of each species group as a product of calcium hypochlorite 
concentration and of time is shown in Figure 1 and Figure 2 respectively.   
For all tested species groups an increase in calcium hypochlorite concentration 
decreased the survival fraction of bacteria, and in most cases there was a reduction 
in the number of surviving bacteria as time increased, particularly at higher 
concentrations of disinfectant (Figure 1). At lower concentrations (2.5 – 5 mg/l) 
though, there was only a decrease in bacterial survival (up to 99% killed) recorded in 
European S. sonnei and S. flexneri (Figure 2B) within the contact time of the 
experiments. EPEC strains were able to tolerate higher calcium hypochlorite 
concentrations (10 mg/l) with Vietnamese S. sonnei exhibiting the highest resistance 
of the Shigella groups (Figure 2C). This was also true for the highest concentration 
of calcium hypochlorite (20 mg/l) (Figure 2D), though the populations of all species 
groups were reduced by over 99.9% after 30 minutes of contact time. At these higher 
concentrations of calcium hypochlorite, European S. sonnei and Vietnamese S. 
flexneri were the most sensitive to disinfection, with near or completely undetectable 
CFU counts. For all groups there was greater within group variance of the survival 
fraction across all time points at higher concentrations (10-20mg/l), This could be due 
to some variation in strain tolerance within each species group at these 
concentrations, along with stochasticity in bacterial response to chlorine disinfection. 
It is not likely due to innate fitness differences between strains as this level of 
variation is not seen at low concentrations of chlorine (Figure 2A), or in controls 
(Supplementary materials). 
Chlorine inactivation kinetics  
To compare the sensitivity of each species group to chlorination, the Chick-Watson 
disinfection model was employed to determine the rate of disinfection and the log-3 
inactivation CT99.9% value. In these experiments the rate of disinfection follows a first-
order linear kinetic rate of decay (Figure 3), and thus the rate constant k can be 
found by finding the linear least-squares regression of the natural log of the survival 
fraction (ln N/No) plotted against the CT value (Cnt), where a is the y intercept and b 
is the slope constant: 
𝑙𝑛
𝑁
𝑁𝑜
=  −𝑘𝐶𝑛𝑡 
𝑘 = 𝑦 = 𝑎 +  𝑏𝑥 
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This can then be used to find the CT value for the 99.9% (3-log) inactivation of each 
species group, where the 99.9% reduction in bacterial colony counts from the initial 
number will be the natural log of the survival fraction 0.001: 
 
𝑙𝑛
𝑁
𝑁𝑜
= 𝑙𝑛(0.001) 
𝑙𝑛 (0.001) = −𝑘𝐶𝑛𝑡99.9% 
 
Given k = ln (0.001) this can be rearranged to find x (Cnt): 
 
 
𝐶𝑛𝑡99.9% =
(𝑙𝑛 (0.001) −  𝑎)
𝑏
  
 
Plots of the natural log survival fraction, ln(N/N0), against C
nt for each species group 
with the modelled rate constant are illustrated in Figures 3A-E. All calcium 
hypochlorite concentration data were combined for each species group in the 
analysis as the use of Cnt will explain the survival fraction as a product of the dosage 
and so allows for differences in experimental concentrations or contact time. The 
equation for the rate constant of disinfection k and CT99.9% values for each species 
group are given in Table 2. Linear regression models for each species group 
indicated a goodness of fit, with adjusted R2 ranging from 50.65 – 73.45% and all p 
values ≤0.05.  
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(E)
 
Figure 3. Plots showing the natural log survival fraction (ln (N/N0)) against CT value 
(mg min L -1) for (A) European S. flexneri, (B) Vietnamese S. flexneri, (C) European S. 
sonnei, (D) Vietnamese S. sonnei, and (E) EPEC. All plots show the fitted least squares 
regression line, with the regression equations given in Table 2. 
 
The CT99.9% values identified from this analysis indicate the dosage of calcium 
hypochlorite required to reduce bacterial populations of each species group by log-3 
(Table 2), with a, the y intercept set at 0. Shigella sonnei from Vietnam appears the 
most resistant to chlorination with this compound, requiring a dose of 383.98 mg min 
L -1 to inactivate the bacteria by 99.9%. For example, with solutions of 20mg/l of 
calcium hypochlorite, 383.98/20 = 19.20 minutes of contact time would be required 
on average to reduce bacterial populations of S. sonnei by log-3. In contrast, 
Vietnamese strains of S. flexneri had the highest sensitivity to calcium hypochlorite 
with a CT99.9% value of 219.22 mg min L-1. In a solution containing 20 mg/l of calcium 
hypochlorite, 99.9% inactivation would be achieved after 219.22/20 = 10.96 minutes.  
Of all Shigella strains tested, Vietnamese S. sonnei exhibited the greatest resistance 
to calcium hypochlorite disinfection. There did not appear to be any species level 
difference in sensitivity between S. sonnei and S. flexneri when combining strains 
from Europe and Vietnam (Welch’s t-test; t = -0.3865, p-value = 0.7376). This 
suggests that any difference in resistance to chlorination is attributable to population 
or strain adaptation and is not a characteristic of the species. 
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Species group 
 
Rate constant of disinfection 
(k) with standard error 
CT99.9% value 
(mg min L -1) 
Regression 
model p value 
S. flexneri (Europe) - 0.02056 (S.E. 0.01) 335.9803151 p = 0.04 
S. flexneri (Asia) - 0.03151 (S.E. 0.013) 219.2242234 p = 0.003 
S. sonnei (Europe) - 0.02852 (S.E. 0.008) 242.2074081 p = 0.01 
S. sonnei (Asia) - 0.01799 (S.E. 0.014) 383.977503 p = 1x10-4 
EPEC - 0.01876 (S.E. 0.006) 368.2172324 p = 0.015 
 
Table 2. The Chick-Watson rate constant of disinfection and CT99.9% values of each 
species group. 
 
Chlorine sensitivity of Vietnamese Shigella 
Modelling the calcium hypochlorite inactivation kinetics of each species group clearly 
indicates that there is a difference in the average resistance between Vietnamese S. 
sonnei and S. flexneri. To determine whether this is due to extreme sensitivity or 
resistance of a single strain influencing the species average, the inactivation kinetic 
model was applied to all Vietnamese Shigella strains individually. The rate constant 
of disinfection and CT99.9% value of each strain in response to calcium hypochlorite 
inactivation is shown in Table 3. There was a significant difference between 
CT99.9%values of S. sonnei and S. flexneri (Welch’s t test; t = -8.9752, df = 2.373, p-
value = 0.0069) with all CT99.9% values higher in S. sonnei isolates, indicating 
Vietnamese S. sonnei strains had a markedly higher chlorination resistance. 
Inactivation by sodium dodecyl sulphate (SDS) 
Sensitivity to sodium dodecyl sulphate (SDS) was tested through inactivation assays 
in solutions of 15, 22.5, and 30 % SDS, with population counts recorded at 0, 5, 15 
and 30 minutes. The upper limit of SDS (30%) was chosen as this is the micelle 
concentration the aqueous reagent49 and allows for adequate mixing of the test 
media with the bacterial culture inoculate. 
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Species and strain 
 
Rate constant of disinfection 
(k) with standard error 
CT99.9% value 
(mg min L -1) 
Regression 
model p 
value 
S. flexneri (MS0052) – 0.02998 (S.E. 0.009) 230.435176 p = 0.006 
S. flexneri (DE0350) – 0.02875 (S.E. 0.007) 240.253035 p = 0.027
 
S. flexneri (EG419) – 0.03108 (S.E. 0.007) 222.271551 p = 0.025 
S. sonnei (MS004) – 0.01936 (S.E. 0.006) 356.805541 p = 0.009 
S. sonnei (DE1208) – 0.01676 (S.E. 0.008) 412.231024 p = 0.05 
S. sonnei (EG0430) – 0.01721 (S.E. 0.005) 401.31036 p = 0.01 
 
Table 3. The Chick-Watson rate constant of disinfection and CT99.9% values of 
Vietnamese Shigella strains. 
  
The log survival fraction of all species groups in varying concentrations of SDS is 
illustrated in Figure 4. The response of all species groups to SDS is characterised by 
a rapid decrease in the log population size after 5 mins of disinfection followed by a 
plateau or slight increase until the termination of the assay at 30 mins. The 
magnitude of the initial population decrease is determined by the concentration of 
SDS in solution, with 15% SDS yielding a change in survival fraction of ~ 1x10-1 
(±0.5x101) and ~1x10-2 (±1x102) in 30% SDS. This pattern of bacterial survival can 
be explained by two alternative theories. Firstly, it may be that SDS is acting as a 
weak disinfectant on the bacteria, where only the susceptible organisms are killed 
before the populations stabilise. Alternatively, there may have been the initial 
population decrease due to a lowering of the carrying capacity of the nutrient media 
in solutions as the concentration of SDS increases. In this situation SDS would not 
be having a direct antibacterial effect and the maximum load of the bacteria will be 
defined by the available nutrients. If the reduction in bacterial survival is indeed due 
to a weak antimicrobial action of the detergent, the maximum concentration of SDS 
in cleaning products is 30%50, and thus the levels needed to achieve effective killing 
of Shigella and E. coli groups in isolation was higher than is in commercial use.
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(C) 
 
Figure 4. Survival of Shigella species and EPEC against contact time in minutes in SDS 
solutions. The log survival fraction (N/No) is shown for each tested concentration of SDS, (A) 
15%, (B) 22.5%, and (C) 30%. Error bars denote the standard error at each recorded point. 
 
Competitive fitness of Vietnamese S. sonnei and S. flexneri 
The relative competitive fitness of Vietnamese Shigella flexneri and S. sonnei strains 
in disinfectant solutions was investigated by conducting pairwise competition assays 
with all isolates of S. sonnei against all S. flexneri in varying sub-lethal 
concentrations of calcium hypochlorite (0, 1.25, 2.5, and 5 mg/l) for 24 hours. The 
initial and final population counts were taken in these experiments rather than a 
series of time points as the disinfectant concentration will decline within this 
timeframe. The rationale behind these experiments is to determine the extent that S. 
sonnei and S. flexneri will respond to disinfectant injury when in direct competition. 
As reported previously, SDS solutions at these concentrations did not have any 
significant effect on the survival of Vietnamese Shigella isolates in inactivation 
experiments over longer contact times, and thus these competition assays were not 
investigated further (data is available in Supplementary materials). 
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The relative fitness of two strains in competition can be expressed as the difference 
between the Malthusian (exponential) growth of each strain at time point, t. The 
Malthusian growth coefficient of each population, mpop, can be expressed as the 
natural log of the colony count of each population at time t over the initial population 
count: 
 
𝑚𝑝𝑜𝑝 = 𝑙𝑛 (
𝑁𝑡
𝑁𝑜
) 
 
In growing populations, the fitness coefficient, w, will be the ratio between the 
Malthusian growth of each population (ma and mb) 51: 
 
𝑤 = 𝑚𝑎/ 𝑚𝑏  
 
When population growth is equal, the fitness coefficient, w, will give a dimensionless 
value of 1. Any deviation will suggest a difference in growth rates, i.e. w = 0.5 would 
indicate that the growth rate of mb is 50% faster than ma, and w = 1.5 the reverse. 
Competitive fitness in calcium hypochlorite 
In the population count data from these experiments, though, I observed some 
treatments where one or more of the populations in direct competition were in decline 
and thus the fitness coefficient, w, would not be suitable for these data. To account 
for instances where one or both populations may be in decline, the selection rate, r, 
was instead applied, which is the difference between the Malthusian growth 
coefficients of each population at time t 52: 
 
𝑟 =
(𝑚𝑎 − 𝑚𝑏)
𝑡
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 Selection coefficient (r) 
Concentration 
of calcium 
hypochlorite 0 mg/l 1.25 mg/l 2.5 mg/l 5 mg/l 
S. sonnei MS / 
S. flexneri MS 1.322299397 1.873962467 7.177348345 13.92256376 
S. sonnei MS / 
S. flexneri DE 1.313153982 4.286032651 11.48572123 10.59724976 
S. sonnei MS / 
S. flexneri EG -0.064143801 0.591695536 13.55299336 20.38761824 
S. sonnei DE / 
S. flexneri MS 1.58532322 3.874333341 9.560730874 24.4261022 
S. sonnei DE / 
S. flexneri DE -0.712741406 5.578419462 9.788150591 33.21928095 
S. sonnei DE / 
S. flexneri EG 0.877691624 1.084635482 1.228615623 16.69518288 
S. sonnei EG / 
S. flexneri MS -0.23317226 0.428843299 6.760084964 23.22419103 
S. sonnei EG / 
S. flexneri DE 0.204951973 2.56130666 15.03511972 33.90598993 
S. sonnei EG / 
S. flexneri EG 0.867848033 -0.799887462 2.162574524 11.36861478 
 
 
Figure 5. The selection coefficients (r) of competition assays from all-against-all 
experiments of Vietnamese S. sonnei and S. flexneri at varying concentrations of 
calcium hypochlorite. 
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When the both populations are in growth or decline equally, r = 0. A positive r value 
will indicate that the Malthusian growth rate, ma, is greater than mb, measured in t 
-1. 
For example, when r = 5 and t = 24 hours, the Malthusian rate ma will have increased 
by 5 natural logs, or e5, more than mb in 24 hours. 
Excluding a single pairwise assay (S. sonnei EG0430 vs S. flexneri EG419; 1.25mg/l 
calcium hypochlorite), all Vietnamese S. sonnei had markedly higher Malthusian 
growth rates than S. flexneri when in competition at all concentrations of calcium 
hypochlorite (Figure 5). The difference in growth rates were most striking at higher 
concentrations (>2.5mg/l), where all S. sonnei strains had a significantly higher 
growth rate than S. flexneri, with some occurrences of declining population sizes to 
undetectable levels (<10 CFU/ml) in the latter species (Supplementary materials). 
At concentrations of 5 mg/l, the difference in growth rates was the highest, with S. 
sonnei having an advantage of between ~ 10.5 – 34 natural log growth in 24 hours 
over S. flexneri strains.  
It is also interesting to note that a concentration of 5 mg/l calcium hypochlorite in 
solution was within a resistance range for both Vietnamese S. sonnei and S. flexneri 
after 30 minutes of contact time (Figure 2B). In these competition experiments, 
though, the populations of S. flexneri declined on average in seven of the nine 
pairwise assays, with bacterial populations undetectable in S. flexneri DE0350 in two 
assays (Supplementary materials). S. sonnei populations increased in all 
treatments, which suggests that S. sonnei was having an antagonistic effect on S. 
flexneri growth in the presence of high concentrations of calcium hypochlorite.  
 
2.5 Discussion 
The replacement of Shigella flexneri as the primary cause of bacillary dysentery by 
S. sonnei in many developing countries2–4 has impacted the management and 
treatment of the disease in these regions. Understanding the underlying reasons for 
the successful emergence of S. sonnei is important to develop strategies to stop the 
spread of infection. One proposed hypothesis is that the increasing use of cleaning 
products and improving sanitation may be contributing to a shift in the dominant 
species of Shigella in these regions39,52,  and this may be driven, in part, by the 
species’ ability to withstand disinfection of environmental sources of transmission. To 
my knowledge, this study is the first to directly compare chlorine and detergent 
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disinfection in Shigella species using clinical isolates from populations undergoing 
this species replacement.  
Though it is difficult to accurately predict the absolute efficacy of disinfectants on 
these bacterial pathogens due to the limited number of samples tested in this study, 
the results of the work presented here suggest that there are significant differences 
in resistance to calcium hypochlorite disinfection between Vietnamese S. sonnei and 
S. flexneri isolates in the tested strains. This has been demonstrated through both 
inactivation assays and pairwise competitive growth experiments. There was also 
validation of the antibacterial potential of chlorine disinfection on Shigella and 
enteropathogenic E. coli, with all populations reduced by 99.9% after 30 mins contact 
time in solutions of 20 mg/l calcium hypochlorite.  
The evidence for any direct antimicrobial action by SDS on both Shigella and EPEC 
was less clear. The response of all populations to SDS treatment was characterised 
by a rapid decrease in the surviving fraction of populations followed by a plateau, 
with the magnitude of the decrease in population size from the initial count 
dependent on the percentage concentration of SDS in solution (Figure 4). The 
reaction of populations in this way is described as tolerance to a particular 
compound, where an organism is able to survive transient exposure to high 
concentrations of a treatment 53. Alternatively, this period of microbial death after 
inoculation could be attributed to the lower nutrient load available for viable growth in 
high SDS concentration solutions, lowering the carrying capacity for supporting 
bacterial growth. This may explain the stabilizing of the population size after initial 
contact with the detergent. Previously there has only been limited evidence for SDS 
to act as an antibacterial, which was linked to biofilm formation in very high 
concentrations of the detergent33. The results of this study do not lend conclusive 
support for direct biocidal action by SDS on Shigella species or EPEC.  
All strains of Shigella and EPEC decreased in population size when tested against 
calcium hypochlorite above 2.5mg/l in solution. When considering the difference 
between Vietnamese populations in sensitivity to this treatment, the levels of calcium 
hypochlorite required for 99.9% inactivation of bacterial populations as a product of 
concentration and contact time (the CT99.9% value), Vietnamese S. sonnei were able 
to withstand significantly higher concentrations of disinfectant (356.80 – 412.23 mg 
min L -1) than S. flexneri (222.27 – 240.25 mg min L -1) (Table 3). These figures 
should not be taken as the absolute quantity of calcium hypochlorite required to 
inactivate the organisms to these levels as it has been shown that using a higher 
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concentration with a lower contact time will have a greater biocidal impact14. For a 
comparison of the average resistance between strains though, this measure is 
effective for discerning variation.  
When co-cultured in direct competition with solutions containing calcium 
hypochlorite, Vietnamese S. sonnei strains possessed a greater selective advantage 
over S. flexneri, with the difference in the population survival fraction increasing with 
disinfectant concentration. There was also evidence that S. sonnei can 
antagonistically affect the survival of S. flexneri by increasing its susceptibility to 
calcium hypochlorite, which causes a significant reduction in some S. flexneri 
bacteria if in solutions that were within the tolerable range for the strains when grown 
separately (Figure 5). There are different mechanisms by which a species can inhibit 
the growth of another when in mixed cultures. There may be competition for 
metabolic substrates, a change to the environment through toxins released by one 
species, or a build-up of metabolic waste54,55. It may also be that calcium hypochlorite 
at these lower concentrations is causing sub-lethal injury to S. flexneri bacteria rather 
than killing the cells but populations are unable to respond in mixed cultures where 
the stress on microorganisms will be greater. It would be interesting to further 
investigate the extent to which Shigella species interact to influence the sensitivity to 
various disinfectants. 
Previously, S. sonnei has been reported to be readily taken up and maintained by the 
common environmental amoeba, Acanthamoeba, where the encapsulated 
microorganism will be protected from extreme environmental conditions56,57. S. 
flexneri, though, will inhibit the growth of Acanthamoeba through the induction of 
apoptosis in the amoeba cell58,59. It has been hypothesised that S. sonnei may have 
an ability to withstand greater levels of chlorination than S. flexneri due to the 
protection offered from this phagocytic process and this may be contributing to the 
replacement of S. flexneri with S. sonnei in the developing world39. The experimental 
results here, however, indicate that there are significant differences in chlorine 
resistance between Shigella strains isolated from a region undergoing species 
replacement, even in the absence of Acanthamoeba. This suggests that there are 
key intrinsic differences between the species that influences their sensitivity to 
chlorine disinfection. 
Inactivation experiments with European isolates of S. sonnei and S. flexneri 
suggested that the differences in chlorine sensitivity identified in Vietnamese isolates 
does not extend to the species-level. Combined analysis of all Shigella strains found 
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no meaningful difference in resistance between S. sonnei and S. flexneri (t = -0.3865, 
p = 0.7376), and there was also no distinction between the CT99.9% values when 
considering only the European Shigella isolates (t = 2.4872, p = 0.1243). In addition, 
the EPEC strains tested showed high levels of resistance to chlorination, falling 
between that of the least sensitive group, Vietnamese S. sonnei, and European S. 
flexneri. S. flexneri is known to share many chromosomal genes with pathogenic and 
non-pathogenic E. coli60, whereas S. sonnei has been proposed as one the most 
divergent serotypes61,62. This suggests that S. sonnei in Vietnam may have 
undergone some local adaptation that has increased their resistance to chlorine in 
response to the selective pressure of disinfection. These phenotypic alterations may 
be associated with the process by which chlorine will disrupt and kill bacterial cells.  
While Shigella strains used in this study were selected to represent the major 
lineages and serotypes found in Vietnam, a limitation with this work is that the full 
range of global genetic variation found in each species in either the Vietnamese or 
European samples. It may be, therefore, suggested that the results presented here 
are more reflective of lineage specific characteristics rather than species or 
geographic variation. European strains were selected predominately for the 
availability of sequencing data, again not representing the full evolutionary range of 
Shigella strains present globally. There was some heterogeneity of samples in each 
species, with one S. sonnei lineage 1 and one S. flexneri serotype 1a sample in the 
European strains, though we did not find any differences in chlorine resistance 
between these strains compared to other European strains of the same species 
(Supplementary data).  
The proposed mechanism for the chlorine inactivation of microorganism populations 
is by attacking the cellular envelope of the cell and compromising the integrity of cell 
wall16,24,25. This will lead to interactions with components of the cell membrane that 
can affect the permeability of the cell across channels in the membrane. Two recent 
studies have proposed that efflux pumps may have an impact on chlorine resistance 
in bacteria, with the effect of the disinfectant also linked to antibiotic resistance63,64. 
The role of efflux pumps in resistance to antibiotics and bacterial fitness has been 
studied in detail, with the extrusion of drugs and toxic substances found to be an 
significant mechanism for maintaining homeostasis in viable cells65–68. Evaluating the 
importance of membrane pumps in chlorine resistance has motivated the research 
presented in Chapter 3 of this thesis.  
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In conclusion, inactivation and competition assays investigating the sensitivity of 
clinical isolates of Shigella sonnei and Shigella flexneri in Vietnam to calcium 
hypochlorite and SDS detergent disinfection found significant differences between 
the species’ ability to survive chlorination, though SDS did not have a direct 
antimicrobial effect. Comparing survival of these strains against European S. sonnei 
and S. flexneri strains, as well as European enteropathogenic E. coli, indicated that 
this variation in chlorine sensitivity is likely due to local differences in the populations 
and is not characteristic of each species. Though the number of isolates tested in this 
study is limited, the results presented here suggest further work to determine the 
impact of disinfectant resistance and the mechanisms by which bacteria become 
resistant can be important for managing microbial diseases. 
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Chapter 3 
The role of efflux pumps in chlorine resistance in Shigella 
sonnei and Shigella flexneri 
3.1 Abstract 
Transport proteins situated in the cellular envelope of bacteria, termed efflux pumps, have 
been shown to play an important role in removing toxic substances from within the cell. A 
number of these pumps can extrude a variety of substrates, including antibiotics, detergents 
and metals. Importantly, it has been shown that overexpression of the tripartite efflux system 
AcrAB-TolC, found in E. coli and Shigella, is involved in conferring fluoroquinolone 
resistance. Furthermore, efflux pumps have been proposed to have a direct association with 
resistance to chlorine disinfection in Gram-negative bacteria. 
The aim of this study is to determine whether these generalised efflux pumps will be involved 
in the response to chlorine disinfection in Shigella species, and in particular, whether any 
differences in resistance to chlorine can be explained by variation in genes encoding and 
regulating these pumps. In addition, resistance to fluoroquinolones is characterised in the 
Shigella strains, with the purpose of finding links between resistance to these antimicrobials 
and different levels of chlorine resistance. 
The results of this chapter show that, overall, there is significant decrease in bacterial 
survival in the presence of chlorine when efflux pumps are inhibited by carbonyl cyanide 3-
chlorophenylhydrazone (CCCP). Unfortunately, due to the small number of fluoroquinolone 
resistant strains in this study I was unable to robustly discern any differences in chlorine 
resistance between drug resistant and susceptible isolates. Finally, though there was 
variation detected in genes associated with efflux pumps, no candidates for increased 
resistance could be confidently identified without further work on differential expression or 
functional changes. 
These findings lend support to previous studies finding that efflux pumps play an important 
role in the response to chlorination in bacteria, particularly at high concentrations, with this 
work the first to describe this process in Shigella. Though I was unable to detect any key 
mutational differences that correlated with higher chlorine resistance, further work looking at 
expression levels in pump encoding genes could help to better understand the bacterial 
response to chlorination, and the development of disinfectant resistance.
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3.2 Introduction 
Both Gram–positive and Gram–negative bacteria contain transport proteins within the 
cellular membrane, known as efflux pumps, that are involved in the removal of substrates, 
including toxic substances, out of the cell1,2. Pumps can be substrate-specific, such as the 
tetracycline-specific efflux pump encoded by the tetA gene3, though many will be able to 
move a range of different compounds, including multiple classes of antibiotics4–6 and other 
potentially harmful materials, such as heavy metals7. In addition, there is evidence that these 
proteins can be important for other physiological processes in pathogens including 
increasing virulence by moving host-defence molecules out from within the cell8. 
Bacterial efflux pumps are divided into five main categories that can be composed of either a 
single channel or made up of multiple sections that can span both the inner and outer 
membrane depending on the taxon9. The five families of efflux pumps are; resistance-
nodulation-division (RND), major facilitator superfamily (MFS), ATP-binding cassette 
superfamily (ABC), small multidrug resistance (SMR), and multidrug and toxic compound 
extrusion (MATE). The most common mechanism by which these proteins move compounds 
out of cells is by utilising a proton-motive force generated by an electron transport chain 
across the membrane10. 
The RND family of pumps in particular have been shown to be important in antibiotic 
resistance in Gram-negative bacteria, for example, the AcrAB-TolC pump in Escherichia coli 
that is able to transport a variety of dissimilar compounds and, as such, is known as a 
multidrug efflux pump. The transporter protein will lower the intracellular concentration of 
antibiotic through active expulsion of the toxin, thus increasing the minimum inhibitory 
concentration (MIC) of the drug required to kill the organism. In prokaryotes, genes encoding 
these proteins can be found on both the chromosomal genome and on plasmids9, though 
those controlled by genes on the chromosome will be of most importance as these will relate 
to innate mechanisms in bacteria, including taxa with low levels of recombination. An over-
expression in pump genes has been shown to be associated with resistance to 
antimicrobials1,5,6,11, as well as an increase in the movement of other substances across the 
membrane, such as dyes and detergents12.  
In chapter 2 of this thesis I discussed the differential survival rates discovered in Vietnamese 
Shigella sonnei and S. flexneri strains when subjected to chlorine disinfection and how this 
may relate to the successful emergence of S. sonnei strains in developing regions. It has 
been proposed that the same efflux pumps that are involved in resistance to antimicrobials 
can also affect bacterial sensitivity to disinfectants, including chlorine13,14. This non-specificity 
of drug efflux systems suggests the presence of greater resistance to one selective pressure 
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can automatically confer a level of cross-resistance against other toxic compounds1, and 
thus it can be theorised that antibiotic resistant bacteria will also have a reduced sensitivity 
to chlorine. In addition, exposure to chlorine has been proposed to increase susceptibility to 
some antibiotics13–15, suggesting an association in the response to these toxic substances. 
To investigate whether efflux pumps are involved in the bacterial response to chlorination 
and potential resistance in Shigella, I have conducted in vitro inactivation assays on six 
strains of each Shigella species (three Vietnamese and three of European origin), both in the 
presence and absence of a general efflux pump inhibitor, carbonyl cyanide 3-
chlorophenylhydrazone (CCCP). This compound will inactivate transport pumps by 
disrupting the gradient potential and has been shown to increase the susceptibility of 
resistant bacteria to antibiotics16,17.  
In addition, whole genome sequence data is available for the Shigella isolates used in this 
study and thus it is possible to look for key variants that are likely to confer antibiotic 
resistance to fluoroquinolones. There has been extensive research on the role of efflux 
pumps in resistance to quinolones in Gram-negative bacteria, particularly overexpression in 
genes of the AcrAB-TolC pump located in E. coli and Shigella cellular envelopes11,18–20, and 
thus I will also be looking for significant correlations between drug and chlorine resistance. 
Finally, mutations in pump genes will be identified through the analysis of variation in the 
chromosomal genomes of the tested strains within a set of genes previously described as 
being associated with efflux pumps. The aim is to determine whether variation in these 
genes will be associated with differential susceptibility to disinfectants, as well as any links to 
fluoroquinolone resistance.  
 
3.3 Materials and methods 
Bacterial isolates, sample preparation and population counts 
Details of the Shigella isolates used in this study are available with accompanying metadata 
in chapter 2 (Chapter 2, Table 1). Live bacterial cultures were stored and prepared for 
inoculation, and population counts estimated in CFU/ml, using the methods stated in chapter 
2. 
Inactivation assays 
The role of efflux pumps in Shigella chlorine disinfection was examined by comparing the 
survival of bacterial populations in varying concentrations of calcium hypochlorite in the 
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Gene 
name Description 
S. sonnei 
start position 
S. sonnei 
end position 
S. flexneri 
start position 
S. flexneri 
end position 
acrA AcrAB-TolC pump 
gene21 
477813 476620 420957 422150 
acrB AcrAB-TolC pump 
gene21 
476597 473448 417785 420934 
acrD 
AcrD 
aminoglycosides 
resistance pump22 
2689662 2692775 2575652 2578765 
tolC AcrAB-TolC pump 
gene21 
3331624 3333105 3171250 3172731 
emrB 
EmrB efflux protein1 
2973840 2975378 2786513 2788051 
emrD 
EmrD efflux protein1 
3796932 3798122 3897623 3898675 
ydhE Transporter 
membrane protein19 
1568520 1567147 1723184 1723866 
marA 
AcrAB expression18 
1678452 1678069 1595773 1596156 
SoxS 
AcrAB expression18 
4501826 4501503 4287490 4287813 
acrR Regulation of acrAB 
genes23 
477955 478602 422292 422939 
marR egulation of acrAB 
genes23 
1678906 1678472 1596553 1596176 
cmr Chloramphenicol 
resistance pump24 
- - 829096 830322 
 
Table 1. Genes associated with membrane efflux pumps in Shigella species. Genes considered 
to have an association with the expression and regulation of efflux pumps were identified either 
through a manual search of current literature, or through keywords, such as ‘Multidrug efflux’ in 
reference strain annotations.  
 
presence or absence of the efflux pump inhibitor CCCP. 1 mM CCCP stock solutions were 
prepared by dissolving solid 1.02g CCCP (Sigma-Aldrich, Dorset UK) in 5ml Dimethyl 
sulfoxide (DMSO) (Sigma-Aldrich, Dorset UK). Preparations of 2.5, 5 and 10 mg/l calcium 
hypochlorite solutions were added to 15ml centrifuge tubes, with 1 mg/l of CCCP solution 
added to tests with the inhibitor, to a total volume of 8ml for each test condition. Tubes were 
then inoculated with 2 ml of the tested bacterial strain and experiments run for a total of 30 
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minutes. Population counts were taken at 5, 15 and 30 minutes after neutralisation of free 
chlorine in solution with 100l of 0.1M sodium thiosulphate (Na2S2O3) (Sigma-Aldrich, Dorset 
UK). 
Inactivation kinetics and statistical analysis 
CT99.9% values relating to the concentration of calcium hypochlorite required to inactivate 
bacterial populations by 99.9% were calculated for each Shigella strain, both in the absence 
and presence of the efflux pump inhibitor, as described in chapter 2. Paired t tests to 
compare CT99.9% values between tests with and without CCCP were conducted in R25.  
Genomic analysis 
Putative variation is genes reported previously to be involved in membrane pump activation 
(Table 1) will be identified through by analysing whole genome sequence data. Raw FASTQ 
paired read sequence data for each strain was obtained from the Wellcome Trust Sanger 
Institute online database26. Reads were aligned against either the S. sonnei Ss046 or S. 
flexneri str. 2a 301 reference strains using the Burrows-Wheeler Aligner (BWA)27. Single 
nucleotide polymorphisms (SNPs) were called in each sample against the reference strain 
using Samtools ‘mpileup’28 and low quality and low coverage variants (DP <10; GQ >30) 
were filtered with the vcfProcess function in R v1.3.2 (Supplementary materials).  
 
3.4 Results and discussion 
Chlorine inactivation with efflux pump inhibition 
To determine the role of efflux pumps in chlorine resistance in Shigella species, in vitro 
inactivation assays were conducted in solutions of varying calcium hypochlorite 
concentration, both in the presence and absence of the general efflux pump inhibitor CCCP. 
To quantify the biocidal activity of calcium hypochlorite on S. sonnei and S. flexneri, the 
average survival fraction of bacteria was calculated from population counts in triplicate after 
treatment with varying concentrations of the disinfectant. CT99.9% values, a measure of 
amount of the disinfectant required to reduce the population by 99.9%, were obtained from 
the survival fractions, using the methods described in chapter 2, These values were 
calculated for each strain in the presence and absence of CCCP, and then compared to 
determine strain sensitivity to chlorination when efflux pumps are active and inhibited (Table 
2). Control experiments were also run with CCCP in the absence of calcium hypochlorite in 
the solution. These experiments showed that CCCP alone did not significantly alter the  
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Strain No CCCP CCCP 
S. flexneri 1266 220.6171 135.7801 
S. flexneri 262.78 166.4345 139.6551 
S. flexneri 9.63 274.5846 126.5635 
S. flexneri MS0052 138.1009 168.1002 
S. flexneri DE0530 182.9997 153.4162 
S. flexneri EG419 154.2753 158.1901 
S. sonnei 54210 156.6956 144.8029 
S. sonnei 88.83 176.6425 151.1814 
S. sonnei 43.74 162.5593 162.5182 
S. sonnei MS004 245.0319 204.4516 
S. sonnei DE1208 215.2096 161.2225 
S. sonnei EG0430 239.4178 220.2689 
 
Table 3.2. CT99.9% values for S. sonnei and S. flexneri strains tested in this study in the 
presence and absence of CCCP. Values calculated using linear regression model the rate 
coefficient of disinfection. (See chapter 2 for more detailed description of the calculations used). All 
models fit the data significantly (p < 0.05).    
 
survival of any Shigella strain (Supplementary materials), thus any difference in chlorine 
resistance in a particular strain when in the presence of CCCP is likely due to the lack of 
efflux pump activity. 
The results show that overall there was a significant difference in resistance to chlorination 
of Shigella when tested in the presence of the efflux inhibitor CCCP (Paired t-test; t = 
2.5346, p-value = 0.02774). The average CT99.9% value across all strains when efflux pump 
activity was uninhibited (absence of CCCP) was 194.38 (SD 43.26), and 160.51 (SD 27.22) 
with CCCP added. The effect of efflux pump inhibition was not consistent across all strains, 
with the greatest effect seen in European S. flexneri 9.63, with a decrease in CT99.9% value 
from 274.58 to 126.56. In contrast, the average CT99.9% value of the Vietnamese S. flexneri 
strain MS0052 increased when tested with CCCP, though when comparing the raw survival 
counts in replicates of this strain there was no significant difference between treatments with 
and without CCCP (p = 0.765). This suggests that in this strain there was no effect of efflux 
pump inhibition on chlorine resistance.  
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It appears that the addition of CCCP had the greatest effect on chlorine resistance in 
European S. flexneri and Vietnamese S. sonnei, with these groups also displaying the 
highest innate resistance with unihibated efflux pump activity (Table 2 and chapter 2 
results).  It may be that increased efflux pump activity in these groups is causing a higher 
resistance to chlorine, with other systems involved in maintaining a baseline level of 
sensitivity. The inhibition of these pumps will return the levels of resistance to those 
conferred by these other processes. 
Indeed, it has been reported that bacteria will have a variety of responses to chlorine, 
including changes to carbon metabolism and the activation of other stress responses, 
depending on the strength of the disinfectant29. It may be that raising the activity of efflux 
pumps is only one mechanism, chiefly employed by the organism to increase resistance at 
particularly high concentrations of chlorine whilst at lower, sub-lethal levels these other 
processes will encompass the initial response to weaker disinfection. The results of these 
experiments suggest that efflux pumps are most important in conferring resistance to high 
chlorine concentrations, and thus there may be a variety of mechanisms activated in Shigella 
in response to varying disinfectant strengths. Conducting gene expression profiling, such as 
DNA microarrays, to elucidate which genes are involved in this response will help to better 
understand the process of chlorine resistance.  
Furthermore, CCCP is a generalised pump inhibitor that has been shown to constrain the 
activity of many common efflux pumps, in particular AcrAB-TolC, but will have variable 
efficacy against some other systems30. The activity of the AcrAB-TolC pump was the main 
focus of this chapter as it had been previously shown to be associated with bacterial chlorine 
resistance15, though most microorganisms will contain a variety of additional generalised and 
substrate-specific transport systems. Again a measure of gene expression in these 
organisms with exposure to varying concentrations of chlorine will identify the extent that 
certain pumps are involved in chlorine resistance.  
Fluoroquinolone resistance and chlorine disinfection 
Fluoroquinolone resistance could be confidently predicted in the tested samples through 
mutations in the DNA gyrase gene gyrA, an essential component of the DNA supercoiling 
process11,19, and phenotypic susceptibility data (Chapter 2, Table 1). Key SNPs in codon 83 
and 87 of the gene have been shown previously to confer a greater resistance to 
fluoroquinolones, with these mutations identified in Shigella populations within Vietnam31,32 
(Chapter 4).  
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Of the 12 strains tested here, only two carried one of these key mutations at the gyrA locus, 
inferring resistance to fluoroquinolones, thus it proved difficult to accurately predict the effect 
of this trait on chlorine resistance. Strains S. flexneri EG419 and S. sonnei EG0430 from 
Vietnam harboured the mutations conferring drug resistance and did not appear to have a 
higher average level of resistance to chlorine disinfection than susceptible strains of same 
group (species and location).  
Interestingly, the European S. flexneri strain 9.63 had the greatest difference in chlorine 
resistance when efflux pump activity was inhibited (CT99.9% value 274.58 to 126.56), and also 
the highest individual resistance of all strains. Phenotypic drug susceptibility tests showed 
that this strain resistance to the highest number of antibiotics (chapter 2, Table 1) and thus 
is may be that the additive effect of multiple drug resistances is increasing efflux pump 
activity, which in turn will increase chlorine resistance. This theory is consistent with previous 
work describing the synergistic effects of multiple drug resistance on efflux pumps33, though 
owing to the low number of strains tested here, further experiments would be required to 
assess the validity of this hypothesis.  
Genomic variation in efflux pump genes 
The analysis of whole genome sequences of the S. sonnei and S. flexneri strains used in 
this study identified variation in genes that had been previously associated with encoding 
and regulating efflux pumps, either in Shigella species or closely related Enterobacteriaceae, 
such as E. coli (Table 1). There were six non-synonymous single nucleotide polymorphisms 
(SNPs) in five known pump associated genes in S. sonnei, though none of these mutations 
appeared to be involved in an increased resistance to chlorine or a greater change in 
resistance with the inactivation of general efflux pumps. Additionally, no SNPs in pump 
genes were found only in S. sonnei EG0430, known to be resistant to fluoroquinolones.  
The sequence analysis identified 39 non-synonymous mutations (55 total mutations) across 
S. flexneri isolates in 10 of the 12 selected pump genes. The increased number of mutations 
in S. flexneri compared to S. sonnei is likely due to the increased genetic diversity across S. 
flexneri populations (Chapter 4). There was an excessive of non-synonymous mutations in 
acrB, cmr and acrD, though the majority of these SNPs were only found in a single isolate 
and so it was difficult to determine the effect on chlorine sensitivity. The highest levels of 
resistance to chlorine were found in S. flexneri were in European strains 1266 and 9.63, and 
there were no mutations found only in these strains. The ratio of non-synonymous to 
synonymous mutations in these genes (39/16) does suggest that there may be selection 
driving variation in these regions, though the non-specificity of these pump systems and the 
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lack of associations with decreased susceptibility to chlorine makes it complicated to suggest 
putative variants that can be contributing to resistance in Shigella. 
 
3.5 Conclusions 
Efflux pumps found in the cellular envelope of a variety of bacterial taxa have been 
previously shown to be associated with increased resistance to a variety of toxic substrates, 
including antibiotics. Resistance to chlorine has also been proposed to be influenced by 
increased activity in these transport proteins. Results of inactivation assays in the presence 
of a generalised efflux pump inhibitor, CCCP, suggest that these proteins are involved in 
chlorine sensitivity in Shigella, with an increased efficacy of the disinfectant against strains 
that were previously resistant to higher concentrations of chlorine when the activity of these 
pumps is constrained.  
The effects of pump inhibition were not consistent across all isolates tested and appeared to 
have the most impact on strains that were inherently more resistant to chlorine. This 
indicates that other stress induced processes will be activated with exposure to lower levels 
of chlorine. Additionally, these experiments were unable to resolutely find associations with 
chlorine sensitivity and resistance to fluoroquinolones and, though some variation in efflux 
pump genes was identified, this did not appear to correlate with differential chlorine 
resistance. Given the association between efflux pump activity and chlorine susceptibility 
demonstrated here in Shigella, the implementation of gene expression profiling techniques to 
identify genes that may be involved in the bacterial response to chlorine exposure would 
help to better understand the evolution of disinfectant resistance in these organisms.  
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Chapter 4 
The characterisation of antibiotic resistance genes and 
compensatory mutations in Shigella sonnei and Shigella 
flexneri in Vietnam 
4.1 Abstract 
The acquisition of antimicrobial resistance in bacterial pathogens is of great concern to 
global human health. The fitness benefits of harbouring a resistance gene can allow a 
particular strain to spread rapidly in an area, with the beneficial gene also becoming more 
prevalent. There has been evidence, though, of some costs associated with mutations at 
chromosomal resistance loci through the loss or disruption of original gene functions. 
Recently there has been growing evidence of additional mutations in resistant strains that 
will restore fitness to high levels in the absence of the antibiotic, termed ‘compensatory 
mutations’.  
Shigella sonnei has been rapidly emerging as a major disease causing pathogen in many 
developing countries, replacing S. flexneri as the primary cause of dysentery in these 
regions. Several hypotheses have been suggested to explain this process, with the 
development of antibiotic resistance proposed as contributing factor in the spread of 
pathogens. This work aims to characterise key resistance mutations in Vietnamese 
populations of S. sonnei and S. flexneri by identifying single nucleotide polymorphisms 
(SNPs) that may be under selection. Variation in previously described resistance genes is 
also detected in order to determine the resistance profile of all Shigella strains. Finally, 
variants that are significantly associated with harbouring drug resistance are identified to 
search for putative compensatory mutations. 
The results of this work show that drug resistance genes were identifiable in both S. sonnei 
and S. flexneri, with the latter species possessing a greater potential number of resistance 
conferring mutations but a lower proportion of resistant strains. From these variants, 
resistance to fluoroquinolones could be accurately predicted for each strain, with S. sonnei 
having a larger proportion of resistant isolates in the tested sample. Finally, no variants that 
were significantly more likely to be found in resistant or susceptible strains could be 
proposed as potential compensatory mutations.       
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4.2 Introduction 
Antibiotic resistance in bacteria is among the greatest challenges facing global health, with 
estimates of around 2 million people infected by antibiotic resistant pathogens each year1. 
With the number of resistant bacteria increasing2,3, there is a growing need to investigate the 
aetiology of strains harbouring these phenotypes in order to better influence effective 
strategies to control the spread of resistance, and to inform the development of new drugs. 
One such strategy to constrain the spread of resistance genes among populations is to limit 
the circulation of a particular antibiotic from a region for a period of time to lessen the 
selective pressure on bacteria to develop resistance. The acquisition and maintenance of 
chromosomal resistance mutations has been shown to have a deleterious effect on the 
fitness of an individual in the absence of the antibiotic, thus in an antibiotic-free environment 
susceptible individuals will possess a higher fitness4. It is theorised that by removing an 
antibiotic from circulation, resistance will be reversed in a population, and re-introduction at a 
later time will be effective in fighting the disease.  
The recent identification of associated mutations in resistant bacteria that can compensate 
for these fitness costs eliminates the efficacy of this approach5,6. The specifics of 
compensatory mutations are detailed in Chapter 1 of this thesis. The benefit of these 
mechanisms that mitigate this reduction in fitness suggests that harbouring resistance and 
compensatory mutations together could, therefore, be a major factor influence on the 
potential for a particular species or strain of pathogen to successfully persist and spread in 
areas of increasing antimicrobial use. This study will focus on identifying putative antibiotic 
resistance and compensatory mutations in Vietnamese populations of S. sonnei and S. 
flexneri, and in particular on the potential for these processes to be driving the expansion of 
the S. sonnei in this region.  
The impact of antibiotic resistance of the evolutionary history of Shigella has been explored 
previously, both within Vietnam and globally. Using whole genome sequences of 132 S. 
sonnei isolates collected between 1943 and 2010 from over 20 countries (including 19 from 
Vietnam), Holt et al reconstructed the phylogeny of the species using maximum-likelihood7. 
This analysis determined a most recent common ancestor (MRCA) of all isolates of less than 
500 years ago and also sorted S. sonnei into four distinct lineages corresponding to different 
emergence times. The study examined the distribution of known antibiotic resistance 
mutations in the phylogeny and found that global dissemination is strongly linked with the 
development of multidrug resistance (MDR). The evidence for independent acquisition of the 
same resistance mutations among different clades in the tree, along with little evidence for 
positive selection in other genes, suggests strong selective pressure in these genes. In 
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lineage III, the globally distributed clade to which the majority of Vietnamese isolates belong, 
there is evidence for the plasmid-mediated acquisition of class 2 integrons (In2) immediately 
prior to international dissemination, as well as some cases of point mutations conferring 
quinolone resistance in the chromosomal gyrA, DNA gyrase, gene. This suggests that the 
first S. sonnei strains to reach Vietnam already had MDR to a number of antibiotics, which 
would have given them a selective advantage over other susceptible pathogens. Evidence 
suggests that, although antibiotics may not actually resolve infections caused by S. sonnei, 
treatments can prevent the shedding of the bacteria after the symptoms have resolved, 
preventing transmission between humans8. Thus resistance phenotypes may be important in 
sustaining the bacteria within host populations and facilitating its spread. 
A further study from Holt et al sequenced the whole genomes of 244 isolates of S. sonnei 
from three regions in Vietnam between 1995 and 2010 and reconstructed their evolutionary 
history, including the 19 Vietnamese isolates from the previous study9. This analysis traced 
the MRCA of all S. sonnei in this study to a single MDR ancestor around 1982, suggesting 
either a novel introduction to the region or a historical bottleneck, with the greater support for 
the introduction hypothesis. The inclusion of isolates from three geographic areas in this 
study allowed for phylogeographic analysis to explore the spread of S. sonnei within the 
region. Isolates were collected from three provinces with the majority of dysentery cases in 
Vietnam, Ho Chi Minh City (HCMC), Hue and Khanh Hoa province (KH). It was found that 
the MRCA of the Hue and KH isolates was closely linked to the HCMC isolates and a large 
number of these strains were clonal, suggesting local recent clonal expansion into these 
areas from HCMC. There were also multiple KH and Hue isolates scattered throughout the 
phylogeny indicating separate events where S. sonnei has spread to these areas. These 
isolated events were only rarely successful in establishing new populations though (around 
10% of establishments), pointing to potential differences in fitness and transmissibility 
between strains. 
Closer inspection of the evolution dynamics of the HCMC isolates revealed four population 
bottlenecks which coincided with increases in the proportion of reported dysentery cases 
caused by S. sonnei and reports of increases in antibiotic resistance. Genetic data found 
that in these bottlenecks, a subset of accumulated mutations became fixed in the local 
population whilst others were lost. This indicates four incidences of selective sweeps, an 
elimination of variation around strongly selected mutations, where selection is driving 
competition between strains and the emergence of successful clonal populations. Single 
nucleotide polymorphism (SNP) analysis of plasmid mutations revealed four SNPs that 
became fixed in the first bottleneck and one in the second sweep, including the ipgD gene 
encoding an effector protein involved with cellular invasion10.  
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Chromosomal SNPs were distributed evenly across the genome showing no general pattern 
of selection. Some mutations were found to have been independently acquired more 
recently among different populations, including point mutations in the DNA gyrase gyrA 
gene, associated with fluoroquinolone resistance, that became fixed during the third 
selective sweep. This more recent evolution of antibiotic resistance, along with evidence of 
further differentiation of from the accessory genome among isolates from the three 
geographic regions, suggests that these populations have continued to evolve since the 
introduction of their MRCA into Vietnam, which may have contributed to their ability to 
expand into new areas. With this pathogen becoming a growing concern for human health in 
the region, it is important to understand the mechanisms, including the accumulation of 
resistance genes, by which particular strains are able to successful spread and become 
established. 
A recent study detailing the evolutionary history of S. flexneri on the other hand, did not find 
evidence of any significant global dissemination of antimicrobial resistant populations of the 
pathogen in spite of multiple occurrences of local acquisition of resistance genes11. It was 
reported that S. flexneri populations were likely to be remain localised for long periods of 
time without intercontinental spread, in contrast to the patterns common in S. sonnei 
expansions. Again, the evolutionary history of the species was reconstructed, finding that S. 
flexneri strains could be classified into seven, highly diverse lineages. It was proposed that 
the long term maintenance of diverse pathogen populations in smaller geographic regions 
would lessen the selective advantage of transient antimicrobial resistance gene acquisition 
in S. flexneri, and as a result there are a greater proportion of S. flexneri strains are less 
likely to carry these mutations or genomic elements conferring resistance. Thus, it may that 
the recently emerged S. sonnei populations will contain a greater number of resistant strains 
as there is a greater selective pressure on the organism to acquire resistance for successful 
persistence and spread of particular strains. With the increasing use of antibiotics in 
developing countries in recent history12, the higher proportion of resistant S. sonnei strains 
be accelerating its spread over S. flexneri. 
Additionally, it is possible that compensatory mutations may be increasing the fitness of S. 
sonnei strains in Vietnam. Experimental work carried out on the fitness effects of antibiotic 
resistance genes in S. sonnei from Vietnam showed that resistance to fluoroquinolones does 
not reduce the selective fitness of strains carrying resistant gene copies when competing 
with wild-type antibiotic-susceptible strains in mixed cultures (S. Baker 2013, pers comm., 
14th May). This could suggest either that there are some epistatic interactions between 
genes or compensatory mutations that will be restoring the fitness of resistant bacteria. 
Whilst epistasis in genes is not being ruled out, it is likely that compensatory mutations are 
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contributing somewhat to this increase in fitness as this has been observed numerous 
occasions in other bacterial pathogens13–16, as well as in theoretical models of gene and 
function losses17. If these compensatory mechanisms are characteristic of S. sonnei only, 
co-evolution with antibiotic resistance genes may contribute to the observed spread of S. 
sonnei, and associated decrease in S. flexneri infections, in developing regions.   
The primary focus of this chapter is to gain a further insight into the genetic features that 
have supported the rapid emergence of S. sonnei and the replacement of S. flexneri as the 
primary cause of dysentery in Vietnam, discussed in detail in Chapter 1. Based upon 
previous findings on the global spread of each species, it appears that there may be key 
differences in the impact of resistance on their chances of successful establishment, with 
evidence that S. sonnei expansion will be in part driven by the acquisition of these genes. 
Potential resistance genes in the core chromosomal genome of S. sonnei and S. flexneri 
isolates will be identified from whole genome sequence data through a combination of 
techniques, with putative mutations involved in the compensation of fitness costs associated 
with resistance also targeted. 
  
 
Figure 1. Diagrammatical representation of convergent evolution across a phylogenetic tree. 
The red allele is carried by individuals A and D, whilst all other individuals carry the blue copy. 
Reconstruction of ancestral state of the allele across the branches of the tree reveals that blue is the 
ancestral version of the gene, thus the red allele will have arisen independently through convergent 
evolution at tips A and D and is a homoplasy.  
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Genomic regions under selection will be identified by maximum parsimony analysis, 
identifying mutations that have arisen at multiple independent times across a population, and 
manual inspection of known, high-confidence resistance genes. Widely used techniques 
such as the ratio of non-synonymous to synonymous mutations (dN/dS), are not suitable for 
detecting recent positive selection in highly related populations such as S. sonnei18. 
Parsimony though can be used to identify homoplastic SNPs that have evolved through 
convergent evolution (Figure 1)19, and this has been shown to be an effective tool for 
distinguishing areas of the genome that are under strong, recent selection in species of 
closely related pathogenic bacteria19,20. The genomes of Shigella species are known to be 
relatively stable11, with little recombination and thus gene variants that have arisen in 
multiple, independent linages within a population will likely be driven by some selective 
pressure. This method can also detect SNPs non-genic regions of the genome, such as 
promotors, that may be under selection. The aim is to use these tools to detect regions of S. 
sonnei and S. flexneri chromosomal genomes under selection, and link any variation to traits 
that may be associated with antibiotic resistance within the organism. This allows for 
resistant and susceptible isolates for a particular antibiotic to be identified within each 
population, and putative compensatory mutations can be revealed by common gene variants 
found in a higher frequency in the resistant populations.  
 
4.3 Methodology 
Shigella isolate collection 
High coverage whole genome sequences of 134 Shigella flexneri and 145 Shigella sonnei 
clinical isolates were obtained from the Wellcome Trust Sanger Institute online database21. 
Strains were collected from patients in three regions of Vietnam, Ho Chi Minh, Hue and 
Khanh Hoa between 1995-2010 as detailed in Holt et al9. All S. sonnei isolates were 
members of the global lineage III clade, and S. flexneri samples were predominately lineage 
2a, the most common group within Vietnam. Further information including the date of 
isolation, location and individual accession numbers can be found in the supplementary 
materials. 
Assembly and genomic analysis 
Paired read FASTQ files were quality checked with adapter removal and read trimming 
performed with Trimmomatic22. Reads were then aligned against either S. sonnei Ss046 or 
S. flexneri 2a. 301 reference strains using BWA -mem and -sampe programs (v.0.7.12)23, 
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with the median coverage across S. sonnei and S. flexneri alignments 150x and 125x 
respectively. Aligned sequences were converted to BAM format with Samtools (v1.3.1)24 and 
multi-sample variant calling implemented with the ‘mpileup’ command in the same program.  
SNPs were discarded from problematic repeat regions and filtered for low quality (QC <30) 
and low coverage (DP <10) variants using vcfProcess, a R function developed for post-
processing variant caller outputs (Supplementary materials). To maximise the genetic 
variation identifiable in samples, mixed (heterozygous) calls were assigned as the reference 
or alternative allele if supported by >80% of reads at a site, otherwise these were marked as 
a gap. SNPs falling <10bp apart were excluded from the phylogenetic input but considered 
when identifying genes under selection. Sequences of high confidence SNPs were then 
concatenated for phylogenetic and selection analyses.  
Phylogenetic analysis 
High confidence SNPs were used to reconstruct the maximum-likelihood phylogeny for S. 
sonnei and S. flexneri isolates using RaxML25, using the GTRGAMMA model of base 
substitution and site heterogeneity. 1,000 bootstrap replicates were run to calculate support 
for the final tree topology of each species. Trees were visualised with selected SNPs of 
interest mapped against tips using a bespoke script in the R package ‘ape’26. 
Identification of genes under selection 
Homoplastic SNPs that have arisen multiple times over each species’ phylogeny were 
identified using the ‘phangorn’ package in R27. The ancestral state of sites was reconstructed 
at each node by ‘Fitch’s’ parsimony algorithm and the number of mutational changes forward 
through time that have taken place across the tree to result in the distribution of derived 
alleles at tips is calculated for each SNP. A figure of >1 at any site indicates at least two 
independent mutations across the tree, evidence of convergent evolution. The resulting 
homoplastic SNPs were mapped to gene regions using the reference strain annotation, and 
the likelihood of conferring antibiotic resistance or fitness compensation considered by 
determining gene function using the PANTHER database28. 
Resistance genes were also identified through a search of current literature and were 
manually examined for genetic variation within Shigella genomes. Finally, S. sonnei and S. 
flexneri strains were tested for likely resistance to fluoroquinolones in silico using ARIBA29. 
With these groupings, allele frequency differences between resistant/susceptible isolates 
were used SNPs that were found in a significantly higher frequency in isolates harbouring a 
particular resistance conferring mutation and thus may be a candidate compensatory 
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mutation, through Discriminate Analysis of Principal Components (DAPC), implemented in 
the ‘adegenet’ package in R. v1.3.230. This will search for SNPs that contribute most to the 
pre-defined resistant/susceptible groups, while controlling for any population structuring 
within these groups that may give rise to false-positive associations due to the underlying 
evolutionary relationships within the groups. 
4.4 Results and Discussion 
Population structure and genetic variation 
Species-level population structure and evolutionary relationships in Vietnamese S. sonnei 
and S. flexneri were determined by conducting phylogenetic analysis on 145 S. sonnei and 
134 S. flexneri whole genome sequences. Sequence reads were aligned to either the S. 
sonnei Ss046 or S. flexneri 2a str301 reference genome, and genomic variants detected 
between isolates. The number of SNPs found within each species is indicative of the 
disparity in genetic diversity between populations of S. sonnei and S. flexneri, with 1,050 
SNPs identified in S. sonnei and 39,571 in S. flexneri. Of the variants found in S. sonnei, 412 
were found in single isolates (39.24%), while only 0.026% (1,040) of SNPs in S. flexneri 
were present in only one sample. The average pairwise SNP distance between individuals 
was 37.42 in S. sonnei isolates and 8,604.13 between S. flexneri. The difference in the 
levels of variation between individuals of each species is in line with previous evidence of 
more recent, clonal evolution of S. sonnei in Vietnam in contrast to S. flexneri populations, 
which can be characterised by distinct, deeply-rooted lineages, with relatively high diversity 
both between and within these groups.  
A robust maximum-likelihood phylogeny of high quality SNPs across each species was built 
to infer evolutionary relationships between isolates (Figures 2 & 3). The resulting tree 
topologies also reflect the differing population structure between Shigella species. S. sonnei 
isolates largely form a single monophyletic clade with low diversity, with the individuals 
falling outside of this group representing the reference strain and one individual isolated in 
1995. In contrast, S. flexneri forms at least five distinct clades, likely distinguishing lineage 
differences, that are highly divergent. There are 13 S. flexneri isolates that form a very 
distant branch of the tree from all other strains, suggesting a deep-rooted evolutionary 
divergence. These samples were collected across all three sites in Vietnam between 2003-
2010 and so will not likely be due to a single outbreak of closely related infections. This 
illustrates that the major source of genomic diversity in S. flexneri will be due to lineage 
specific mutations, which supports previous evidence of high diversity in this species11. 
Chapter 4. Antibiotic resistance and compensatory mutations in Vietnamese Shigella 
 
 89 
A 
B 
Figure 2. Unrooted maximum-likelihood phylogeny produced by RaxML of (A) Shigella 
sonnei and (B) Shigella flexneri strains used in this study. All major nodes have >95% 
bootstrapping support. Mutations in the DNA gyrase gene, gyrA, which have been shown to 
confer resistance to fluoroquinolones are plotted on the tree tips and the gene coordinates shown 
in the legend.  
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Identification of homoplastic sites 
Sites under positive selection were identified through reconstruction of the most 
parsimonious ancestral states of SNPs at each node of the maximum-likelihood tree, with 
homoplasies defined as occurrences of multiple mutations at a site given the sequence at 
the tips. The number of homoplastic sites in S. flexneri and S. sonnei populations varied 
markedly. There were six SNPs identified in the S. sonnei population that appear to have 
evolved on multiple, independent occasions. Of these sites, three are found in protein coding 
regions, with one non-synonymous mutation, S83L, in gyrA identified in 23/145 isolates and 
known to confer fluoroquinolone resistance, described previously in Vietnamese S. sonnei 
populations9,31 (Figure 2A). 
The other homoplastic SNPs in protein coding regions of S. sonnei were identified as a 
synonymous mutation in 18/145 isolates found in the heat shock protein yceA, and a double 
synonymous mutation (A>G in 144/145 and A>T 1/145 isolates) in metR, a regulatory 
protein of the pathway involved in methionine metabolism32. It is improbable that these 
mutations are involved in antimicrobial resistance. Similarly, the remaining three homoplastic 
SNPs were found in the same non-coding region of the genome, though due to their 
distance from the nearest gene and close proximity it is likely they are a result of a 
previously unidentified mobile element.  
In contrast, there were 413 homoplastic SNPs identified across S. flexneri isolates, with 300 
falling in coding regions. Of the SNPs in coding regions, 120 were non-synonymous 
mutations, altering the amino acid sequence of the gene. Mutations were found again in 
gyrA (A87Y, 7/134 isolates; S83L, 47/134 isolates), conferring fluoroquinolone resistance 
(Figure 2B), with these mutations previously identified in Vietnamese S. flexneri 
populations33. 55 homoplastic genes were assigned molecular function GO terms using the 
PANTHER classification tool28. The majority of these genes were termed catalytic activity 
(GO:0003824) (26/55 genes) and eight were involved in transporter activity (GO:0005215), 
though there is no previous evidence of antimicrobial activity associated with any of these 
genes.  
Six non-synonymous SNPs were nonsense mutations, resulting in a premature ‘STOP’ 
codon in a gene that will arrest the amino acid sequence and cause pseudogenisation. One 
such gene containing a nonsense mutation was in the mdaA gene (9/134 isolates), which 
has been shown in E. coli systems to be associated with increased resistance to tumoricidal 
drugs when over-expressed, including DMP 84034. In addition, mdaA has been shown to 
confer resistance to nitrofurantoin, a second line antibiotic used to treat bladder infections35. 
Interestingly, the gene is controlled by the MarA regulon, shown to also regulate the activity 
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of the multidrug efflux pump AcrAB-TolC35. It is possible that the loss of function in the mdaA 
gene may be associated in some way either with resistance to one of these compounds, or 
having an epistatic relationship with the genes involved in efflux pump regulation, though 
more work would be required to investigate any consequence of this function loss.  
Variation at known resistance loci 
Genes that have been previously shown to be associated with antibiotic resistance, either in 
Shigella species or other Gram-negative bacteria, were also manually inspected for variants 
in S. sonnei and S. flexneri genomes. Only non-synonymous SNPs were considered in this 
analysis as it is known that these mutations will change the amino acid sequence of the 
coding region. 19 genes were chosen for further analysis based upon evidence of an 
association with either specific drug resistance, such as mecillinam susceptibility in aroK, or 
broad-spectrum effects, for example the genes encoding the AcrAB-tolC drug efflux pump.  
There were six non-synonymous SNPs found in known resistance conferring genes in S. 
sonnei strains. Along with the homoplastic non-synonymous mutation discovered in the DNA 
gyrase gene through parsimony analysis, a further gyrA mutation, A87Y, was identified in 
93/145 S. sonnei isolates. In addition, looking at heterozygous variant calls in the gyrA gene, 
a further isolate was identified that appeared to constitute a mixed infection of resistant and 
susceptible bacteria, with the A87Y mutation present in around 60% of the raw sequence 
reads. Phenotypic susceptibility information on this sample showed resistance to 
fluoroquinolones (Supplementary materials) and so this strain was characterised as 
resistant for the DAPC analysis presented later in this chapter.  
In addition, there were two mutations in another gene known to be associated with higher 
levels of resistance to fluoroquinolones, parC. One variant was identified in 144/145 isolates, 
with a single sample harbouring an additional mutation in the gene. The remaining strain 
showed a heterozygous call at this locus, again suggesting a mixed infection. The ubiquity of 
this mutation across the population containing both fluoroquinolone resistant and susceptible 
strains suggests that this mutation in isolation will not confer resistance to this class of 
antibiotics, but there may be some epistatic or additive effect with the mutation when in 
combination with further resistance genes in gyrA. Research has shown the efficacy of 
fluoroquinolones can vary against E. coli carrying only variants in the parC gene with no 
gyrA mutations36, with particular SNPs only having a weak effect on the MIC of these 
antibiotics if situated outside of the resistance-determining region.  
There were 47 non-synonymous SNPs identified in previously described resistance genes in 
Vietnamese S. flexneri isolates, including the same gyrA and parC loci as were detected  
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Gene 
Name Antimicrobial Activity 
S. sonnei 
start position 
S. sonnei 
end position 
No. of S. 
sonnei SNPs 
(no. of 
isolates) 
S. flexneri 
start position 
S. flexneri 
end position 
No. of S. 
flexneri 
SNPs (no. of 
isolates) 
aadA Aminoglycoside resistance41 4110458 4111246 0 (0) - - 0 (0) 
acrA AcrAB-TolC multidrug efflux pump40 477813 476620 0 (0) 420957 422150 6 (68) 
acrB AcrAB-TolC multidrug efflux pump40 476597 473448 1 (1) 417785 420934 7 (134) 
ampC Resistance to beta-lactam antibiotics31 4604316 4605449 0 (0) 4482197 4483330 5 (53) 
ampD Regulation of ampC32 127961 128512 0 (0) 116997 117548 1 (13) 
ampE Regulates of ampC32 128509 129363 0 (0) 117545 118399 3 (14) 
aroK Mecillinam resistance33 3681190 3681711 0 (0) 3487756 3488478 2 (21) 
gyrA Fluoroquinolone resistance34 2408970 2411597 2 (116) 2352232 2354859 5 (73) 
gyrB Fluoroquinolone resistance35 3818616 3821030 0 (0) 3872637 3875051 1 (13) 
marA Multiple antibiotic resistance37 1678069 1678458 0 (0) 1596156 1595773 0 (0) 
marB Multiple antibiotic resistance38 1677819 1678037 0 (0) 1595523 1595741 1 (65) 
marR Overexpression of marA37 1678472 1678849 0 (0) 1596176 1596553 3 (133) 
parC Fluoroquinolone resistance36 3320041 3322299 2 (144) 3159155 3161413 5 (107) 
parE Fluoroquinolone resistance35 3327013 3328905 0 (0) 3166639 3168531 3 (53) 
rpoA Compensation of rpoB16 3612840 3613829 0 (0) 3424423 3425412 0 (0) 
rpoB Rifampicin resistance16 4400376 4404404 1 (1) 4200998 4205026 2 (21) 
rpoC Compensation of rpoB13 4404481 4408704 0 (0) 4205103 4209326 0 (0) 
soxS AcrAB-TolC multidrug efflux pump39 4501503 4501826 0 (0) 4287490 4287813 1 (13) 
tolC AcrAB-TolC multidrug efflux pump40 3331624 3333105 0 (0) 3171250 3172731 4 (53) 
 
Table 1. Selected chromosomal genes with evidence for an association with antibiotic resistance in S. sonnei and S. flexneri. The number of non-
synonymous SNPs identified within each gene is shown, along with the number of isolates of each species that harbour at least one derived allele.  
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in the S. sonnei population. In addition, there were three other SNPs found in DNA gyrase in 
S. flexneri, with mutations at A87G, H338Y and LL424R. The A87G variant has been 
previously associated with increased fluoroquinolone resistance in Vietnamese Shigella9,37, 
though these other SNPs appear to be novel variants in this population. The extent to which 
they will increase resistance to fluoroquinolones would need to be investigated through drug 
susceptibility testing, though there does not appear to be support for resistance through 
mutations outside of the short, resistance-determining region that includes codons 83 and 87 
in this gene38.  
Similarly, the majority of the mutations in parC were not found at previously described 
resistance-determining loci, though one mutation, G80A, in 21/134 isolates had been shown 
to increase the MIC of fluoroquinolones to E. coli38. Based on previous characterisation of 
this G80A parC variant, strains harbouring this mutation are proposed to have some level of 
resistance to fluoroquinolones and will be considered as such when grouping strains as 
resistant or susceptible for the identification of putative compensatory mutations. All isolates 
that harboured this variant also had a mutation in rpoB, a common rifampicin resistance 
gene16. Mapping these mutations on to the phylogenetic tree showed that they were found in 
one monophyletic clade, as such it is not possible to determine if they are functionally 
connected, though it is likely they have evolved through independent events. This clade 
comprised the oldest S. flexneri isolates considered in this analysis from between 1995-
1996, and interestingly this same gene was found in a single S. sonnei strain, again dating 
from the mid 1990’s. This suggests that at this time there was a circulating population of 
rifampicin-resistant Shigella, though this resistance did not continue in more recent 
populations. 
A number of SNPs were also identified in genes associated with the AcrAB-TolC efflux 
pump, a system that has been shown to influence antibiotic resistance in Gram-negative 
bacteria. The results from chapter 3 of this thesis show that these pumps can also have an 
effect on chlorine resistance, though it was found that Vietnamese S. flexneri were more 
susceptible to chlorination than S. sonnei, and so it is unclear to the extent that mutations in 
the pump genes acrA and acrB will influence antibiotic resistance. 
Finally, multiple non-synonymous mutations were identified in a repressor gene of the 
multiple antibiotic resistance (mar) operon, marR, with all but one strain harbouring at least a 
single SNP in this coding region. This gene encodes a group of regulatory factors that are 
modulated by environmental stress signals, such as exposure to antibiotics39. They have 
been associated with the transcription of virulence factors in pathogens and the regulation of 
drug efflux pumps40. Closer inspection reveals that there are multiple non-synonymous 
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variants yet no synonymous mutations in this gene, suggesting that there may be ongoing 
selection acting at this locus. S. flexneri infections are often typified by more a severe 
disease than S. sonnei41 and it may be that mutations in this gene are contributing to 
increased pathogenicity in this species. 
The detection of allelic variation in key resistance genes shows that there are differences in 
the diversity of these regions between Shigella species. Comparison of these genes 
between species is problematic, though, as variation will only be identified if there are intra-
species nucleotide differences within the population, or variation between the tested isolates 
and the reference strain, thus fixed variants, irrespective of their selective benefits, will not 
be detected. To this end, it is difficult to assess all fitness differences informed by genomic 
variation between these species using this process in isolation, though it has been suitable 
to detect further informative resistance conferring variants in Vietnamese Shigella 
populations.  
Compensatory mutations in fluoroquinolone resistance 
The analysis of SNPs in whole genome sequences of S. sonnei and S. flexneri isolates from 
Vietnam identified mutations in resistance genes through the detection of homoplastic 
variants that have likely evolved due to selection, and by manually inspecting known 
resistance genes. Based on the characterisation of resistance genes in previous studies, 
and phenotypic susceptibility data in S. sonnei, I can confidently consider that variants 
identified here at codons 83 and 87 of gyrA in S. sonnei and S. flexneri, and codon 80 of 
parC in S. flexneri are likely to predict bacterial resistance to fluoroquinolones. Classification 
of strains is also confirmed by in silico testing of resistance using the ARIBA tool29 
(Supplementary materials), with 73/134 S. flexneri and 116/145 S. sonnei resistant strains. 
Strains were separated into groups of either resistant or susceptible individuals within each 
species to search for evidence of compensatory mutations, as well as other associated 
variants. To identify mutations that are found in significantly higher frequencies in either 
susceptible or resistant strains, a Discriminant Analysis of Principal Components (DAPC) 
analysis was carried out comparing allele frequencies of all SNPs in these groups within 
each species (Figure 4). Discriminating SNPs between fluoroquinolone-resistant and –
susceptible S. sonnei were identified that revealed five mutations in coding regions and one 
in a non-coding region that were significantly more likely to be associated with one of the 
groups (Table 2A). Intuitively, the most common gyrA variant in this population, A87Y, was 
detected through this process. Two further non-synonymous mutations were identified, 
though neither were candidates for compensatory mutations based on their annotated 
functions (proY encodes a proline transporter protein and yfaA is uncharacterised).  
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(A) 
 
 
(B) 
 
Figure 4. Discriminant Analysis of Principal Components identifying discriminating variables 
(SNPs) for each group (resistant/susceptible to fluoroquinolones). (A) DAPC plots for S. sonnei 
based on the top highest PCs contributing to group discrimination and a contribution threshold of 
0.02. (B) DAPC plots for S. flexneri based on the highest 20 PCs contributing to group discrimination 
and a contribution threshold of 0.008. The SNP ID of discriminating SNPs over the threshold are 
shown. 
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(A) 
SNP position Gene name dN or dS 
406723 proY non-synonymous 
416501 tsx synonymous 
1624522 ydgA synonymous 
2407844 yfaA non-synonymous 
2411339 gyrA non-synonymous 
   
(B) 
SNP position Gene name dN or dS 
164493 fhuB synonymous 
1357086 aldH non-synonymous 
2424196 pta synonymous 
1034324 ymcA non-synonymous 
1866734 zntB non-synonymous 
1997465 fliA non-synonymous 
2354612 gyrA non-synonymous 
2540695 cysP non-synonymous 
2877071 ygcX non-synonymous 
3265586 yhaU non-synonymous 
 
Table 2. Gene name and position of SNPs that were found to be discriminating variables in (A) 
S. sonnei and (B) S. flexneri DAPC analysis. 
 
The results of the discriminant analysis in S. flexneri resistant and susceptible groups 
identified three SNPs in S. flexneri in non-coding regions that were situated a relatively large 
distance from the nearest gene, so were unlikely to have any functional effect on each 
group. Of the remaining ten SNPs, two were synonymous mutations and eight non-
synonymous, indicating potential functional differences in these genes between resistant and 
susceptible groups. Again as was expected, a mutation in the gyrA gene was identified in 
this analysis, the S83L variant, which is the most common variant in the group. Of the 
remaining non-synonymous mutations associated with each group, the most notable were 
three genes that encoded cellular transport proteins, cysP, zntB and yhaU. These genes 
were all linked to very specific systems for transporting substrates across the cell 
membrane42,43 and so it is again unlikely that these could be considered as putative 
compensatory mutations. 
As demonstrated by the detection of only one gyrA variant in each species with this 
discriminant analysis, only single sites are considered when looking for associations and 
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thus will not identify all the genomic variation contained in a population. If there are multiple 
variant loci in a gene that can imply similar functional differences, then these may not be 
picked up, with each SNP is considered a single variable. These methods, though, are 
robust for distinguishing sites under selection, and thus it is unlikely that there are any 
compensatory mutations associated with fluoroquinolone resistant in Shigella populations in 
Vietnam. 
 
4.5 Conclusions  
The aim of this study was to identify likely antibiotic resistance mutations from whole 
genome sequences of S. sonnei and S. flexneri strains in Vietnam by detecting sites under 
strong selection and variants in known resistance associated genes to determine possible 
differences in drug resistance profiles between species. In addition, mutations in resistant 
strains that would mitigate any fitness costs associated with antibiotics were targeted 
through discriminate analysis of variants in resistant and susceptible groups in each species.  
Fluoroquinolone resistance could be confidently predicted in both species through well 
described mutations in the DNA gyrase gene, gyrA, an essential gene involved in 
transcription and DNA supercoiling15, as well as signals of strong selection at this gene in 
both species through the detection of homoplastic sites. These classifications were also 
supported by in silico testing for resistance. Non-synonymous SNPs in codons 83 and 87 of 
this gene have been shown repeatedly to confer an increased resistance to a range of 
fluoroquinolones31,44, with these mutations also previously identified in Vietnamese Shigella 
populations9,33. The S83L variant in gyrA was found as an example of convergent evolution 
in both species, with this specific mutation found in the highest number of fluoroquinolone 
resistant S. flexneri strains. This point mutation has been found often to be the first novel 
gyrA mutation to spread in a population as it confers high levels of resistance with low 
functional changes to the DNA supercoiling45. A greater proportion of S. sonnei strains 
tested here (116/135) harboured resistance to fluoroquinolones than the S. flexneri 
population. This may be simply due to sampling bias or it may indicate some differences in 
the circulating resistance to this class of antimicrobials in Vietnamese Shigella species.  
There were no further sites that appeared to be under strong selection in either species that 
could confidently be connected to antimicrobial resistance, though manual inspection of 
previously described resistance genes did identify additional variants that may be linked to 
resistance. Most interesting were SNPs in parC, a topoisomerase gene involved in DNA 
coiling38,46, detected in both Shigella species and known to also play a role in fluoroquinolone 
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resistance44,45. One mutation in S. sonnei was at fixation within the population, yet 
phenotypic susceptibility testing showed that a number of isolates did not have resistance to 
nalidixic acid, a quinolone (Supplementary materials). This suggests that this mutation 
alone does not confer resistance, with further inspection revealing that the position of this 
SNP is outside the proposed resistance determining region of the gene38. Double mutants 
carrying both a parC and gyrA mutation in Salmonella enterica have been shown to have a 
fitness advantage over single mutants and wild type strains47, thus whilst parC may not have 
evolved as a compensatory mutation, epistatic interactions between the genes may be 
mitigating fitness costs. 
Similarly, five non-synonymous mutations were found in the parC gene in S. flexneri, though 
four of these again fell outside of this resistance region. One variant though had been 
previously found to confer a level of resistance to quinolones even in the absence of gyrA 
mutations and thus was proposed to determine resistance in the strains carrying it here.  
S. flexneri appeared to have a greater range of potential resistance determining mutations 
across all isolates than S. sonnei, though a greater proportion of S. sonnei strains harboured 
at least one resistance gene. This supports the theory that the relatively long persistence of 
S. flexneri populations in an area lessens the selective advantage of harbouring transient 
resistance mutations. Thus these mutations are less readily acquired in a population but will 
remain as standing variation in the species even when the selective advantage is reduced11. 
The successful expansion of S. sonnei lineages, on the other hand, will be driven by 
acquisition of resistance mutations, and with the increased use of antibiotics in developing 
regions12, the propensity for resistance to spread through S. sonnei populations may be 
contributing to the successful expansion in these areas. 
Evidence for compensatory mutations in fluoroquinolone resistant strains of either Shigella 
species or E. coli remains limited48, suggesting that the fitness costs associated with 
harbouring resistance to these drugs will be negligible. This result supports evidence in 
previous studies have suggesting that particular quinolone-resistance conferring SNPs, 
notably in gyrA, will not be associated with any loss of fitness in some organisms49.  
Unfortunately, a limitation in this study was the lack of phenotypic data on resistance for a 
range of antibiotics and, though in silico testing allowed for classification of 
susceptible/resistant to fluoroquinolones, full phenotypic testing would extend the scope of 
the results in this chapter. In spite of these challenges, the analysis undertaken here 
identified some clear differences between antibiotic resistance profiles in Vietnamese 
Shigella populations that may be contributing to the replacement of S. flexneri with S. sonnei 
in this region. 
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Chapter 5 
Environmental persistence and niche adaptation in 
Vietnamese Shigella sonnei and Shigella flexneri – insights 
from the pan genome 
5.1 Abstract 
Advances in next-generation sequencing (NGS) have driven a range of studies to 
characterise the key genomic features and epidemiology of a variety of important human and 
wildlife diseases. The spread of an infectious pathogen can be driven by its relative fitness, 
and this is often influenced by its ability to adapt to selective pressures, such as exposure to 
antimicrobials and changes to the host environment. Bacteria, notably, can acquire genes 
from other organisms or the environment through horizontal gene transfer and natural 
transformation, allowing for fast adaptation to challenges and rapid fixation of beneficial 
genes. Such selective pressures can contribute to variation in gene content between 
lineages, with genes overrepresented in certain lineages constituting likely candidates for 
recent or ongoing adaptation.  
In this study, I have used de novo assembly to construct the pan genome of Shigella sonnei 
and Shigella flexneri in Vietnam, the two most common species causing shigellosis, or 
bacillary dysentery. Though S. flexneri has historically been the most prevalent species in 
developing countries, including Vietnam, there has been an observed shift towards infections 
caused by S. sonnei. 
 Our results show variation in the gene content of the average pan genomes of these 
Shigella species, with a number of genes identified in S. sonnei that can be associated with 
metabolism and host adaptation. These key phenotypic differences between Shigella 
species may influence survival and niche adaptation in a changing environment, and could 
be one of the factors driving the spread of S. sonnei in many developing countries.
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5.2 Introduction 
Whole genome sequencing (WGS) of common bacterial species has now become relatively 
inexpensive, with an abundance of new research aiming to improve technologies that 
increase the efficiency and accuracy of genome assemblies. As such, our knowledge of the 
genetic variation and evolution of major disease causing bacteria, such as Escherichia coli1–4 
and Staphylococcus aureus5 is very well understood, with numerous studies aiming to 
characterise the genes that are present in these species, as well as their functions. Applying 
this knowledge to the epidemiology and transmission of emerging or re-emerging pathogens 
can help to identify genetic drivers that may be responsible for influencing the spread of a 
disease in a particular environment6–8. 
Short read sequencing is the most commonly utilised technology for WGS due to its 
relatively low cost; piecing together these short, fragmented stretches of DNA to reconstruct 
the ‘true’ complete genome of a species does, though, present some challenges9. The 
standard method for building genomes and detecting variation among samples of previously 
characterised species is to map the short reads of sequenced DNA against a previously 
assembled, closely related ‘reference’ strain10. This will allow comparison of the similarity of 
shared genes between the reference and sampled strains by identifying single nucleotide 
polymorphisms (SNPs), single sites of variation, which can provide insights into their 
homology and evolution. This method is often favourable as it is generally fairly 
straightforward to assemble a large number of genomes with reasonable accuracy. The 
major shortfall though is that only genomic regions that are present in the reference strain 
will be mapped in the sampled strains, so the full genetic variation between samples will not 
be captured9. Additionally, regions missing from any one sample will be ignored when 
conducting phylogenetic reconstructions from alignments and so information on genomic 
regions present in the reference strains may also be lost if these are not shared by all 
strains. This is somewhat problematic in bacterial taxa that can undergo high rates of 
horizontal gene transfer (HGT)  or in cases where a closely related reference genome is not 
available11,12. 
In contrast, the de novo assembly of genomes involves stitching together the fragmented 
short reads of DNA without the use of a reference strain, instead relying on complex 
computations and probabilistic methods to construct continuous stretches of DNA, or 
contigs9. This process commonly uses De Bruijn graphs to construct a putative consensus 
sequence through overlapping reads by a particular length, the k parameter or hash length, 
of the matching nucleotides13. These uninterrupted ‘contigs’ can contain multiple genes 
including those that may not have been present in a reference strain. Contigs can also then 
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be joined and extended by ‘scaffolding’ with reads mapped to a reference to capture any 
genetic information which may be present in the reference strain but were missed through 
inaccuracies in the de novo assembly. The contigs can be annotated to determine protein 
coding regions which can then compared to the sequences of previously described genes in 
other species or strains through tools such as BLAST14. 
Due to the plasticity of the bacterial genome through processes such as HGT and 
conjugation, it is thought that the ‘true’ complete genome of a species can never be fully 
described15. However, reconstructing genomes with de novo assemblies can result in a 
greater approximation of content of both the ‘core genome’ - genes that are shared by all 
individuals – and ‘accessory genome’ - genes found at different frequencies (<99%) – of a 
population. The core and accessory genomes can be described together as the ‘pan-
genome’ of a particular species. Describing the differences in pan genomes either between 
or within species allows us to use the presence and absence of genes as the unit of 
comparison, as well as the variation within core genes from standard reference-based SNP 
analysis12,15–19. This is particularly effective for discovering new genes and functions or 
identifying recombination and gene loss events within in a population.  
Shigella is a genus of Gram-negative bacteria responsible for causing shigellosis, or 
bacillary dysentery, which can cause severe diarrhoea and even death in some cases, 
particularly in children under 5 years of age or people with a compromised immune 
response20,21. There are four serogroups that have formed the basis for the delineation into 
species: S. sonnei, S. flexneri, S. boydii and S. dysenteriae, with all but S. sonnei comprising 
multiple serotypes based on the somatic O-antigen, and the serocomplex is closely related 
to Escherichia coli22,23. The most commonly found species are S. sonnei and S. flexneri with 
the latter historically associated with infections isolated from developing countries24–27. These 
species also show different epidemiological patterns, with S. flexneri typically causing a 
more severe disease and being responsible for more fatalities28.  
Recently, patterns have begun to emerge of a species shift in many developing countries, 
with shigellosis infections caused by S. sonnei becoming more prevalent to the degree that it 
is now replacing S. flexneri as the primary agent of bacillary dysentery in many of these 
regions28–30. The emergence of S. sonnei in these regions has been investigated using 
phylogeographic tools 31,32 and different studies have identified differences in 
transmission33,34, epidemiological35–37 and antimicrobial resistance26,30,38 features between 
the two species. Yet, the reasons for the species replacement remain unclear as there is 
some uncertainty over how these factors may have contributed to the observed spread of S. 
sonnei.  Additionally, there is evidence that there may be an environmental component in the 
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transmission of Shigella spp., with organisms able to occupy environmental reservoirs such 
as on food37,39,40, fomites41 and in waterways24,29,42, though again their impact on the 
transmission and potential differences between Shigella species is not yet fully understood.  
Direct and indirect associations with other organisms both in the environment and within a 
host may also impact on the relative shifts in distribution of the two species. S. sonnei has 
been shown to be protected in the environment through phagocytosis by the common 
amoeba Acanthamoeba castellanii which can shield the bacteria from otherwise inhabitable 
conditions43,44. There is also evidence of secondary host immunity to S. sonnei acquired 
through exposure to Plesiomonas shigelloides, a bacterial species commonly occupying 
poor quality water systems, which shares the same major lipopolysaccharide (LPS) O-side 
chain surface antigen, the first target of an immune response22,45.  
Both S. flexneri and S. sonnei contain a major plasmid, pINV, which encodes many essential 
and beneficial phenotypic traits, including virulence and antibiotic resistance46. This plasmid 
is less likely to be maintained in environmental temperatures in S. sonnei though, which will 
lower the ability of the species to cause disease outside of the host47. This may suggest key 
environmental differences between Shigella species, with S. sonnei better adapted to life 
within a host with transmission as person-to-person. 
Despite the previous efforts to identify the causes behind the replacement in the two Shigella 
species, the possible role of differences in genome content between the two species has 
been ignored to date. This prompted a study aiming to reconstruct the complete pan genome 
of clinical strains of S. sonnei and S. flexneri isolated from Vietnam, a region that has 
recently undergone this pattern of species replacement. I expect that by using de novo 
assembly rather than a reference-based approach I will be able to better capture the full 
genomic content of both Shigella species in this population and identify genes that may 
contribute to phenotypic and ecological differences. In addition, a set of globally distributed 
strains were analysed to characterize broad species-level variation in gene content. 
Additionally, understanding the genetics underlying differences in Shigella spp. Life histories 
and epidemiology may help us to improve the management of shigellosis infections, and 
more generally contribute to our knowledge of infectious disease emergence and 
transmission27.  
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5.3 Methodology 
Shigella isolates  
135 Shigella flexneri and 146 Shigella sonnei clinical isolates from three regions in Vietnam, 
Ho Chi Minh, Hue and Khanh Hoa, were selected from data sequenced in Holt et al., 201332, 
with raw paired-read FASTQ files obtained from the Wellcome Trust Sanger Institute online 
database48. In addition, 60 isolates of both species were chosen from a global dataset 
comprising S. sonnei and S. flexneri samples from 25 and 34 countries respectively, with all 
subsequent analysis carried out separately to the Vietnamese samples for later pan genome 
comparison. Sequence data was also taken from the Wellcome Trust Sanger Institute online 
database48, details of the selected samples including accession number and location are 
available in the supplementary materials. 
 
De Novo assembly 
Paired read FASTQ files were quality checked with adapter removal and read trimming was 
carried out where required using the methods detailed in Chapter 4. High quality forward and 
reverse reads were assembled for each sample strain using VelvetOptimiser49, a Perl 
wrapper tool for optimising Velvet assemblies. Velvet attempts to build contigs, continuous 
lengths of uninterrupted nucleotides, by constructing a De Bruijn graph that works to link 
lengths of matching of nucleotide bases. These lengths of nucleotides are substrings of the 
reads called k-mers with a length determined by the hash/word length or k parameter, and 
these will be linked by k-1 bases so that a contig is extended by one base with each added 
k-mer. VelvetOptimister optimizes the hash/word length and expected coverage parameters 
in the assembly by searching through user defined minimum and maximum bounds. 
Assembled contigs were then joined by scaffolding with raw reads mapped to complete 
genomes of a reference strain (S. sonnei strain 046 NC_007384 or S. flexneri strain 2a 301 
NC_004337.2) using AlignGraph50. Both extended and remaining contigs were then 
combined into one FASTA file for annotation and building the pan genome. 
 
Annotation and pan genome construction 
Prokka51 was used to annotate assembled and joined contigs (>100bp) with genomic 
features such as genes and RNAs as well as hypothetical coding regions which do not 
match any previously annotated features found in the searched databases. The resulting 
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annotated contig files were then analysed by Roary52 to build the pan genome and resulting 
presence/absence tables of homologous gene clusters (HGCs) through clustering of 
transcribed protein sequences by similarity (98% CD-HIT, 95% BLASTP sequence identity). 
Roary assigns a gene name and genomic function annotation to each HGC where possible 
through searches with BLASTP, with paralogous genes (gene duplication events) identified 
and retained in separate clusters. Separate HGCs may also be assigned the same gene 
name and function in cases where the BLASTP result is the same gene by descent from a 
different species of origin (orthology). The results were separated into isolates belonging to 
either S. flexneri or S. sonnei and the presence/absence of HGCs in these samples 
recalculated in R53. When analysing homologous groups, hypothetical proteins and 
duplicated genes that were markedly shorter than the annotated gene from the origin 
species were removed, as these are often indicative of non-functional pseudogenes. The 
complete workflow is described in Figure 1. 
 
 
Figure 1: A methodological workflow of de novo assembly and pan genome construction as used in 
this study. 
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Analysis of homologous groups 
Pairwise all-against-all genetic distance of the consensus contig sequences of all isolates 
was carried out using MASH54 which calculates simple, rapid distance estimation between 
sequences using a MinHash algorithm. The resulting distance matrix was compared to a 
matrix of the pairwise shared number of HGCs between isolates by calculating the Pearson 
product-moment correlation coefficient to determine whether there is a significant correlation 
between gene presence/absence and genome wide diversity (including within gene variation 
and non-coding regions). 
Gene ontology (GO) terms were found by clustering annotated gene names into categories 
of molecular function with the PANTHER Classification System from the Gene Ontology 
Consortium55,56 to illustrate broad, genome-wide patterns of gene function predicted for each 
species. Specific HGCs assigned a gene name that were present in significantly different 
frequencies in each species were manually reviewed for previous characterization of the 
function and resulting phenotype in Shigella or related species. 
 
 
 
Shigella flexneri Shigella sonnei 
HGCs 
HGCs w/ 
assigned gene 
HGCs 
HGCs w/ 
assigned gene 
Core (99% <= isolates <= 100%) 
 
1928 1902 2951 2722 
Softcore (95% <= isolates < 
99%) 
 
445 560 475 462 
Shell (15% <= isolates < 95%) 
 
2994 1432 1495 559 
Cloud (0% <= isolates < 15%) 
 
7683 2157 4988 1280 
Total 
 
13050 6051 9909 5023 
 
Table 1: The number of Homologous Gene Clusters (HGCs) in S. sonnei and S. flexneri both before 
and after the removal of potential pseudogenes, hypothetical proteins and non-annotated groups.  
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5.4 Results 
Pan genome estimation 
Overall, 12,708 homologous gene cluster (HGCs) were identified through the construction of 
the de novo pan genome of all isolates belonging to both S. sonnei and S. flexneri. The 
removal of groups missing a gene name and putative functional annotation (hypothetical 
proteins) decreased the number to 6,854 clusters and of the annotated HGCs there were 
3,003 unique previously described gene names.  The average number of annotated HGCs 
identified for a single sample is 3,548 (σ=61.66) in S. sonnei and 3,417 (S σ=78.9) in S. 
flexneri. This is in line with previous estimates for the number of CDS regions in the 
reference genomes for each species, with 3,569 genes in S. sonnei 046 and 3,565 in S. 
flexneri 30121. 
The construction of the pan genome from de novo assemblies identified 1,104 genes found 
in S. sonnei (916 in >=95% of isolates) and 1,237 in S. flexneri (718 in >=95% of isolates) 
that were not found in the respective S. sonnei 046 and S. flexneri 301 reference genomes. 
This reflects the variability in gene content that can be present between tested strains and 
widely used reference genomes thus underlining the advantage of using de novo assemblies 
when searching for novel genes or functions. 
The pan genome of S. sonnei (with hypothetical proteins and potential pseudogenes 
removed) comprises 5,023 HGCs, with 2,722 HGCs classed as ‘core’, found in >=99% 
isolates, and 462 HGCs ‘softcore’, >=95% isolates (Table 1). The pan genome of S. flexneri 
differs in its relative proportion of the 6,051 total HGCs classified as core and softcore, with 
1,902 and 560 HGCs in each category respectively. This number is again analogous to 
previous estimates of the core genome of E. coli and Shigella spp.2, although the number of 
core genes in S. sonnei is marginally higher, likely owing to the strongly clonal evolution of 
the tested isolates32. The number of rare HGCs (‘cloud’ genes, shared by <15% isolates) 
was significantly higher in the S. flexneri pan genome with these clusters accounting for 
around 35.65% of the total HGCs identified in S. flexneri samples compared to 25.58% in S. 
sonnei. 
The difference in the number of shared HGCs found in at least 95% of strains between S. 
sonnei and S. flexneri may reflect the true difference in softcore genome size or it may be 
biased through variation in intra-species genetic diversity. It has been reported that 
Increasing the number of samples and adding more diverse strains when estimating 
bacterial pan genomes will decrease the number of genes shared between isolates and 
reduce the size of the core genome19,57.  
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Rarefaction curves were produced for both the shared and total number of HGCs for each 
species by randomly sampling an increasing number of isolates, (up to the total number for 
each species) over 1,000 iterations, and estimating the number of total and shared genes 
captured at these sample numbers (Figure 2). The total HGC accumulation curves (Figure 
2A) for both S. sonnei and S. flexneri begin to plateau at around 35 samples, with 95% of 
the total HGCs captured, suggesting that adding further samples will only negligibly increase 
the number of novel HGCs identified and thus the number of isolates used in this study 
accurately capture the majority of the total genes found in the population. Consistent with the 
patterns shown in previous studies, the rarefaction curves for the number of shared HGCs 
decline as more samples are added (Figure 2B), indicating that the core genome of a 
species will also decrease. The number of shared genes in S. sonnei, although not reaching 
a clear plateau, appears to decline less rapidly than in S. flexneri indicating fewer shared 
genes between any two S. flexneri samples on average, and suggesting higher diversity 
within the S. flexneri isolates included in this study. 
To determine whether genetic diversity was linked to the number of shared HGCs, and thus 
the size of the core genome, I computed the pairwise genetic distance between samples and 
compared these estimates to the number of shared genes between each pair using the 
Pearson product-moment correlation coefficient (Figure 3). The average intra specific 
genetic distance between pairs was 1.175x10-3 (σ=5.32x10-4) for S. sonnei samples and 
6.62x10-3 (σ=6.38x10-3) for S. flexneri, with the average number of shared genes 6,562.77 
(σ=88.879) and 6,193.78 (σ=347.67) respectively. Overall there was a significant negative 
correlation between genetic diversity and number of shared genes (Pearson’s r = -0.9674). 
As the genetic diversity of S. flexneri was higher than S. sonnei this may explain the reason 
that the number of shared HGCs was lower in this species and the greater number of novel 
and low frequency HGCs identified.  
 
Genome wide functional variation 
Unique gene names assigned to HCGs identified in each species, both overall and in at least 
the softcore genome, were analysed with the PANTHER Classification System to infer 
potential functional differences between S. sonnei and S. flexneri (Table 2). The categories 
used for classification were based on GO-slim terms for molecular function to capture a 
general representation of the broad function of the genes in each group. Of the 2,839 unique 
gene names identified in the total pan genomes of S. sonnei and 2,921 in S. flexneri, 1,720 
and 1,748 genes were assigned to a functional category. The most represented category 
was for both species was catalytic activity (GO:0003824), genes involved in catalysis of  
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B
 
Figure 2: a) Accummulation and b) rarefaction curves illustrating the number of new and shared 
HGCs that were identified within each species when increasing the number of samples. Random 
sampling was carried out 1000 times at each sampling number to attain an average number of HGCs. 
Dotted lines represent the upper and lower bounds of HGCs present and solid line is the mean 
average. 
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Figure 3: A heatmap illustrating the number of shared genes (red) and the genetic distance (blue) 
between all pairs of isolates used in this study. Genetic distance was measured by a MinHash 
algorithm and correlation between the number of shared genes and distance was computed using the 
Pearson product-moment correlation coefficient. 
 
substrates in biochemical reactions, with the majority of other genes involved in binding 
(GO:0005488) and transporter activity (GO:0005215).  
Overall, there was no significant difference between numbers of genes represented by each 
molecular function category in each species (Χ2 = 2.080, df = 11, p-value = 0.9982); this was 
also true for genes found in at least 95% of isolates, the softcore genome, (Χ2 = 3.734, df = 
11, p-value = 0.9771). The bfr gene found to be present in all sampled S. flexneri genomes 
and allocated the molecular function of nutrient reservoir activity (GO:0045735), was the only 
instance where a functional category was present in only one of the species. This gene 
confers bacterioferritin, a haemoprotein involved in iron storage, which has been linked to 
oxidative stress response in Bacteroides fragilis, an anaerobic bacterial pathogen, with 
mutants lacking this gene exhibiting a lower oxygen tolerance58,59. 
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 Number of genes % of total genes 
 S. sonnei S. flexneri S. sonnei S. flexneri 
Catalytic activity (GO:0003824) 
 
1015 (947) 1027 (835) 41.1% (40.7%) 40.8% (42.1%) 
Binding (GO:0005488) 
 
279 (258) 282 (238) 11.3% (11.1%) 11.2% (12.0%) 
Transporter activity (GO:0005215) 
 
224 (211) 231 (175) 9.1% (9.1%) 9.2% (8.8%) 
Nucleic acid binding transcription 
factor activity (GO:0001071) 
70 (66) 70 (56) 2.8% (2.8%) 2.8% (2.8%) 
Structural molecule activity 
(GO:0005198) 
58 (56) 58 (54) 2.3% (2.4%) 2.3% (2.7%) 
Translation regulator activity 
(GO:0045182) 
37 (31) 40 (31) 1.5% (1.5%) 1.6% (1.6%) 
Antioxidant activity (GO:0016209) 
 
12 (12) 12 (10) 0.5% (0.5%) 0.5% (0.5%) 
Enzyme regulator activity 
(GO:0030234) 
11 (9) 14 (8) 0.4% (0.4%) 0.6% (0.4%) 
Electron carrier activity 
(GO:0009055) 
 
5 (4) 5 (4) 0.2% (0.2%) 0.2% (0.2%) 
Protein binding transcription 
factor activity (GO:0000988) 
5 (5) 4 (4) 0.2% (0.2%) 0.2% (0.2%) 
Receptor activity (GO:0004872) 
 
4 (4) 4 (3) 0.2% (0.2%) 0.2% (0.2%) 
Nutrient reservoir activity 
(GO:0045735) 
0 (0) 1 (1) 0.0% (0.0%) 0.0% (0.1%) 
 
Table 2: Classification of HGCs by Molecular Function GO term by the PANTHER Functional 
Classification System. 
 
Species-specific genome content  
Comparing the presence and absence of specific genes in the pan genomes of S. sonnei 
and S. flexneri allows for the inference of potential differences in expressed phenotypes 
between the species. Notably, genes found in essentially every sample from one species (in 
the core or softcore genomes) yet at very low frequencies or absent in the other can point 
towards genes that characterise true functional differences between the species. In addition, 
due to the relatively high relatedness between Shigella spp., a gene that is completely 
absent in one species yet in the core or softcore of another suggests either a gain of a gene 
function and subsequently sweep to near or complete fixation, or can be evidence of gene 
loss through genetic drift or species specific selection differences. Either mechanism will 
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shape the pan genome content and potential functional variation that may be important in 
informing the ecology or lifestyle of an organism. 
There were 117 HGCs present in at least the core genome of S. sonnei (>99% of isolates) 
that were not found in any of the pan genomes of S. flexneri isolates and this number rises 
to 131 when including those in the softcore genome of S. sonnei (>=95% of isolates). There 
were fewer HGCs present only in the S. flexneri pan genome, with 34 unique HGCs in the 
core and 53 in the softcore genome likely due to the smaller core and softcore genome 
compared to S. sonnei. These numbers include separate HGCs assigned the same gene 
name and those that were not assigned a gene name but were given a putative function, 
typically integrated phage proteins. These genomic features still may confer some 
phenotypic variation in the species that could influence the ecology. 
Expanding the analysis to include HGCs that were present in one species at a high 
frequency (softcore genome, >=95% isolates) but were also present at low frequencies in 
the other species (<15% isolates) further identifies genes that may be likely candidates for 
broad functional differences between the species. An additional 185 HGCs were found in at 
least the softcore genome of S. sonnei that were found in less than 15% of S. flexneri 
isolates, and 12 HGCs in the softcore of S. flexneri that were found at a low frequency in S. 
sonnei. Again, the difference in the number of HGCs found in these proportions between the 
species is likely a result of the larger core genome of S. sonnei as well as the relatively 
smaller number of cloud, or low frequency, HGCs. 
A full list of HGCs that were present, either solely or significantly more frequently, in each 
species is available in Supplementary materials. 
 
Functional characterization of species-specific genes 
Further analysis of the functional annotations assigned to HGCs that were present in 
significantly different frequencies in S. sonnei and S. flexneri revealed some putative 
candidate genes that may be linked to ecological and phenotypic differences between 
species (Table 3). HGCs found in significantly higher numbers in only one species but with 
another HGC with the same assigned gene name and functional annotation present in the 
other species in more than 15% of isolates was excluded from this analysis, along with 
groups not assigned a gene name. Although there may be functional differences conferred 
by these features, this is beyond the scope of this study and it would require experimental 
validation to test for any variation in the expressed phenotype. 
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Of the genes identified that segregated either completely or in significantly higher numbers 
in S. sonnei, a large number have been associated with ecological niche adaptation, 
particularly through utilization of a variety of sources of catabolic substrates and stress 
response mechanisms. These associations include adaptations to the host organism, such 
as the hcpA gene, linked to intestinal adherence, and the platelet binding gene gspB 
previously isolated in Streptococcus gordonii, as well as to the external environment, 
including involvement in the nitroduction cycle (nar genes) and degradation of the herbicide 
atrazine in Pseudomonas with the gene atzC. The S. flexneri genome notably contained no 
genes that could be linked directly to environmental survival that were not also found in 
significant numbers of S. sonnei. 
Genes involved in the catabolism of specific carbohydrates and other metabolic substrates 
were identified in markedly different proportions in S. sonnei and S. flexneri. Metabolic genes 
have been previously shown to distinguish between E. coli and Shigella genomes, with a 
number of genes found in E. coli absent in Shigella spp., proposed to be due to narrower 
niche specialization in Shigella60. The variation in metabolic mechanisms in S. sonnei and S. 
flexneri may demonstrate that these species are optimally adapted to employ different 
niches, with the larger catabolism associated genome content of S. sonnei appearing to 
enable the organism to utilize a wider breadth of energy sources.  
Six genes (the cas operon and ygb gene family) associated with the CRISPR/Cas system of 
protection from phages and other mobile genetic elements were discovered in more than 
95% of S. sonnei isolates, highlighting the presence of an acquired immunity mechanism in 
S. sonnei that appears not to be present in all the S. flexneri isolates sampled. This system 
may assist in the persistence and survival of this species through protection against 
bacteriophages, both in the host organism and the external environment61. 
The S. sonnei genome also contains a variety of genes linked to toxin/antitoxin systems that 
are not found in S. flexneri. These systems are common in prokaryotes and when found on 
plasmids are predominately linked to ensuring these plasmids are inherited by daughter cells 
after segregation62. Chromosomal toxin/antitoxin systems are less well understood and have 
been hypothesized to be associated with mechanisms for biofilm formation63, antibiotic 
resistance64 and gene regulation65. Interestingly, it has been theorized that these systems 
can be a response to nutrient stress or starvation, with the E. coli MazEF and RelE2 
toxin/antitoxin systems, identified here in S. sonnei, either inducing death in an individual to 
altruistically lower the nutrient uptake of the population, or by inhibiting translation to 
decrease individual nutrient demand66,67. These response mechanisms to nutrient depletion 
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could play an important role in ensuring the survival of S. sonnei in nutrient poor 
environments.  
Antibiotic resistance associated genes were also identified in S. sonnei, including the sbmC 
gene that has been shown to be up-regulated in Salmonella enterica var. Typhimurium in the 
presence of sub-minimum inhibitory concentrations of fluroquinolones. The use of these 
antimicrobials is known to be widespread in Vietnam where bacterial resistance common29. 
 
Geographic gene differences 
There were no HGCs that segregated completely by geographic region when considering 
both S. sonnei and S. flexneri samples together that were isolated from three provinces in 
Vietnam; Ho Chi Minh City, Hue and Khanh Hoa. In addition, no HGCs were significantly 
more likely to be found in both species isolated from one region (present in more than 95% 
of isolates compared to less than 15% of isolates from another province). This suggests that 
there is limited evidence of a shared gene pool and recombination of newly acquired genes 
between S. sonnei and S. flexneri in these local populations, and that the species-level pan 
genome has been formed predominately by species-specific gene acquisition and loss.   
Comparing local populations of each S. sonnei and S. flexneri separately, there were also no 
HGCs that segregated by geography within each species, either completely or in markedly 
higher proportions. The majority of HGCs that were found only in one region were identified 
in single individuals, suggesting either that the majority of recombination is individual, or that 
it is transient within the population and the shared genome of each species will have been 
formed prior to the spread of the pathogen across Vietnam. Alternatively, it suggests that 
strongly beneficial genes will sweep rapidly to fixation or be acquired at multiple, convergent 
times within a species, such as has been shown previously with antimicrobial resistance 
genes in S. sonnei in this region32
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HGC 
gene 
name 
Function 
Shigella 
sonnei 
presence 
(n=146) 
Shigella 
flexneri 
presence 
(n=135) 
Additional notes 
aarA Rhomboid protease AarA 146 13 Involved in aminoglycoside resistance in Providencia stuartii.68 
abgA p-aminobenzoyl-glutamate hydrolase subunit A 144 10 Folate uptake - increase resistance to sulfonamide antibiotics.69 
abgB p-aminobenzoyl-glutamate hydrolase subunit B 146 10 Folate uptake - increase resistance to sulfonamide antibiotics.69 
abgT p-aminobenzoyl-glutamate transport protein 146 10 Folate uptake - increase resistance to sulfonamide antibiotics.69 
acoR 
Acetoin dehydrogenase operon transcriptional 
activator AcoR 
0 129 
Involved in carbon storage or avoiding acidification. Acetoin excreted 
when with glucose or other fermentable carbon sources.70 
adhB Alcohol dehydrogenase 2 0 134 Ethanol oxidation in aerobic respiration.71 
adhT Alcohol dehydrogenase 0 133 Ethanol oxidation in aerobic respiration.71 
aldB Aldehyde dehydrogenase B 0 133 Ethanol oxidation in aerobic respiration.72 
allA Ureidoglycolate lyase 0 135 - 
allB Allantoinase 146 14 - 
allR HTH-type transcriptional repressor AllR 0 134 - 
aplIR Type-2 restriction enzyme AplI 146 0 - 
arcC2 Carbamate kinase 2 146 0 - 
argF Ornithine carbamoyltransferase 145 13 - 
atoA Acetate CoA-transferase subunit beta 145 0 Degradation of short chain fatty acids.73 
atoD Acetate CoA-transferase subunit alpha 145 0 Degradation of short chain fatty acids.73 
atoE Short-chain fatty acids transporter 146 0 Degradation of short chain fatty acids.73 
atzC N-isopropylammelide isopropyl amidohydrolase 146 0 Degradation of herbicide Atrazine.74 
avtA Valine--pyruvate aminotransferase 0 134 - 
bfd Bacterioferritin-associated ferredoxin 0 135 Oxidative stress. 
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bfr Bacterioferritin 0 135 - 
cadA Lysine decarboxylase, inducible 146 0 Bacterial acid stress.75 
cadC Transcriptional activator CadC 146 0 Bacterial acid stress.75 
casA CRISPR system Cascade subunit CasA 146 13 Protection against viruses and other mobile genetic elements.76 
casC CRISPR system Cascade subunit CasC 146 13 Protection against viruses and other mobile genetic elements.76 
casD CRISPR system Cascade subunit CasD 138 11 Protection against viruses and other mobile genetic elements.76 
casE CRISPR associated protein 144 13 Protection against viruses and other mobile genetic elements.76 
ccmL 
Carbon dioxide concentrating mechanism 
protein CcmL 
146 0 Persistence in aquatic environments.77 
cdhB Caffeine dehydrogenase subunit beta 143 0 Degradation of caffeine in Pseudomonas.78 
clpP1 
ATP-dependent Clp protease proteolytic subunit 
1 
145 0 Acclimation to UV-B and low temperature in cyanobacteria.79 
dacD 
D-alanyl-D-alanine carboxypeptidase DacD 
precursor 
146 0 Cell wall biosynthesis - penicillin binding protein (PBP).80 
ddpA 
putative D,D-dipeptide-binding periplasmic 
protein DdpA precursor 
143 13 - 
ddpB 
putative D,D-dipeptide transport system 
permease protein DdpB 
146 13 - 
ddrA 
Diol dehydratase-reactivating factor alpha 
subunit 
146 19 Preserves genome integrity.81 
dhaK 
PTS-dependent dihydroxyacetone kinase, 
dihydroxyacetone-binding subunit DhaK 
0 131 
PTS-dependent dihydroxyacetone kinase instead of ATP - involved in 
carbohydrate uptake and control of carbon metabolism in bacteria.82 
dhaL 
PTS-dependent dihydroxyacetone kinase, ADP-
binding subunit DhaL 
0 130 
PTS-dependent dihydroxyacetone kinase instead of ATP - involved in 
carbohydrate uptake and control of carbon metabolism in bacteria.82 
dinJ Antitoxin DinJ 146 0 With yafQ forms dinJ-yafQ operon - toxin/antitoxin stress response.83 
dlgD 2,3-diketo-L-gulonate reductase 0 133 - 
dmlA D-malate dehydrogenase [decarboxylating] 146 13 
Growth on D-malate as sole carbon source and in butanoate 
metabolism, a by-product of anaerobic respiration and highly 
concentrated in the human gut.84 
ecfT 
Energy-coupling factor transporter 
transmembrane protein EcfT 
0 134 Cellular transport. 
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envR putative acrEF/envCD operon repressor 146 13 Drug efflux pump gene.85 
flr Flavoredoxin 145 0 Only characterised in Desulfovibrio gigas. 
frmA S-(hydroxymethyl)glutathione dehydrogenase 144 0 Detoxificaiton of formaldehyde.86 
frmB S-formylglutathione hydrolase FrmB 144 0 Detoxificaiton of formaldehyde.86 
frmR Transcriptional repressor FrmR 144 0 Detoxificaiton of formaldehyde.86 
galF UTP--glucose-1-phosphate uridylyltransferase 0 135 
Increasing the intracellular concentration of UDP-glucose and enhancing 
the thermal stability of the UDP-glucose pyrophosphorylase.87 
gbpR HTH-type transcriptional regulator GbpR 146 10 Found in Agrobacterium - involved in sugar chemotaxis.88 
gno Gluconate 5-dehydrogenase 146 0 Oxidation of glucose.89 
gspB Putative general secretion pathway protein B 146 0 Platelet binding in Streptococcus gordonii.90 
guaD Guanine deaminase 145 19 - 
hcpA Major exported protein 146 7 May be linked to intestinal adherence.91  
hicB Antitoxin HicB 146 8 Toxin/antoxin operon along with HicA - nutrient stress.92 
hilA Transcriptional regulator HilA 146 0 Invasion gene regulator in Salmonella entericaserovar Typhimurium.93 
hipA Serine/threonine-protein kinase HipA 146 0 
Toxin/antitoxin system - mutations linked to multidrug resistant 'persister' 
cells and can influence biofilm formation.94 
hipB Antitoxin HipB 146 0 
Toxin/antitoxin system - mutations linked to multidrug resistant 'persister' 
cells and can influence biofilm formation.94 
hyuA D-phenylhydantoinase 146 13 - 
iadA Isoaspartyl dipeptidase 0 132 - 
idnD L-idonate 5-dehydrogenase (NAD(P)( )) 146 1 Growth on L-idonate as sole carbon source.95 
idnT Gnt-II system L-idonate transporter 146 0 Growth on L-idonate as sole carbon source.95 
iraD Anti-adapter protein IraD 0 131 Stress response.96 
lacY Lactose permease 146 0 Lactose metabolism.97 
leuE Leucine efflux protein 146 13 - 
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lysU Lysine--tRNA ligase, heat inducible 146 0 Heat shock/stress response. 
malS Alpha-amylase precursor 0 134 - 
matA HTH-type transcriptional regulator MatA 146 10 Regulation of adherence to epithelium or biofilm formation.98 
mazE Antitoxin MazE 146 13 Toxin/antitoxin - stress response.99 
mazF mRNA interferase MazF 146 13 Toxin/antitoxin - stress response.99 
merA Mercuric reductase 146 4 Mercury resistance.100 
mhpC 
2-hydroxy-6-oxononadienedioate/2-hydroxy-6-
oxononatrienedioate hydrolase 
144 0 Mhp cluster- recycling of carbon sources in the ecosystem.101 
mhpD 2-keto-4-pentenoate hydratase 143 0 Mhp cluster- recycling of carbon sources in the ecosystem.101 
mhpF Acetaldehyde dehydrogenase 144 0 Mhp cluster- recycling of carbon sources in the ecosystem.101 
mkaC Virulence genes transcriptional activator 146 18 Activation of virulence genes in Salmonella serovar Typhimurium.102 
mocA Molybdenum cofactor cytidylyltransferase 145 13 Molybdopterin Cytosine Dinucleotide biosynthesis.103 
mshB 
1D-myo-inositol 2-acetamido-2-deoxy-alpha-D-
glucopyranoside deacetylase 
144 0 Production of mycothiol - only found in Actinobacteria.104 
mtaD 
5-methylthioadenosine/S-adenosylhomocysteine 
deaminase 
145 0 - 
narV Respiratory nitrate reductase 2 gamma chain 144 0 Nitroduction cycle in the environment.105 
narW 
putative nitrate reductase molybdenum cofactor 
assembly chaperone NarW 
145 0 Nitroduction cycle in the environment.105 
nhoA N-hydroxyarylamine O-acetyltransferase 143 0 - 
outO 
Type 4 prepilin-like proteins leader peptide-
processing enzyme 
19 133 - 
pac Penicillin G acylase precursor 145 20 Production of semisynthetic penicillin.106 
pbpX Putative penicillin-binding protein PbpX 146 13 
Endospore formation and vegetative state in Bacillus - environmental 
stress response.107 
pcaK 4-hydroxybenzoate transporter PcaK 144 0 Metabolism of aromatic compounds in Pseudomonas.108 
pduA Propanediol utilization protein PduA 146 0 
1,2 propanediol utilization - propylene glycol which is used in many 
manufactured products and shown to be a pollutant in waterways.109,110 
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pduB Propanediol utilization protein PduB 146 0 
1,2 propanediol utilization - propylene glycol which is used in many 
manufactured products and shown to be a pollutant in waterways.109,110 
pduC Propanediol dehydratase large subunit 146 0 
1,2 propanediol utilization - propylene glycol which is used in many 
manufactured products and shown to be a pollutant in waterways.109,110 
pduD Propanediol dehydratase medium subunit 145 0 
1,2 propanediol utilization - propylene glycol which is used in many 
manufactured products and shown to be a pollutant in waterways.109,110 
pduE Propanediol dehydratase small subunit 146 0 
1,2 propanediol utilization - propylene glycol which is used in many 
manufactured products and shown to be a pollutant in waterways.109,110 
pduF Propanediol diffusion facilitator 146 0 
1,2 propanediol utilization - propylene glycol which is used in many 
manufactured products and shown to be a pollutant in waterways.109,110 
pduL Phosphate propanoyltransferase 146 0 
1,2 propanediol utilization - propylene glycol which is used in many 
manufactured products and shown to be a pollutant in waterways.109,110 
pduU Propanediol utilization protein PduU 146 0 
1,2 propanediol utilization - propylene glycol which is used in many 
manufactured products and shown to be a pollutant in waterways.109,110 
pemK mRNA interferase PemK 1 135 
Stable inheritance of R100 resistance plasmid - mercuric ion 
sensitivity.111 
pimB 
GDP-mannose-dependent alpha-(1-6)-
phosphatidylinositol monomannoside 
mannosyltransferase 
0 133 
Cell wall synthesis - M. tuberculosis - can increase rate of human 
macrophage death.112 
pptA Tautomerase PptA 145 0 - 
pstS1 Phosphate-binding protein PstS 1 precursor 146 12 Involved in phosphate uptake and virulence in M. tuberculosis.113 
pucA putative xanthine dehydrogenase subunit A 146 13 - 
putA Bifunctional protein PutA 146 13 
Proline utilization - critical for survival of S. aureus in low proline 
environments with the host.114 
putP Sodium/proline symporter 145 13 
Proline utilization - critical for survival of S. aureus in low proline 
environments with the host.114 
racX putative amino-acid racemase 0 134 - 
relE2 Toxin RelE2 146 4 Toxin/antoxin operon. 
rfaL O-antigen ligase 146 13 Outer membrane biosynthesis. 
rfbC dTDP-4-dehydrorhamnose 3,5-epimerase 0 134 O antigen synthesis.115 
rfbD dTDP-4-dehydrorhamnose reductase 0 133 O antigen synthesis.115 
rhmD L-rhamnonate dehydratase 146 13 Fructose and mannose metabolism, and transcription. 
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rhmR 
putative HTH-type transcriptional regulator 
RhmR 
145 13 Fructose and mannose metabolism, and transcription. 
rhsA putative deoxyribonuclease RhsA 146 1 Intracellular competition.116 
rmlA1 Glucose-1-phosphate thymidylyltransferase 1 0 134 - 
rpiB Ribose-5-phosphate isomerase B 146 13 Sugar phosphate isomerase and metabolism of rare sugar allose.117  
salL Adenosyl-chloride synthase 146 13 
Chlorine incorporation in Salinispora tropica - a marine bacterial 
species.118 
sbmC DNA gyrase inhibitor 146 0 
Up-regulated in Salmonella enterica var. Typhimurium in sub-MIC 
fluroquinolones.119 
sfaG S-fimbrial protein subunit SfaG precursor 0 131 Virulence factor.120 
sfaS S-fimbrial adhesin protein SfaS precursor 0 134 Virulence factor.120 
sicA Chaperone protein SicA 146 0 Linked to virulence in Salmonella spp.121 
sinR HTH-type transcriptional regulator SinR 145 8 Involved in biofilm formation and lactate utilization in Bacillus subtilis.122 
taqIM Modification methylase TaqI 146 0 - 
torI Response regulator inhibitor for tor operon 146 0 Regulation of environmental response torCAD opern.123 
wcaJ 
UDP-glucose:undecaprenyl-phosphate glucose-
1-phosphate transferase 
0 132 Lipid-linked glycan biosynthesis.124 
wzxC Lipopolysaccharide biosynthesis protein WzxC 0 134 - 
xylF D-xylose-binding periplasmic protein precursor 0 135 Xylose sugar transport.125 
xylG 
2-hydroxymuconic semialdehyde 
dehydrogenase 
1 134 Xylose sugar transport.125 
xylH Xylose transport system permease protein XylH 0 132 Xylose sugar transport.125 
xylR Xylose operon regulatory protein 0 134 Xylose sugar transport.125 
yafQ mRNA interferase YafQ 146 0 With dinJ forms dinJ-yafQ operon - toxin/antitoxin stress response.83 
yagU Inner membrane protein YagU 146 13 Extreme acid tolerance.126 
yahK Aldehyde reductase YahK 145 0 Glucose metabolism and the production of aldehydes.127 
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ybbY Putative purine permease YbbY 146 14 - 
ybhA Pyridoxal phosphate phosphatase YbhA 0 135 Sugar metabolism. 
ydcR putative HTH-type transcriptional regulator YdcR 146 0 - 
yddE putative isomerase YddE 145 0 - 
yedR Inner membrane protein YedR 146 13 - 
ygbF CRISPR-associated endoribonuclease Cas2 146 13 - 
ygbT CRISPR-associated endonuclease Cas1 146 13 - 
ygeX Diaminopropionate ammonia-lyase 146 13 Growth on DL-DAP as carbon source.128 
yggF Fructose-1,6-bisphosphatase 2 class 2 0 134 Sugar metabolism. 
yhaI Inner membrane protein YhaI 145 13 - 
yjdF Inner membrane protein YjdF 0 132 - 
yjdL putative dipeptide and tripeptide permease YjdL 146 0 Nutrient transport. 129 
yjiE HTH-type transcriptional regulator YjiE 1 133 - 
yjiG Inner membrane protein YjiG 0 132 - 
yjmD 
putative zinc-type alcohol dehydrogenase-like 
protein YjmD 
146 3 Characterized in Bacillus subtilis. 
ymfD Bacillibactin exporter 146 13 Iron acquisition in Bacillus subtilus.130 
yqiJ Inner membrane protein YqiJ 146 20 - 
ytbE putative oxidoreductase YtbE 146 1 Aldehyde catabolism in Bacillus subtilis.131 
yvqK 
Cob(I)yrinic acid a,c-diamide 
adenosyltransferase 
146 0 - 
 
Table 3: Genes that segregated completely or in significantly higher numbers in Vietnamese isolates of S. sonnei (n=146) and S. flexneri (n=135). 
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Global S. sonnei and S. flexneri pan genome content 
A global set of S. sonnei and S. flexneri isolates (n = 60 of each species) was analysed with 
the same measures as Vietnamese samples, with pan genome construction and functional 
annotation revealing species level differences not subject to localized adaptation and gene 
flow that could be occurring uniquely in Vietnam.  
The size of the global pan genomes of each species was analogous to the Vietnamese 
isolates (S. sonnei = 5,731 genes, S. flexneri = 6,296 genes), albeit with a marginally larger 
‘cloud’ genome (genes found in less than 15% of isolates; S. sonnei = 2,008, S. flexneri = 
2,531), which is to be expected due to the greater diversity, and therefore more variable 
potential gene pool, of the global isolates. The number of genes present in at least 95% of 
the tested isolates (the softcore genome) was comparable in the global and Vietnamese S. 
flexneri samples (genes in ≥95% global isolates = 2,695, genes in ≥95% Vietnamese 
isolates = 2,462), though the number was lower in the global S. sonnei softcore genome 
than that of the Vietnamese isolates (genes in ≥95% global isolates = 2,720, genes in ≥95% 
Vietnamese isolates = 3,184). Again, this is likely due to the clonal history and low genetic 
diversity of the Vietnamese S. sonnei samples used in this study. 
Interestingly, of the genes that segregated exclusively, or in significantly higher numbers, in 
one species of the Vietnamese Shigella spp., 76 of the 106 genes found in S. sonnei and 27 
of the 37 genes in S. flexneri were also identified at significantly different their frequency in 
the analysis of global isolates. Many of the genes associated with adaptation to 
environmental stress and metabolic differences are conserved in the global pan genomes of 
each species, indicating that these species level adaptive differences identified in the 
Vietnamese isolates are also evident at the global scale.  
There were a total of 151 genes identified in significantly different numbers in either S. 
sonnei or S. flexneri global isolates, with 50 of these genes further to those found through 
the analysis of the Vietnamese samples (Table 4). The majority of these genes appear to be 
associated with inner membrane proteins and cellular transport, including three genes within 
the LsrABCD transporter complex. Notably though, there were also three genes found within 
the ethanolamine (eut) operon predominately in the global S. sonnei pan genome. This suite 
of genes is involved in the metabolism of the alcohol ethanolamine, a common ingredient in 
industrial detergents, with these genes also found in >98% of the Vietnamese samples of S. 
sonnei and around 20-25% of S. flexneri. 
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Gene name  Roary Annotation Shigella sonnei 
presence (n=60) 
Shigella flexneri 
presence (n=60) 
aarA Rhomboid protease AarA 60 0 
abgT p-aminobenzoyl-glutamate transport protein 59 0 
aceK Isocitrate dehydrogenase kinase/phosphatase 0 60 
adhT Alcohol dehydrogenase 0 59 
allA Ureidoglycolate lyase 3 60 
allC Allantoate amidohydrolase 0 60 
allR HTH-type transcriptional repressor AllR 3 60 
aplIR Type-2 restriction enzyme AplI 57 0 
arfA Alternative ribosome-rescue factor A 59 6 
argF Ornithine carbamoyltransferase 59 0 
atoA Acetate CoA-transferase subunit beta 58 0 
atoD Acetate CoA-transferase subunit alpha 59 0 
atoE Short-chain fatty acids transporter 60 0 
avtA Valine--pyruvate aminotransferase 3 60 
bfd Bacterioferritin-associated ferredoxin 0 60 
bfr Bacterioferritin 0 60 
bsdC Phenolic acid decarboxylase subunit C 0 59 
cadA Lysine decarboxylase, inducible 60 0 
cadC Transcriptional activator CadC 60 0 
casD CRISPR system Cascade subunit CasD 60 0 
ccmL Carbon dioxide concentrating mechanism protein CcmL 59 0 
cdhB Caffeine dehydrogenase subunit beta 60 1 
cdhR HTH-type transcriptional regulator CdhR 0 60 
cmtB Mannitol-specific cryptic phosphotransferase enzyme IIA component 60 4 
cotSA Spore coat protein SA 0 60 
ddpA putative D,D-dipeptide-binding periplasmic protein DdpA precursor 60 0 
ddrA Diol dehydratase-reactivating factor alpha subunit 59 5 
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dlgD 2,3-diketo-L-gulonate reductase 3 60 
dmlA D-malate dehydrogenase [decarboxylating] 59 0 
eamA putative amino-acid metabolite efflux pump 0 60 
envR putative acrEF/envCD operon repressor 58 5 
eutD Ethanolamine utilization protein EutD 60 5 
eutM Ethanolamine utilization protein EutL 59 5 
eutN Ethanolamine utilization protein EutM precursor 60 5 
flr Flavoredoxin 58 0 
frmA S-(hydroxymethyl)glutathione dehydrogenase 58 0 
frmB S-formylglutathione hydrolase FrmB 59 0 
frmR Transcriptional repressor FrmR 58 0 
gadB Glutamate decarboxylase beta 6 60 
galD 4-oxalomesaconate tautomerase 0 58 
galF UTP--glucose-1-phosphate uridylyltransferase 0 60 
glcB Malate synthase G 0 59 
gno Gluconate 5-dehydrogenase 59 0 
guaD Guanine deaminase 60 3 
hcpA Major exported protein 60 0 
hilA Transcriptional regulator HilA 59 0 
hipA Serine/threonine-protein kinase HipA 59 0 
hosA Transcriptional regulator HosA 0 59 
hyuA D-phenylhydantoinase 60 0 
iadA Isoaspartyl dipeptidase 0 59 
icaA N-glycosyltransferase 59 0 
idnD L-idonate 5-dehydrogenase (NAD(P)( )) 60 0 
idnT Gnt-II system L-idonate transporter 60 0 
iraD Anti-adapter protein IraD 0 59 
lacY Lactose permease 57 0 
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lsrB Autoinducer 2-binding protein LsrB precursor 0 59 
lsrD Autoinducer 2 import system permease protein LsrD 0 59 
lsrF putative aldolase LsrF 0 59 
lsrG Autoinducer 2-degrading protein LsrG 0 59 
lysU Lysine--tRNA ligase, heat inducible 59 0 
malS Alpha-amylase precursor 3 60 
matA HTH-type transcriptional regulator MatA 58 0 
mazE Antitoxin MazE 60 0 
mazF mRNA interferase MazF 60 0 
merA Mercuric reductase 60 0 
mhpC 2-hydroxy-6-oxononadienedioate/2-hydroxy-6-oxononatrienedioate hydrolase 58 0 
mhpD 2-keto-4-pentenoate hydratase 59 0 
mhpE 4-hydroxy-2-oxovalerate aldolase 59 0 
mhpF Acetaldehyde dehydrogenase 59 0 
mkaC Virulence genes transcriptional activator 57 1 
mocA Molybdenum cofactor cytidylyltransferase 59 1 
mscL Large-conductance mechanosensitive channel 60 6 
mshB 1D-myo-inositol 2-acetamido-2-deoxy-alpha-D-glucopyranoside deacetylase 59 0 
mtaD 5-methylthioadenosine/S-adenosylhomocysteine deaminase 59 1 
narV Respiratory nitrate reductase 2 gamma chain 60 0 
narY Respiratory nitrate reductase 2 beta chain 58 2 
nhoA N-hydroxyarylamine O-acetyltransferase 58 0 
outO Type 4 prepilin-like proteins leader peptide-processing enzyme 3 60 
pac Penicillin G acylase precursor 60 0 
pad1 putative aromatic acid decarboxylase 0 59 
pbpX Putative penicillin-binding protein PbpX 59 0 
pduA Propanediol utilization protein PduA 59 0 
pduB Propanediol utilization protein PduB 57 0 
Chapter 5. Shigella pan genomics  
 
 128 
pduC Propanediol dehydratase large subunit 59 0 
pduD Propanediol dehydratase medium subunit 58 0 
pduE Propanediol dehydratase small subunit 58 0 
pduF Propanediol diffusion facilitator 57 0 
pduL Phosphate propanoyltransferase 58 0 
pduU Propanediol utilization protein PduU 60 0 
pemK mRNA interferase PemK 0 60 
phnR Putative transcriptional regulator of 2-aminoethylphosphonate degradation operons 0 60 
pimB GDP-mannose-dependent alpha-(1-6)-phosphatidylinositol monomannoside mannosyltransferase 0 60 
pptA Tautomerase PptA 57 0 
pstS1 Phosphate-binding protein PstS 1 precursor 60 0 
pucA putative xanthine dehydrogenase subunit A 60 0 
putA Bifunctional protein PutA 59 0 
putP Sodium/proline symporter 57 0 
relB Antitoxin RelB 0 57 
rfbC dTDP-4-dehydrorhamnose 3,5-epimerase 0 60 
rfbD dTDP-4-dehydrorhamnose reductase 0 60 
rhsA putative deoxyribonuclease RhsA 60 0 
rmlA1 Glucose-1-phosphate thymidylyltransferase 1 0 59 
rnz Ribonuclease Z 0 60 
rpiB Ribose-5-phosphate isomerase B 57 0 
rspA 30S ribosomal protein S1 0 60 
salL Adenosyl-chloride synthase 60 0 
sbmC DNA gyrase inhibitor 58 0 
sinR HTH-type transcriptional regulator SinR 57 0 
symE Toxic protein SymE 0 60 
tam Trans-aconitate 2-methyltransferase 0 60 
tnaB Low affinity tryptophan permease 3 60 
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torI Response regulator inhibitor for tor operon 58 0 
traA Pilin precursor 58 8 
wcaJ UDP-glucose:undecaprenyl-phosphate glucose-1-phosphate transferase 0 60 
wzxC Lipopolysaccharide biosynthesis protein WzxC 0 60 
xylF D-xylose-binding periplasmic protein precursor 3 60 
xylG 2-hydroxymuconic semialdehyde dehydrogenase 3 60 
xylR Xylose operon regulatory protein 3 60 
yafO mRNA interferase YafO 0 60 
yagU Inner membrane protein YagU 57 0 
yajR Inner membrane transport protein YajR 60 6 
ybhA Pyridoxal phosphate phosphatase YbhA 0 60 
ybhI Inner membrane protein YbhI 0 58 
ydcO Inner membrane protein YdcO 57 0 
yddE putative isomerase YddE 60 0 
ydjE Inner membrane metabolite transport protein YdjE 0 60 
ydjH putative sugar kinase YdjH 0 60 
ygbF CRISPR-associated endoribonuclease Cas2 60 0 
ygbM Putative hydroxypyruvate isomerase YgbM 59 6 
ygbN Inner membrane permease YgbN 58 6 
ygbT CRISPR-associated endonuclease Cas1 60 0 
ygeX Diaminopropionate ammonia-lyase 60 0 
yggF Fructose-1,6-bisphosphatase 2 class 2 0 59 
yhaI Inner membrane protein YhaI 58 2 
yhaV Toxin YhaV 58 0 
yiaO 2,3-diketo-L-gulonate-binding periplasmic protein YiaO precursor 60 1 
yidK putative symporter YidK 0 60 
yigG Inner membrane protein YigG 0 60 
yjdF Inner membrane protein YjdF 1 60 
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yjdL putative dipeptide and tripeptide permease YjdL 57 0 
yjiE HTH-type transcriptional regulator YjiE 2 59 
yjiG Inner membrane protein YjiG 0 59 
yjmD putative zinc-type alcohol dehydrogenase-like protein YjmD 59 0 
ykgB Inner membrane protein YkgB 58 0 
ymfD Bacillibactin exporter 59 0 
ymgF Inner membrane protein YmgF 0 60 
ynfE Putative dimethyl sulfoxide reductase chain YnfE precursor 8 58 
yoeB Toxin YoeB 60 5 
ytbE putative oxidoreductase YtbE 57 0 
yvqK Cob(I)yrinic acid a,c-diamide adenosyltransferase 58 0 
zntR HTH-type transcriptional regulator ZntR 60 6 
 
Table 4: Genes that segregated completely or in significantly higher numbers in global isolates of S. sonnei and S. flexneri (n=60).
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5.5 Discussion 
In this study, I identified differences in the presence of particular genes, and thus potential 
functional differences, within the individual genomes of isolates of S. sonnei and S. flexneri 
in Vietnam to infer population-level variation between phenotypic traits of each species, 
which may contribute to their niche adaptation or environmental survival (Table 3). Building 
a representative pan genome for these species that have undergone a recent shift in 
prevalence in this region has resulted in the identification of potential key genomic 
determinants of ecology and lifestyle that may, in part, explain the epidemiological 
differences observed in Vietnamese Shigella.  
Many of the species-level gene differences described between the Vietnamese isolates are 
also found in a global subset of S. sonnei and S. flexneri strains (Table 4). This suggests 
rather than local adaptation in Vietnamese S. sonnei leading to a spread of the species in 
this region, a change in the external or host environment in Vietnam may be responsible for 
the recent observed patterns of species prevalence. S. sonnei may either be fundamentally 
better adapted, or faster to adapt, to this changing environment whilst S. flexneri infections 
have become rarer as they are less suited to the new conditions. This theory would be 
congruent with observed and anecdotal evidence of both host changes, including diet132 and 
increased antibiotic use133, and increased awareness of sanitary practices in this region134.   
An absence of many E. coli catabolic genes has been described in Shigella, including the 
inability to ferment lactose and mucate and the lack of decarboxylation of lysine46,135. The 
reason for these functional losses was attributed to the specialization of Shigella to 
intracellular life within the epithelia and so the breadth of catabolic pathways present in the 
E. coli, which can live freely in the intestine, is not required. Additionally, there is evidence of 
the antagonistic role of the cadA gene, involved in lysine decarboxylation, in virulence, as 
demonstrated through the introduction of the gene into S. flexneri136. Interestingly, the cadA 
gene (and the transcriptional regulator cadC) was identified here in Vietnamese S. sonnei 
along with a number of other E. coli catabolic genes such as those responsible for malate, 
idonate, lactose, and fructose metabolism (dmlA, idnD, lacY and rhmD respectively). 
Evidence of differential stability of the major virulence plasmid, pINV, at environmental 
temperatures in S. sonnei and S. flexneri, suggesting further host adaptation in S. sonnei47, 
may also explain differences in catabolic genes present between species. It may be 
beneficial for S. sonnei to maintain a wider range of catabolic genes for persisitence in a 
host if the organisms is only predominately transmitted through person-to-person contact 
with an absence of any environmental lifestyle component. 
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This increased range of catabolic genes may indicate that S. sonnei has the ability to occupy 
a niche more similar to commensal E. coli than S. flexneri and is not restricted solely to 
intracellular survival within epithelial cells. As Shigella spp. are non-motile and lack a 
flagellum, it is possible that the presence of genes involved in biofilm formation identified 
here in S. sonnei; matA98, hipAB94 and sinR122 as well as the potential role of toxin/antitoxin 
systems, play an important part in allowing the species to live outside epithelial cells inside a 
host.  Biofilm formation may also compensate for a loss of virulence that can occur from the 
antagonistic effect of catabolic genes, with evidence of increase virulence gene expression 
in pathogenic bacterial strains that form biofilms137,138. 
In contrast to previous suggestions that S. sonnei has limited persistence outside a host47, 
the capacity for S. sonnei to form biofilms may be important for survival outside of the host 
cells. Shigella spp. are known to persist for a short time in a variety of external environments 
including foodstuffs37,39,40, fomites41 and waterways24,29,42. Along with the ability of biofilms to 
protect bacteria and boost growth139, there is evidence of genes in the Vietnamese S. sonnei 
pan genome that could also increase survival in an external environment. These include 
genes associated with persistence in aquatic environments77 (ccmL), acclimation to UV-B 
and low temperature79 (clpP1), degradation of the herbicide atrazine74 (atzC), detoxification 
of formaldehyde86 (frm genes), and utilization of propylene glycol, a common water 
pollutant109,110 (pdu genes). These mechanisms for adaptation to prolonged environmental 
survival in S. sonnei appears to be, in part, through gene transfer from other exogenous 
bacteria, which is supported by the presence of multiple genes identified in these strains with 
origins in Bacillus subtilis107,116,122,130,131, a common soil bacteria, as well as single genes 
from the marine bacterium Salinispora tropica118 and species of aquatic cyanobacteria 
Synechocystis77 (Table 3).  
The potential similarity in lifestyles of S. sonnei and E. coli may indicate that factors that will 
determine the distribution and occurrence of commensal E. coli, including diet140, may also 
affect the spread of S. sonnei. Changes to food consumption have been described in the 
developing world, with a move towards a higher calorie and fat and protein-rich diet132. Data 
are available for national averages of calories, fat, protein and carbohydrates consumed 
taken from the Food and Agriculture Organization of the United Nations141. Using data from 
Thompson et al, 2015 looking at the ratio between the frequency of S. sonnei and S. flexneri 
from 1990-2014 in 87 countries globally142, we can estimate the predictive effect of each 
dietary component on the proportion of infections by each species over this time (Figure 4).  
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Figure 4: Comparison of the components of daily average dietary intake per person to the ratio of S. 
sonnei to S. flexneri infections in 87 countries. The lines represent the linear regression model for 
each dietary factor. A) Average calorie intake (kcal) (R2 = 0.2189, p = 4.889x10-6), B) Average 
carbohydrate intake (g) (R2 = 0.1506, p = 2.039x10-5), C) Average fat intake (g) (R2 = 0.1416, p = 
3.275x10-5), and D) Average protein intake (g) (R2 = 0.07676, p = 9.378x10-4). 
 
There is a significant correlation between the ratio of S. sonnei to S. flexneri infections and 
the combined effect of the country-level average dietary intake of fat, carbohydrates, protein 
and calories (R2 = 0.2303, p < 0.001). The greatest individual contribution to this linear 
regression model was by the average per country calorie intake, which was positively 
associated with likelihood of infection by S. sonnei (p = 0.013) when also controlling for the 
other dietary factors. There is also a strong association between calorific intake and Shigella 
infection ratio when controlling for the country-level GDP143 (p = 0.055), an indicator of socio-
economic status, though there is no significant correlation between GDP and the ratio of 
Shigella infection (p = 0.542). Although this does not directly indicate that these dietary 
factors are having a causative effect on the frequency of infections from either Shigella 
species, the evidence for this relationship coupled with the variation in the metabolic genes 
between species does suggest that diet may be one factor in determining the presence of 
particular Shigella species. It has been known that diet and nutritional status can influence 
the composition of microbial gut flora144 so it may be that higher calorie diets introduce a 
wider variety of catabolic substrates into the host gut, which S. sonnei is able to effectively 
utilize to increase growth and survival. 
A B 
C D 
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In addition to genes associated with metabolism and host adaptation, another important 
suite of genes identified in the S. sonnei pan genome was those involved in the 
CRISPR/Cas system. This system acts as an acquired immune system for prokaryotes 
against phages and other mobile genetic elements by recognizing and cutting sections of 
foreign DNA that has been incorporated into the prokaryote genome76. The presence of this 
system in S. sonnei could provide a defence against undesirable foreign genetic elements 
that can reduce the fitness of the organism.   
The method of pan genome construction employed in this study offers an effective 
framework for investigating gene presence differences between populations of the same or 
closely related species, particularly in bacteria that can have highly variable genomes 
through recombination and transformation. The genomic differences between S. sonnei and 
S. flexneri identified here likely do not explain entirely the causes for the shift in species 
prevalence observed in Vietnam and many developing countries, though logical inferences 
have been made based of potential functional differences that could influence species-wide 
epidemiological patterns. Clearly, there is evidence of some key lifestyle differences 
between Shigella species and it is possible that a combination of genomic variation, along 
with the widespread use of antibiotics and potential association with other organisms, has 
contributed to the increased incidence of S. sonnei infections in this region. 
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Chapter 6  
 
General Discussion  
 
The work presented in this thesis explores different experimental and bioinformatics 
approaches to examine key differences in the genetics and ecology of Shigella sonnei and 
Shigella flexneri in Vietnam. The underlying motivation for this work is to better understand 
the biological factors that have contributed to the replacement of S. flexneri with S. sonnei as 
the cause of bacillary dysentery, or shigellosis, in many developing countries, including 
Vietnam. Here, I discuss the main findings of my work in the context of this question and 
propose future directions of study in this area of research. 
The results of the work presented here lend support to the argument that there are inherent 
differences in the genetics and ecology of S. sonnei and S. flexneri populations in Vietnam 
that may, in part, contribute to the more recent, rapid emergence of S. sonnei in this region. 
Chapter two is the first of the experimental chapters where I examined differences in S. 
sonnei and S. flexneri survival and resistance when exposed to varying concentrations of 
chlorine and SDS detergent. This conception of these experiments came from the 
hypothesis that a potentially higher innate resistance to these disinfectants could be 
influencing the persistence and spread of S. sonnei over S. flexneri in developing countries. 
The emergence of S. sonnei in these regions has coincided with increased development in 
many of these places1, which in turn has seen an increase in the use of disinfectants as 
antimicrobials. A differential resistance to these chemicals could affect the survival and 
transmission of pathogens. 
Individual inactivation assays were conducted on three strains of Vietnamese S. sonnei and 
S. flexneri, and three strains of European S. sonnei, S. flexneri and enteropathogenic E. coli 
to look for inherent differences in chlorine and SDS resistance. SDS did not appear to have 
a direct biocidal effect on any of the tested strains, with all populations able to tolerate high 
concentrations of the compound. Exposure to varying concentrations of the chlorine-based 
disinfectant calcium hypochlorite, though, resulted in different survival rates among species 
groups (species/location), indicating different levels of resistance to chlorination. These 
differences were consistent within all tested strains of a group suggesting that these 
resistance differences are innate in these species groups.  
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The highest levels of resistance were seen in S. sonnei strains from Vietnam, with S. flexneri 
isolates from this region showing a significantly greater susceptibility to chlorination. 
Additional pairwise competition assays testing each Vietnamese S. sonnei against 
Vietnamese S. flexneri strain also found that direct competition increased the susceptibility 
of S. flexneri to chlorination, with S. sonnei strains possessing a significant selective 
advantage. These species-level resistance differences were not seen in European strains 
though, which suggests that the increased resistance to these chemicals in Vietnamese S. 
sonnei strains is due to recent, local adaptation. These results are consistent with the theory 
that S. sonnei population expansion will be driven by mutations in response to strong 
selective pressures, such as antibiotic resistance2,3, and thus the evolution of a greater 
resistance to chlorine may be contributing to the emergence of this pathogen in areas of 
increased disinfectant use. 
Leading on from these experiments, further work was carried out to determine the 
mechanisms that may be employed by the bacterial cell to increase resistance to 
chlorination, notably the role of efflux pumps in this process. The systems have been shown 
to be active in the cellular stress response to toxins, including exposure to antimicrobials4–6, 
and thus it is proposed that these transport proteins will also be important in determining 
resistance to chlorination. Inactivation assays were repeated for all Vietnamese and 
European Shigella strains in both the presence and absence of a general efflux pump 
inhibitor CCCP to examine the role of these systems in response to chlorine exposure. 
Inhibition of these pumps increased the susceptibility of strains that had previously exhibited 
the greatest resistance to chlorine, such as Vietnamese S. sonnei, but did not significantly 
affect strains with the greatest innate susceptibility.  
These results suggest that efflux pumps are most important in these organisms in response 
to high concentrations of chlorine but other initial stress responses may be activated in lower 
levels of disinfection. This indicates that the evolution of higher levels of resistance to 
chlorination in Shigella may be determined by variation in the activity of these pumps. 
Analysis of mutations in the genes encoding the most common of these pump systems in 
the tested strains could not identify any genetic variation between the most resistant and 
susceptible strains that may be associated with increased resistance, though future work 
looking at the levels of expression in these genes may help to better understand the role of 
these pumps in the response to chlorine disinfection. 
Chapter four of the thesis begins the first of two chapters using a large set of whole genome 
sequence (WGS) data of S. sonnei and S. flexneri clinical isolates from Vietnam to identify 
genetic variation between the species that may be contributing to the rapid spread of S. 
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sonnei in this region. This chapter used various population genetics techniques, including 
signals of selection through convergent evolution, to characterise antibiotic resistance 
mutations in species. A discriminant analysis was then carried out on antibiotic resistant and 
susceptible groups to identify compensatory mutations that will restore any fitness loss 
arising from gene changes with resistance mutations7,8.  
Differences in species level resistance was found between Shigella species, with S. flexneri 
harbouring a greater repertoire of variants and polymorphism in a number of other 
resistance conferring genes, including rifampicin resistance in rpoB and the regulatory gene 
of the multiple antibiotic resistance operon marR. In contrast, resistance mutations in S. 
sonnei were only detected in genes associated with fluoroquinolones, but a greater 
proportion of the isolates tested here showed resistance. These results were consistent with 
the theory that S. sonnei expansion can be driven by the acquisition of highly beneficial 
antibiotic resistance mutations and resistant strains will spread rapidly through a region, thus 
standing levels of variation will be relatively low in this species3. S. flexneri will persist for 
longer in an area with resistance having a lesser selective advantage and thus resistance 
tends to be acquired slower at multiple occasions in a population. It was also postulated that 
the evolution of compensatory mutations, particularly with fluoroquinolone resistance in S. 
sonnei, may contribute to the spread of a pathogen. There was no evidence here for 
compensatory mutations in Vietnamese Shigella populations. 
Finally, WGS data for these same strains were again used to construct a representative pan-
genome, comprising all genes present in a population at any frequency (core and accessory 
genomes)9,10, for Vietnamese S. sonnei and S. flexneri. Species level gene content 
differences were then compared to look for potential functional differences between Shigella 
species that may inform the ecology and transmission of the species. This analysis identified 
a number of genes that were found in significantly different proportions in S. sonnei and S. 
flexneri populations, with many genes found only in S. sonnei involved in environmental 
niche adaptation and utilisation of a wider range of metabolic substrates. This suggests that 
S. sonnei may be better able to adapt to changing environments than S. flexneri, with 
ecological transmission of both species previously described11–13. 
The results presented in the studies contained in this thesis show species level differences 
between Vietnamese S. sonnei and S. flexneri in their ecology and adaptive response to 
selective pressures. There appears to be significant differences in chlorine resistance 
between Shigella populations in this region, with variation in efflux pump activity likely to 
influence the levels of resistance in these microorganisms, particularly at high 
concentrations of the disinfectant. In addition, genomic variation in antibiotic resistance 
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profiles and gene content highlights differences in the adaptive response and transmission 
of these species, with S. sonnei population expansion driven by strong selection for 
antimicrobial resistance. In addition, S. sonnei populations show a greater ability to adapt 
and persist in changing environments, and this may be influencing the spread of this 
pathogen in regions undergoing relatively rapid development. 
 
Future work 
This work explores a number of different hypotheses to better understand the reasons 
behind the spread of S. sonnei in developing regions and, while contributing some key 
findings on this subject, there are still clearly many possibilities of research that can be 
undertaken to increase our knowledge of how pathogens spread, both specifically with 
respect to S. sonnei and as a general model of bacterial transmission. 
A possible direction of study would be to investigate the likely association between 
chlorination susceptibility and antimicrobial resistance. The experimental work presented 
here on chlorine resistance in Shigella, along with previous evidence in other bacterial 
taxa14, suggests that expression and regulation of efflux pumps will influence chlorine 
sensitivity, with particularly high concentrations of chlorine. These pumps have been shown 
to play a key role in antibiotic resistance also, and thus it would be interesting to explore the 
effect on chlorine disinfection on antibiotic resistance acquisition.  
There has been some work conducted that suggests that treatment with chlorine will induce 
antibiotic resistance genes in Acinetobacter species14. With the results shown here on the 
role of efflux pumps, as well as, differences in resistance to chlorination, work investigating 
the interaction between antibiotic and chlorine resistance in Shigella would help to 
understand the biological processes for this resistance. In addition, if there is an additive 
effect of chlorine and antibiotic resistance acquisition this may influence treatment strategies 
as pathogens will be coming into ever increasing contact with these compounds as we 
attempt to eradicate diseases through disinfectants and drugs.  
Furthermore, one hypothesis put forward is that the successful emergence of S. sonnei in 
many developing countries is in part through potential environmental protection afforded to 
S. sonnei by Acanthamoeba15. This organism will phagocytise the bacterium and protect it 
from stressful environmental conditions. S. flexneri, though, has been shown to induce 
apoptosis when grown with this amoeba and so this species will not be protected in this way 
in the presence of toxins16. The extent to which Acanthamoeba will influence the resistance 
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of S. sonnei to antibiotics and disinfectants should be explored to increase our knowledge of 
how S. sonnei populations have spread. The work presented here indicates that Vietnamese 
S. sonnei has a selective advantage over S. flexneri in the presence of chlorine, even in the 
absence of the amoeba, and thus a combination of these mechanisms would help to explain 
the rapid expansion of S. sonnei in developing regions.  
It would be beneficial also to conduct these experiments using Shigella strains obtained from 
another region that has been undergoing the same pattern of species replacement to 
determine whether these inferences of resistance differences between S. sonnei and S. 
flexneri are typical of these populations or down to local adaptation in Vietnam. The 
European strains of each species did not suggest there was the same variation in resistance 
between the species from this region, though testing strains from area that will be imparting 
similar selection pressures on Shigella populations would allow for better resolution of these 
questions. 
Finally, the genomic analysis of antibiotic resistance in this thesis only considered 
chromosomal variants when discussing the acquisition and selective advantage of 
resistance. It is known that many antimicrobial resistance-determining genes are found on 
plasmids17–19, as well as genes involved in virulence and other ecological characteristics. 
Whilst there has been work conducted investigating the plasmid profiles of Shigella species 
in India20, it would be of interest to reconstruct and compare the plasmid genomes of the 
Shigella strains used in this thesis to better understand the complete functional and 
characteristic differences between S. sonnei and S. flexneri in Vietnam. 
Conclusion 
The recent rapid expansion of S. sonnei in many developing regions, and the replacement of 
S. flexneri as the primary cause of shigellosis, is a fascinating phenomenon and studying 
this process allows us to gain a great insight into the genetics and epidemiology of the 
emergence of bacterial diseases. This thesis contributes data and results to this increasingly 
important field of research and provides some insight into a number of key factors that may 
have influenced the rapid spread of this pathogen. The hope is that this work can be used to 
better inform management strategies for disease prevention and help to better understand 
the dynamics of microbial pathogen populations.  
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Supplementary Material – Chapter 2 
 
 
By strain average (triplicate) 
Disinfectant 
concentration 
0mg/l Ca(ClO)2 2.5mg/l Ca(ClO)2 5mg/l Ca(ClO)2 10mg/l Ca(ClO)2 20mg/l Ca(ClO)2 
Time 
5mins 15mins 30mins 5mins 15mins 30mins 5mins 15mins 30mins 5mins 15mins 30mins 5mins 15mins 30mins 
S.f1266 1.6 1.02 2.93999 1.32 1.26 0.86 0.24 0.014 0.0106 0.00096 0.00018 0.00000 0.00016 6.9E-05 0.00000 
S.f262-78 0.25352 0.82817 0.89577 0.34648 0.43944 0.53239 0.02423 0.01014 0.00363 0.00012 
2.25352
E-06 
2.8169E
-07 
1.69014
E-06 
1.52113
E-06 
1.69014
E-06 
S.f9-63 1.43925 1.26168 1.18692 1.56075 1.03738 1.03738 1.29907 0.11308 0.11308 0.00042 
2.42991
E-05 
2.42991
E-05 
0.00093
4579 
3.17757
E-05 
3.17757
E-05 
S.f-MS 1.03571 3.21429 1.20238 1.20238 1.14286 1.20238 0.79762 0.15476 0.83333 0.05595 0.00011 0.00000 0.00000 0.00000 0.00000 
S.f-DE 0.51000 0.84000 0.66500 0.50500 0.22500 0.17500 0.30000 0.20000 0.04500 0.00027 0.00078 0.00000 3.5E-06 0.00000 0.00000 
S.f-EG 1.35849 0.62893 0.43396 0.72327 0.60377 0.58491 0.80503 0.37735 0.86792 0.11006 0.00040 
6.28931
E-07 
2.51572
E-06 0.00000 0.00000 
S.s54210 0.23864 0.88636 0.52652 0.67803 0.48485 0.38258 0.00545 0.00341 0.00341 0.00017 
8.52273
E-06 0.00000 
1.13636
E-06 
3.78788
E-07 0.00000 
S.s88-83 1.52778 2.36111 1.83333 3.40278 3.16667 2.33333 0.03000 0.13472 0.04306 0.00013 0.00000 0.00000 
8.33333
E-06 0.00000 0.00000 
S.s43-74 1.21154 1.00962 1.00000 1.93269 2.50962 0.92308 0.03000 0.19519 0.01154 
2.30769
E-05 
6.73077
E-06 0.00000 0.00000 0.00000 0.00000 
S.sMS 0.90426 1.38298 1.08511 0.75887 0.85106 1.11348 0.73050 0.06383 0.43972 0.02777 0.00298 0.00019 
0.904255
319 
2.2695E-
05 
2.12766E
-05 
S.sDE 1.35484 0.53917 0.61751 1.11521 0.32258 0.47005 0.71429 0.38710 0.70968 0.01018 
1.84332
E-06 
1.84332
E-06 0.00046 0.00025 0.00034 
S.sEG 0.37853 0.76271 0.96045 0.73446 0.96045 0.53672 0.59322 0.27966 0.35593 0.04633 0.03051 
4.51977
E-05 
2.82486
E-05 0.00051 
8.47458
E-05 
E.c12 1.08000 2.68000 1.24000 0.34667 2.04000 0.94667 0.69333 0.80000 0.70667 0.21733 0.05333 0.24933 0.02427 0.00200 0.00002 
E.c13 0.61765 0.56618 0.75735 0.71324 0.39706 0.61765 0.91912 1.47794 0.74265 0.22206 0.23824 0.18897 0.00110 
5.51471
E-05 0.00000 
E.c27 0.61806 0.64583 1.02778 0.59722 0.70833 0.61806 0.71528 0.36458 0.93750 0.25069 0.93750 0.26944 0.02847 0.00035 
2.08333
E-06 
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By species group average 
S. flexneri 
(Europe) 1.09759 1.03662 1.67423 1.07574 0.91227 0.80993 0.52110 0.04574 0.04244 0.00050 
6.88509
E-05 
8.19E-
06 0.00037 
3.40989
E-05 
1.11553
E-05 
S. flexneri 
(Asia) 0.96807 1.56107 0.76711 0.81022 0.65721 0.65410 0.63422 1.37612 0.58209 0.05543 0.00043 
2.10E-
07 
2.00524
E-06 0.00000 0.00000 
S. sonnei 
(Europe) 0.99265 1.41903 1.11995 2.00450 2.05371 1.21300 0.02182 0.11111 0.01933 0.00011 
5.0845E
-06 0.00000 
3.15657
E-06 
1.26263
E-07 0.00000 
S. sonnei 
(Asia) 0.87921 0.89495 0.88769 0.86951 0.71137 0.70675 0.67933 0.24353 0.50178 0.02810 0.01116 0.00008 0.30158 0.00026 0.00015 
EPEC 0.77190 1.29734 1.00838 0.55237 1.04846 0.72746 0.77591 0.88084 0.79560 0.23003 0.40969 0.23592 0.01795 0.00080 
6.91667
E-06 
 
Supplementary Table 2.1. Survival fraction from initial CFU counts at each collected time point for varying concentrations of calcium hypochlorite. Survival 
fractions are shown by strain and by species group. 
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By strain average (triplicate) 
Disinfectant  
concentration 
0% SDS 15% SDS 22.5% SDS 30% SDS 
Time 5 mins 15 mins 30 mins 5 mins 15 mins 30 mins 5 mins 15 mins 30 mins 5 mins 15 mins 30 mins 
S.f1266 0.7414 0.9483 0.9425 0.0356 0.0328 0.0356 0.0053 0.0057 0.0037 0.0016 0.0015 0.0017 
S.f262-78 0.9000 0.5400 1.1000 0.0287 0.2250 0.1520 0.0090 0.0102 0.0085 0.0014 0.0022 0.0019 
S.f9-63 0.6782 0.5977 0.4943 0.0249 0.2333 0.2586 0.0062 0.0310 0.0087 0.0005 0.0007 0.0005 
S.f-MS 0.6094 0.8672 0.5781 0.0469 0.0664 0.0727 0.0508 0.0914 0.0922 0.0084 0.0115 0.0060 
S.f-DE 1.0970 0.5697 0.4364 0.0545 0.1164 0.0733 0.0406 0.0424 0.0291 0.0076 0.0053 0.0070 
S.f-EG 0.8710 0.5269 0.5161 0.0930 0.0731 0.0737 0.0952 0.0306 0.0274 0.0029 0.0051 0.0067 
S.s54210 0.6615 0.3438 0.2865 0.0691 0.0604 0.0882 0.0240 0.0192 0.0168 0.0005 0.0006 0.0011 
S.s88-83 1.6286 1.6143 1.2857 0.2886 0.3086 0.1386 0.0059 0.0133 0.0114 0.0020 0.0021 0.0020 
S.s43-74 0.4222 0.5111 0.2815 0.1200 0.1467 0.1037 0.0024 0.0187 0.0158 0.0002 0.0017 0.0013 
S.sMS 0.7333 1.4571 0.8952 0.1810 0.1038 0.1867 0.1552 0.1229 0.1562 0.0695 0.0829 0.0317 
S.sDE 1.3684 1.1053 1.4561 0.2395 0.1912 0.2509 0.1553 0.0324 0.1623 0.0991 0.0776 0.0808 
S.sEG 1.2667 2.1600 1.8933 0.2213 0.1880 0.2347 0.1947 0.1740 0.1460 0.0229 0.0387 0.0633 
E.c12 0.7500 1.3158 1.1316 0.1461 0.1500 0.1829 0.1303 0.2132 0.2355 0.1408 0.1618 0.0803 
E.c13 0.7905 1.5714 1.1905 0.1114 0.1257 0.2286 0.0590 0.0924 0.0914 0.1276 0.0667 0.1029 
E.c27 0.6167 1.6750 0.7333 0.0767 0.1133 0.0908 0.1800 0.0825 0.0325 0.0558 0.1083 0.2092 
By species group average 
S. flexneri (Europe) 0.7732 0.6953 0.8456 0.0298 0.1637 0.1488 0.0069 0.0156 0.0070 0.0012 0.0015 0.0014 
S. flexneri (Asia) 0.8591 0.6546 0.5102 0.0648 0.0853 0.0732 0.0622 0.0548 0.0496 0.0063 0.0073 0.0066 
S. sonnei (Europe) 0.9041 0.8230 0.6179 0.1592 0.1719 0.1102 0.0108 0.0171 0.0147 0.0009 0.0015 0.0015 
S. sonnei (Asia) 1.1228 1.5741 1.4149 0.2139 0.1610 0.2241 0.1684 0.1097 0.1548 0.0638 0.0664 0.0586 
EPEC 0.7190 1.5207 1.0185 0.1114 0.1297 0.1674 0.1231 0.1293 0.1198 0.1081 0.1123 0.1308 
 
Supplementary Table 2.2. Survival fraction from initial CFU counts at each collected time point for varying concentrations of sodium dodecyl sulphate (SDS). 
Survival fractions are shown by strain and by species group.
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(A) 
 
(B) 
 
Supplementary Figure 2.1. Survival of Shigella species and EPEC against contact time in 
minutes of control experiments. The log survival fraction (N/No) each species group is shown for 
the control experiments when testing against (A) calcium hypochlorite, and (B) SDS. Errors bars 
denote the standard deviation at each recorded point. 
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(A) 
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(C) 
 
 
 
(D) 
 
 
 
 
 
 
 
 
 
 
Supplementary materials  
 
 157 
(E) 
 
 
(F) 
 
 
Supplementary Figure 2.2. Plots showing the natural log survival fraction (ln (N/N0)) against CT 
value (mg min L -1) for (A) S. flexneri MS0052, (B) S. flexneri DE0350, (C) S. flexneri EG419, (D) 
S. sonnei MS004, (E) S. sonnei DE1208, and (F) S. sonnei EG0430. All plots show the fitted least 
squares regression line. 
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Chlorine 
concentration 
 
 
5mg/l 2.5mg/l 1.25mg/l 
Time (hours) 0.5 4 24 0.5 4 24 0.5 4 24 
S.f-MS/S.S.sMS S.sMS 0.6042 5.0000 10033.333 1.3214 8.8571 28380.952 6.3158 23.8596 38245.614 
 S.f-MS 0.0180 0.0062 0.6462 0.1838 0.2059 196.0784 1.1571 4.5714 10434.286 
S.f-MS/S.S.sDE S.sDE 0.2347 3.7373 5480.0000 0.8828 15.4688 27187.500 3.8810 16.5079 39682.539 
 S.f-MS 0.0001 0.0000 0.0002 0.0502 0.4010 36.0000 1.2794 2.7059 2705.8824 
S.f-MS/S.S.sEG S.sEG 2.8762 4.7525 5940.5941 3.6711 10.2645 16842.105 5.3750 18.5000 58333.333 
 S.f-MS 0.1750 0.0625 0.0006 0.0969 0.3108 155.3846 2.4667 9.5844 43333.333 
S.f-DE/S.S.sMS S.sMS 2.8072 3.9959 9484.5361 3.0612 10.7143 51938.775 11.3861 14.7525 13762.376 
 S.f-DE 0.0418 0.0021 6.1225 0.1472 0.4222 18.1111 1.1455 1.6545 705.4545 
S.f-DE/S.S.sDE S.sDE 1.8668 2.7356 10344.828 3.2651 4.8313 6385.5422 5.5052 14.7423 10412.371 
 S.f-DE 0.0019 0.0000 0.0000 0.3405 0.0153 7.2222 0.6672 0.1463 217.9104 
S.f-DE/S.S.sEG S.sEG 0.9400 1.5859 8471.6187 0.1216 2.5992 6779.6610 5.8163 9.0816 13877.551 
 S.f-DE 0.0048 0.0000 0.0000 0.0072 0.0069 0.2019 1.3953 1.4070 2351.1628 
S.f-EG/S.S.sMS S.sMS 1.2755 1.2772 20851.061 9.4167 11.9608 27156.862 6.0914 17.6344 30322.581 
 S.f-EG 0.0251 0.0056 0.0152 0.2896 1.9112 2.2596 1.8605 4.5198 20120.930 
S.f-EG/S.S.sDE S.sDE 0.2959 0.9194 13775.510 2.5806 11.1236 30000.000 2.6271 24.7458 58474.576 
 S.f-EG 0.0505 0.0002 0.1298 0.7466 1.9865 12801.802 2.9286 23.7743 27571.429 
S.f-EG/S.S.sEG S.sEG 0.6786 4.6429 9880.9524 3.9189 11.3514 49324.324 2.9227 15.9794 41134.021 
 S.f-EG 0.0458 0.0001 3.7368 0.4237 0.3390 11016.949 1.9032 38.0323 71612.903 
 
Supplementary Table 2.3. Survival fraction of each Shigella species in pairwise competition from initial CFU counts at each collected time point for 
varying concentrations of calcium hypochlorite. 
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Supplementary Materials – Chapter 3 
(A) 
 0mg/l 2.5mg/l 5mg/l 10mg/l 
Time 
(mins) 5 15 30 5 15 30 5 15 30 5 15 30 
No CCCP 
S.f1266 
0.639534
872 
1.337209
302 
1.569767
442 
1.465116
279 
1.593023
256 
0.802325
581 
0.073255
814 
1.383720
93 
0.006162
791 
0.002790
698 
0.000104
651 
8.02326E
-06 
S.f262-78 
0.896414
343 
0.653386
454 
0.418326
693 
0.394422
311 
0.394422
311 
0.278884
462 
0.023505
976 
0.545816
733 
0.005139
442 
0.000254
98 
3.18725E
-06 0 
S.f9-63 
0.642857
143 
1.032967
033 
1.186813
187 
0.835164
725 
1.208791
209 
0.626373
626 
0.069230
769 
1.483516
484 
0.006098
901 
0.001098
901 
2.85714E
-05 
4.28571E
-05 
S.f-MS 
1.535714
286 
1.142857
143 
0.785714
286 
1.619047
619 
0.011904
762 
1.035714
286 
0.797619
048 
0.011428
571 
0.008333
333 
0.148809
524 
0.000107
143 0 
S.f-DE 
0.831325
301 
1.759036
145 
0.704819
277 
0.686746
988 
0.746987
952 
1.228915
663 
1.192771
084 
0.130120
482 
0.043373
494 
0.011566
265 
0.001879
518 
3.61446E
-06 
S.f-EG 
1.318181
795 
1.431818
182 
4.568181
818 
1.386363
636 
0.931818
182 1.5 
0.795454
545 
0.081818
182 0.15 
0.009090
909 
0.001431
818 0 
S.s54210 
1.690909
091 
2.036363
636 
2.345454
545 
1.854545
455 
0.854545
455 
1.636363
636 
0.056181
818 0.084 
0.070909
091 
0.002036
364 
4.09091E
-05 0 
S.s88-83 
1.186666
64 1.32 
1.786666
666 1.76 
1.106666
667 
1.333333
332 0.0172 0.004 
0.001773
333 0.000164 0.000004 
1.33333E
-06 
S.s43-74 
1.428571
357 
2.071428
571 4 
1.714285
714 
0.785714
286 
2.714285
714 
0.058571
429 
0.037857
143 
0.016428
571 
0.000714
286 
1.66667E
-05 
7.14286E
-07 
S.sMS 
1.149425
276 1 
0.827586
207 
0.770114
943 
0.977011
494 
1.551724
138 
1.183908
046 
0.275862
069 
0.678160
92 0.1 
0.004827
586  
S.sDE 
2.014925
373 
1.761194
03 
1.567164
179 
2.104477
612 
1.343283
582 
2.283582
09 
2.313432
836 
1.537313
433 
1.925373
134 
0.488059
701 
0.005970
149 
0.000234
433 
S.sEG 
1.140624
984 1.6875 2.640625 1.5625 0.921875 1.453125 1.640625 0.796875 
0.914062
5 0.15625 0.084375 0.000125 
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(B) 
 0mg/l 2.5mg/l 5mg/l 10mg/l 
Time 
(mins) 5 15 30 5 15 30 5 15 30 5 15 30 
CCCP 
S.f1266 
1.148936
17 
1.489361
681 
2.170212
766 
1.489361
702 
2.042553
191 
1.553191
487 
0.153191
489 
1.304255
319 
0.017085
064 
0.001021
277 
9.14894E
-06 0 
S.f262-78 
0.999999
986 
2.095890
411 
1.780821
916 
0.863013
699 
2.123287
671 
0.863013
699 
0.036986
301 
1.041095
89 
0.005342
466 
0.000123
288 
6.16438E
-06 
4.10959E
-07 
S.f9-63 
0.924999
975 0.825 1.5625 1.2875 0.8625 0.8625 0.24375 0.5625 0.0009 
0.000071
25 
0.000000
375 0 
S.f-MS 
0.736842
105 
1.473684
211 1 
2.842105
263 
0.121052
632 
1.754385
965 
0.017017
544 
0.001578
947 
0.023157
895 
0.016842
105 
0.000121
053 
1.75439E
-06 
S.f-DE 
1.686274
471 
1.529411
765 
1.882352
941 
1.352941
176 
0.549019
608 
2.019607
843 
0.064705
882 
1.333333
333 
0.125490
196 
0.010588
235 
0.001372
549 0 
S.f-EG 
1.207792
208 
1.051948
052 
0.857142
857 
1.636363
636 
0.132467
532 
0.935064
935 
0.000844
156 
7.4026E-
05 
0.003896
104 
0.008181
818 
7.79221E
-06 0 
S.s54210 1.075 0.525 0.625 0.7 
0.369333
333 
0.583333
333 0.023 
0.000216
667 0.025 0.00035 0 0 
S.s88-83 
0.783333
333 
1.966666
667 
0.877777
777 
0.955555
555 
0.722222
222 
1.433333
333 
0.003633
333 
0.000122
222 
0.010666
667 
0.000136
667 0 0 
S.s43-74 
1.843137
235 1 
1.882352
941 
1.745098
039 0.3 
1.117647
059 
0.005882
353 
0.000131
373 
0.011176
471 
0.000588
235 
1.23529E
-05 0 
S.sMS 
2.105263
158 
1.473684
211 
2.105263
158 
1.684210
526 
1.192982
456 
1.175438
596 
1.017543
86 
0.017543
86 
1.736842
105 
0.152631
579 
0.001210
526 
4.73684E
-05 
S.sDE 
0.730769
231 
1.576923
077 
1.192307
692 
0.897435
896 
1.333333
333 
1.333333
333 
2.576923
077 
0.858974
359 
0.756410
256 
0.088461
538 
0.000858
974 
5.12821E
-06 
S.sEG 0.765 1.35 1 
1.009999
998 0.49 
0.979999
998 1 0.5 0.9 0.1 0.063 3.5E-05 
 
Supplementary Table 3.1. Survival fraction of Vietnamese Shigella strains from initial CFU/ml counts in varying concentrations of calcium 
hypochlorite, (A) in the absence of the efflux pump inhibitor CCCP, and (B) in the presence of CCCP. 
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SNP position 
Gene 
name S.sEG S.sMS S.sDE S.s54210 S.s88.83 S.s43.74 
476077 acrB 0 0 0 0 1 0 
2690907 acrD 1 0 1 0 0 0 
2974428 emrB 0 0 0 0 0 1 
3332131 tolC 0 0 0 0 0 1 
3797699 emrD 0 0 0 0 0 1 
3798032 emrD 1 0 0 0 0 1 
SNP position 
Gene 
name S.fMS S.fDE S.fEG S.f-9.63 S.f-12.66 S.f262.78 
418085 acrB 1 0 0 0 0 0 
418151 acrB 1 0 0 0 0 0 
418245 acrB 1 0 0 0 0 0 
418300 acrB 0 1 0 0 0 0 
419126 acrB 0 1 0 0 0 0 
419309 acrB 1 0 0 0 0 0 
419387 acrB 1 1 0 0 0 0 
420080 acrB 1 1 0 0 0 0 
420725 acrB 1 1 1 1 1 1 
420726 acrB 1 1 1 1 1 1 
420792 acrB 1 1 1 1 1 1 
420795 acrB 1 1 1 1 1 1 
420796 acrB 1 1 1 1 1 1 
420836 acrB 0 1 0 0 0 0 
421479 acrA 1 1 0 0 0 0 
421546 acrA 1 1 0 0 0 1 
421726 acrA 1 0 0 0 0 0 
421980 acrA 1 1 0 0 0 1 
422862 acrR 1 0 0 0 0 0 
422927 acrR 0 1 0 0 0 0 
829423 cmr 0 1 0 0 0 0 
829448 cmr 1 0 0 0 0 0 
829450 cmr 1 1 0 0 0 0 
829535 cmr 0 1 0 0 0 0 
829685 cmr 1 1 0 0 0 0 
830202 cmr 0 0 0 0 0 1 
1596294 marR 0 0 0 0 0 1 
1596505 marR 1 1 1 1 1 1 
1723229 ydhE 0 0 1 0 0 0 
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1723527 ydhE 1 1 0 0 0 0 
2575697 acrD 1 1 0 0 0 1 
2576348 acrD 0 1 0 0 0 0 
2576537 acrD 1 1 0 0 0 0 
2577110 acrD 1 1 0 0 0 0 
2577159 acrD 0 1 0 0 0 0 
2577447 acrD 0 1 0 0 0 0 
2577684 acrD 0 1 0 0 0 0 
2577730 acrD 0 0 0 0 0 1 
2577866 acrD 1 0 0 0 0 0 
2578106 acrD 0 1 0 0 0 0 
2578225 acrD 1 0 0 0 0 0 
2578256 acrD 0 1 0 0 0 0 
2578516 acrD 1 1 0 0 0 0 
2786597 emrB 1 1 0 0 0 0 
2786662 emrB 1 0 0 0 0 0 
2786791 emrB 1 1 0 0 0 0 
2787076 emrB 1 1 0 0 0 0 
2787491 emrB 1 0 0 0 0 0 
2787596 emrB 1 1 0 0 0 0 
2787639 emrB 1 1 0 0 0 0 
3171994 tolC 0 1 0 0 0 0 
3172013 tolC 1 1 0 0 0 0 
3172219 tolC 1 0 0 0 0 0 
3172386 tolC 1 1 1 1 1 1 
3898432 emrD 0 1 0 0 0 0 
 
Supplementary Table 3.2. Full list of all SNPs found in known efflux pump genes in the 
experimental S. sonnei and S. flexneri strains. 
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Supplementary Material – Chapter 4 & 5 
 
Species Assension 
No. 
Sample 
Name 
Location Date of 
isolation 
Fluoroquinolone 
resistance 
(phenotypic 
testing) 
Fluoroquinolone 
resistance (in 
silico - ARIBA) 
S.flexneri ERR047222 HUE49 Hue 2009 - Resistant 
S.flexneri ERR047225 HUE54 Hue 2010 - Susceptible 
S.flexneri ERR047231 HUE61 Hue 2010 - Resistant 
S.flexneri ERR047233 HUE63 Hue 2010 - Resistant 
S.flexneri ERR047235 HUE65 Hue 2010 - Resistant 
S.flexneri ERR047236 HUE66 Hue 2010 - Susceptible 
S.flexneri ERR047239 KH01 Khanh 2009 - Resistant 
S.flexneri ERR047272 KH39 Khanh 2009 - Resistant 
S.flexneri ERR047278 KH47 Khanh 2010 - Susceptible 
S.flexneri ERR047279 KH48 Khanh 2010 - Resistant 
S.flexneri ERR047280 KH49 Khanh 2010 - Resistant 
S.flexneri ERR047281 KH50 Khanh 2010 - Resistant 
S.flexneri ERR047282 KH52 Khanh 2010 - Resistant 
S.flexneri ERR047287 KIEM Khanh 2008 - Resistant 
S.flexneri ERR047288 MS0001 HCMC 1995 - Susceptible 
S.flexneri ERR047289 MS0002 HCMC 1995 - Susceptible 
S.flexneri ERR047290 MS0005 HCMC 1995 - Susceptible 
S.flexneri ERR047291 MS0010 HCMC 1995 - Resistant 
S.flexneri ERR047292 MS0012 HCMC 1995 - Susceptible 
S.flexneri ERR047293 MS0014 HCMC 1995 - Susceptible 
S.flexneri ERR047294 MS0019 HCMC 1995 - Susceptible 
S.flexneri ERR047295 MS0020 HCMC 1995 - Susceptible 
S.flexneri ERR047296 MS0021 HCMC 1995 - Susceptible 
S.flexneri ERR047297 MS0022 HCMC 1995 - Resistant 
S.flexneri ERR047298 MS0025 HCMC 1995 - Susceptible 
S.flexneri ERR047299 MS0026 HCMC 1995 - Susceptible 
S.flexneri ERR047300 MS0029 HCMC 1995 - Susceptible 
S.flexneri ERR047301 MS0036 HCMC 1995 - Susceptible 
S.flexneri ERR047302 MS0038 HCMC 1995 - Susceptible 
S.flexneri ERR047303 MS0041 HCMC 1995 - Susceptible 
S.flexneri ERR047305 MS0047 HCMC 1995 - Susceptible 
S.flexneri ERR047306 MS0050 HCMC 1995 - Susceptible 
S.flexneri ERR047307 MS0052 HCMC 1995 - Susceptible 
S.flexneri ERR047308 MS0055 HCMC 1995 - Resistant 
S.flexneri ERR047309 MS0059 HCMC 1995 - Susceptible 
S.flexneri ERR047310 10398 HCMC 2010 - Resistant 
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S.flexneri ERR047329 30078 HCMC 2009 - Resistant 
S.flexneri ERR047333 30157 HCMC 2009 - Resistant 
S.flexneri ERR047346 DE0010 HCMC 2000 - Resistant 
S.flexneri ERR047347 DE0029 HCMC 2000 - Susceptible 
S.flexneri ERR047348 DE0030 HCMC 2000 - Resistant 
S.flexneri ERR047349 DE0042 HCMC 2000 - Susceptible 
S.flexneri ERR047351 DE0090 HCMC 2000 - Susceptible 
S.flexneri ERR047352 DE0119 HCMC 2000 - Resistant 
S.flexneri ERR047353 DE0174 HCMC 2000 - Resistant 
S.flexneri ERR047354 DE0175 HCMC 2000 - Resistant 
S.flexneri ERR047355 DE0184 HCMC 2000 - Resistant 
S.flexneri ERR047357 DE0195 HCMC 2000 - Susceptible 
S.flexneri ERR047358 DE0213 HCMC 2000 - Resistant 
S.flexneri ERR047359 DE0224 HCMC 2000 - Resistant 
S.flexneri ERR047360 DE0319 HCMC 2000 - Susceptible 
S.flexneri ERR047361 DE0350 HCMC 2000 - Susceptible 
S.flexneri ERR047362 DE0366 HCMC 2000 - Susceptible 
S.flexneri ERR047363 DE0438 HCMC 2000 - Susceptible 
S.flexneri ERR047364 DE0457 HCMC 2000 - Resistant 
S.flexneri ERR047365 DE0569 HCMC 2000 - Resistant 
S.flexneri ERR047366 DE0578 HCMC 2001 - Susceptible 
S.flexneri ERR047367 DE0614 HCMC 2001 - Susceptible 
S.flexneri ERR047368 DE0670 HCMC 2001 - Resistant 
S.flexneri ERR047369 DE0692 HCMC 2001 - Resistant 
S.flexneri ERR047370 DE0712 HCMC 2001 - Resistant 
S.flexneri ERR047371 DE0721 HCMC 2001 - Resistant 
S.flexneri ERR047372 DE0804 HCMC 2001 - Resistant 
S.flexneri ERR047373 DE0807 HCMC 2001 - Resistant 
S.flexneri ERR047374 DE0874 HCMC 2002 - Susceptible 
S.flexneri ERR047376 DE1173 HCMC 2002 - Susceptible 
S.flexneri ERR047377 DE1174 HCMC 2002 - Resistant 
S.flexneri ERR047378 DE1179 HCMC 2002 - Resistant 
S.flexneri ERR047379 DE1194 HCMC 2002 - Resistant 
S.flexneri ERR047380 DE1244 HCMC 2002 - Resistant 
S.flexneri ERR047381 DE1252 HCMC 2002 - Resistant 
S.flexneri ERR047382 DE1279 HCMC 2002 - Resistant 
S.flexneri ERR047383 DE1342 HCMC 2002 - Resistant 
S.flexneri ERR047384 DE1455 HCMC 2002 - Susceptible 
S.flexneri ERR047385 DE1461 HCMC 2002 - Susceptible 
S.flexneri ERR047386 DE1496 HCMC 2002 - Resistant 
S.flexneri ERR047387 DE1512 HCMC 2002 - Susceptible 
S.flexneri ERR047388 EG0002 HCMC 2006 - Resistant 
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S.flexneri ERR047389 EG0006 HCMC 2006 - Susceptible 
S.flexneri ERR047390 EG0055 HCMC 2006 - Susceptible 
S.flexneri ERR047391 EG0059 HCMC 2006 - Susceptible 
S.flexneri ERR047392 EG0085 HCMC 2007 - Susceptible 
S.flexneri ERR047393 EG0134 HCMC 2007 - Resistant 
S.flexneri ERR047394 EG0198 HCMC 2008 - Resistant 
S.flexneri ERR047395 EG0257 HCMC 2008 - Resistant 
S.flexneri ERR047396 EG0302 HCMC 2006 - Susceptible 
S.flexneri ERR047397 EG0305 HCMC 2006 - Susceptible 
S.flexneri ERR047398 EG0319 HCMC 2006 - Resistant 
S.flexneri ERR047399 EG0329 HCMC 2006 - Resistant 
S.flexneri ERR047400 EG0380 HCMC 2007 - Resistant 
S.flexneri ERR047401 EG0387 HCMC 2007 - Susceptible 
S.flexneri ERR047402 EG0403 HCMC 2007 - Resistant 
S.flexneri ERR047403 EG0412 HCMC 2007 - Resistant 
S.flexneri ERR047404 EG0419 HCMC 2007 - Resistant 
S.flexneri ERR047405 EG0435 HCMC 2008 - Resistant 
S.flexneri ERR047406 EG0449 HCMC 2008 - Resistant 
S.flexneri ERR047407 EG0461 HCMC 2008 - Resistant 
S.flexneri ERR047408 EG0469 HCMC 2008 - Resistant 
S.flexneri ERR047409 EG0471 HCMC 2008 - Resistant 
S.flexneri ERR047410 EG0474 HCMC 2008 - Resistant 
S.flexneri ERR047429 HUE03 Hue 2008 - Resistant 
S.flexneri ERR047430 HUE04 Hue 2008 - Resistant 
S.flexneri ERR047432 HUE06 Hue 2009 - Resistant 
S.flexneri ERR047433 HUE07 Hue 2009 - Resistant 
S.flexneri ERR047434 HUE08 Hue 2009 - Resistant 
S.flexneri ERR047435 HUE09 Hue 2009 - Resistant 
S.flexneri ERR047436 HUE10 Hue 2009 - Resistant 
S.flexneri ERR047437 HUE12 Hue 2009 - Resistant 
S.flexneri ERR047438 HUE13 Hue 2009 - Resistant 
S.flexneri ERR047439 HUE14 Hue 2009 - Resistant 
S.flexneri ERR047440 HUE15 Hue 2009 - Resistant 
S.flexneri ERR047443 HUE18 Hue 2009 - Resistant 
S.flexneri ERR048230 MS0061 HCMC 1995 - Susceptible 
S.flexneri ERR048231 MS0064 HCMC 1995 - Susceptible 
S.flexneri ERR048232 MS0076 HCMC 1995 - Susceptible 
S.flexneri ERR048233 MS0078 HCMC 1995 - Susceptible 
S.flexneri ERR048234 MS0084 HCMC 1996 - Susceptible 
S.flexneri ERR048235 MS0085 HCMC 1996 - Susceptible 
S.flexneri ERR048236 MS0087 HCMC 1996 - Susceptible 
S.flexneri ERR048237 MS0091 HCMC 1996 - Resistant 
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S.flexneri ERR048238 MS0093 HCMC 1996 - Susceptible 
S.flexneri ERR048240 MS0099 HCMC 1996 - Susceptible 
S.flexneri ERR048241 MS0100 HCMC 1996 - Susceptible 
S.flexneri ERR048242 MS0101 HCMC 1996 - Resistant 
S.flexneri ERR048243 MS0105 HCMC 1996 - Susceptible 
S.flexneri ERR048244 MS0114 HCMC 1996 - Susceptible 
S.flexneri ERR048245 MS0118 HCMC 1996 - Susceptible 
S.flexneri ERR048246 MS0125 HCMC 1996 - Susceptible 
S.flexneri ERR048247 MS0126 HCMC 1996 - Susceptible 
S.flexneri ERR048248 MS0130 HCMC 1996 - Susceptible 
S.flexneri ERR048249 MS0131 HCMC 1996 - Resistant 
S.flexneri ERR048250 MS0134 HCMC 1996 - Susceptible 
S.flexneri ERR048251 MS0135 HCMC 1996 - Susceptible 
S.flexneri ERR049133 10013 HCMC 2010 - Resistant 
S.flexneri ERR049152 10262 HCMC 2010 - Resistant 
S.sonnei ERR047223 HUE50 Hue 2009 Resistant Resistant 
S.sonnei ERR047228 HUE57 Hue 2010 Susceptible Susceptible 
S.sonnei ERR047229 HUE58 Hue 2010 Resistant Resistant 
S.sonnei ERR047232 HUE62 Hue 2010 Susceptible Susceptible 
S.sonnei ERR047234 HUE64 Hue 2010 Susceptible Susceptible 
S.sonnei ERR047237 HUE67 Hue 2010 Susceptible Susceptible 
S.sonnei ERR047238 HUE68 Hue 2010 Susceptible Susceptible 
S.sonnei ERR047240 KH02 Khanh 2009 Resistant Resistant 
S.sonnei ERR047241 KH04 Khanh 2009 Resistant Resistant 
S.sonnei ERR047242 KH05 Khanh 2009 Resistant Resistant 
S.sonnei ERR047243 KH06 Khanh 2009 Resistant Resistant 
S.sonnei ERR047244 KH07 Khanh 2009 Resistant Resistant 
S.sonnei ERR047245 KH09 Khanh 2009 Resistant Resistant 
S.sonnei ERR047246 KH10 Khanh 2009 Resistant Resistant 
S.sonnei ERR047247 KH11 Khanh 2009 Resistant Resistant 
S.sonnei ERR047248 KH12 Khanh 2009 Resistant Resistant 
S.sonnei ERR047249 KH13 Khanh 2009 Resistant Resistant 
S.sonnei ERR047250 KH14 Khanh 2009 Resistant Resistant 
S.sonnei ERR047251 KH15 Khanh 2009 Resistant Resistant 
S.sonnei ERR047252 KH16 Khanh 2009 Resistant Resistant 
S.sonnei ERR047253 KH17 Khanh 2009 Resistant Resistant 
S.sonnei ERR047254 KH18 Khanh 2009 Resistant Resistant 
S.sonnei ERR047255 KH19 Khanh 2009 Resistant Resistant 
S.sonnei ERR047256 KH20 Khanh 2009 Resistant Resistant 
S.sonnei ERR047257 KH21 Khanh 2009 Resistant Resistant 
S.sonnei ERR047258 KH23 Khanh 2009 Resistant Resistant 
S.sonnei ERR047259 KH24 Khanh 2009 Resistant Resistant 
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S.sonnei ERR047260 KH25 Khanh 2009 Resistant Resistant 
S.sonnei ERR047261 KH26 Khanh 2009 Resistant Resistant 
S.sonnei ERR047262 KH27 Khanh 2009 Resistant Resistant 
S.sonnei ERR047263 KH28 Khanh 2009 Resistant Resistant 
S.sonnei ERR047264 KH29 Khanh 2009 Resistant Resistant 
S.sonnei ERR047265 KH30 Khanh 2009 Resistant Resistant 
S.sonnei ERR047266 KH32 Khanh 2009 Resistant Resistant 
S.sonnei ERR047267 KH33 Khanh 2009 Resistant Resistant 
S.sonnei ERR047268 KH34 Khanh 2009 Resistant Resistant 
S.sonnei ERR047269 KH35 Khanh 2009 Resistant Resistant 
S.sonnei ERR047270 KH37 Khanh 2009 Resistant Resistant 
S.sonnei ERR047271 KH38 Khanh 2009 Resistant Resistant 
S.sonnei ERR047273 KH40 Khanh 2009 Resistant Resistant 
S.sonnei ERR047274 KH41 Khanh 2009 Resistant Resistant 
S.sonnei ERR047275 KH42 Khanh 2010 Susceptible Susceptible 
S.sonnei ERR047276 KH43 Khanh 2010 Resistant Resistant 
S.sonnei ERR047277 KH45 Khanh 2010 Resistant Resistant 
S.sonnei ERR047283 KH53 Khanh 2010 Resistant Resistant 
S.sonnei ERR047284 KH54 Khanh 2010 Resistant Resistant 
S.sonnei ERR047285 KH55 Khanh 2010 Resistant Resistant 
S.sonnei ERR047286 KH57 Khanh 2010 Resistant Resistant 
S.sonnei ERR047304 MS0043 HCMC 1995 Susceptible Susceptible 
S.sonnei ERR047311 20006 HCMC 2009 Resistant Resistant 
S.sonnei ERR047312 20021 HCMC 2009 Resistant Resistant 
S.sonnei ERR047313 20023 HCMC 2009 Resistant Resistant 
S.sonnei ERR047314 20037 HCMC 2009 Resistant Resistant 
S.sonnei ERR047315 20070 HCMC 2009 Resistant Resistant 
S.sonnei ERR047316 20094 HCMC 2009 Resistant Resistant 
S.sonnei ERR047317 20228 HCMC 2009 Resistant Resistant 
S.sonnei ERR047318 20261 HCMC 2009 Resistant Resistant 
S.sonnei ERR047319 20263 HCMC 2009 Resistant Resistant 
S.sonnei ERR047320 20343 HCMC 2009 Resistant Resistant 
S.sonnei ERR047321 30003 HCMC 2009 Resistant Resistant 
S.sonnei ERR047322 30008 HCMC 2009 Resistant Resistant 
S.sonnei ERR047323 30010 HCMC 2009 Resistant Resistant 
S.sonnei ERR047324 30037 HCMC 2009 Resistant Resistant 
S.sonnei ERR047325 30054 HCMC 2009 Resistant Resistant 
S.sonnei ERR047326 30059 HCMC 2009 Resistant Resistant 
S.sonnei ERR047327 30071 HCMC 2009 Resistant Resistant 
S.sonnei ERR047328 30073 HCMC 2009 Resistant Resistant 
S.sonnei ERR047330 30100 HCMC 2009 Resistant Resistant 
S.sonnei ERR047331 30112 HCMC 2009 Resistant Resistant 
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S.sonnei ERR047332 30124 HCMC 2009 Resistant Resistant 
S.sonnei ERR047334 30162 HCMC 2009 Resistant Resistant 
S.sonnei ERR047335 30164 HCMC 2009 Resistant Resistant 
S.sonnei ERR047336 30169 HCMC 2009 Resistant Resistant 
S.sonnei ERR047337 30172 HCMC 2009 Resistant Resistant 
S.sonnei ERR047338 30174 HCMC 2009 Resistant Resistant 
S.sonnei ERR047339 30233 HCMC 2009 Resistant Resistant 
S.sonnei ERR047340 30293 HCMC 2009 Resistant Resistant 
S.sonnei ERR047341 30366 HCMC 2009 Resistant Resistant 
S.sonnei ERR047342 30371 HCMC 2009 Resistant Resistant 
S.sonnei ERR047343 30387 HCMC 2010 Resistant Resistant 
S.sonnei ERR047344 30450 HCMC 2010 Resistant Resistant 
S.sonnei ERR047345 30451 HCMC 2010 Resistant Resistant 
S.sonnei ERR047411 EG1014 HCMC 2009 Resistant Resistant 
S.sonnei ERR047412 EG1015 HCMC 2009 Resistant Resistant 
S.sonnei ERR047413 EG1016 HCMC 2009 Resistant Resistant 
S.sonnei ERR047414 EG1017 HCMC 2009 Resistant Resistant 
S.sonnei ERR047415 EG1018 HCMC 2009 Resistant Resistant 
S.sonnei ERR047416 EG1019 HCMC 2009 Resistant Resistant 
S.sonnei ERR047417 EG1020 HCMC 2009 Resistant Resistant 
S.sonnei ERR047418 EG1021 HCMC 2009 Resistant Resistant 
S.sonnei ERR047419 EG1022 HCMC 2009 Resistant Resistant 
S.sonnei ERR047420 EG1023 HCMC 2009 Resistant Resistant 
S.sonnei ERR047421 EG1024 HCMC 2009 Resistant Resistant 
S.sonnei ERR047422 EG1025 HCMC 2009 Resistant Resistant 
S.sonnei ERR047423 EG1026 HCMC 2009 Resistant Resistant 
S.sonnei ERR047424 EG1027 HCMC 2009 Resistant Resistant 
S.sonnei ERR047425 EG1028 HCMC 2009 Resistant Resistant 
S.sonnei ERR047426 EG1029 HCMC 2009 Resistant Resistant 
S.sonnei ERR047427 HUE01 Hue 2008 Susceptible Susceptible 
S.sonnei ERR047428 HUE02 Hue 2008 Susceptible Susceptible 
S.sonnei ERR047431 HUE05 Hue 2008 Susceptible Susceptible 
S.sonnei ERR047441 HUE16 Hue 2009 Susceptible Susceptible 
S.sonnei ERR047442 HUE17 Hue 2009 Resistant Resistant 
S.sonnei ERR047444 HUE19 Hue 2009 Resistant Resistant 
S.sonnei ERR047445 HUE20 Hue 2009 Resistant Resistant 
S.sonnei ERR047446 HUE21 Hue 2009 Susceptible Susceptible 
S.sonnei ERR047447 HUE22 Hue 2009 Resistant Resistant 
S.sonnei ERR047448 HUE23 Hue 2009 Susceptible Susceptible 
S.sonnei ERR047449 HUE24 Hue 2009 Susceptible Susceptible 
S.sonnei ERR047450 HUE25 Hue 2009 Susceptible Susceptible 
S.sonnei ERR047451 HUE26 Hue 2009 Susceptible Susceptible 
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S.sonnei ERR047452 HUE27 Hue 2009 Susceptible Susceptible 
S.sonnei ERR047453 HUE29 Hue 2009 Resistant Resistant 
S.sonnei ERR047454 HUE30 Hue 2009 Susceptible Susceptible 
S.sonnei ERR047455 HUE31 Hue 2009 Susceptible Susceptible 
S.sonnei ERR047456 HUE32 Hue 2009 Susceptible Susceptible 
S.sonnei ERR047457 HUE33 Hue 2009 Susceptible Susceptible 
S.sonnei ERR047458 HUE34 Hue 2009 Susceptible Susceptible 
S.sonnei ERR047461 HUE40 Hue 2009 Susceptible Susceptible 
S.sonnei ERR047462 HUE42 Hue 2009 Susceptible Susceptible 
S.sonnei ERR047463 HUE43 Hue 2009 Susceptible Susceptible 
S.sonnei ERR047464 HUE46 Hue 2009 Resistant Resistant 
S.sonnei ERR047465 HUE47 Hue 2009 Susceptible Susceptible 
S.sonnei ERR047466 HUE48 Hue 2009 Susceptible Susceptible 
S.sonnei ERR048239 MS0094 HCMC 1996 Susceptible Susceptible 
S.sonnei ERR049134 10014 HCMC 2009 Resistant Resistant 
S.sonnei ERR049135 10021 HCMC 2009 Resistant Resistant 
S.sonnei ERR049136 10031 HCMC 2009 Susceptible Susceptible 
S.sonnei ERR049137 10035 HCMC 2009 Resistant Resistant 
S.sonnei ERR049138 10060 HCMC 2009 Resistant Resistant 
S.sonnei ERR049139 10063 HCMC 2009 Resistant Resistant 
S.sonnei ERR049140 10071 HCMC 2009 Susceptible Susceptible 
S.sonnei ERR049141 10073 HCMC 2009 Resistant Resistant 
S.sonnei ERR049142 10083 HCMC 2009 Resistant Resistant 
S.sonnei ERR049143 10093 HCMC 2009 Resistant Resistant 
S.sonnei ERR049144 10102 HCMC 2009 Resistant Resistant 
S.sonnei ERR049145 10111 HCMC 2009 Resistant Resistant 
S.sonnei ERR049146 10115 HCMC 2009 Resistant Resistant 
S.sonnei ERR049147 10134 HCMC 2009 Resistant Resistant 
S.sonnei ERR049148 10135 HCMC 2009 Resistant Resistant 
S.sonnei ERR049149 10152 HCMC 2009 Resistant Resistant 
S.sonnei ERR049150 10159 HCMC 2009 Resistant Resistant 
S.sonnei ERR049151 10188 HCMC 2009 Resistant Resistant 
S.sonnei ERR049153 10263 HCMC 2009 Resistant Resistant 
S.sonnei ERR049154 10320 HCMC 2010 Resistant Resistant 
S.sonnei ERR049155 10365 HCMC 2010 Resistant Resistant 
 
Supplementary Table 4.1.Vietnamese S. sonnei and S. flexenri isolates used in chapters 4 and 
5 of this thesis. The date of isolation, location, accession number and phenotypic resistance to 
nalidixic acid (a quinolone) in S. sonnei are shown 
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Supplementary Material – chapter 5 
 
Species 
name 
Run 
accession 
Strain Name Lineage Serotype Year of Isolation Country of isolation 
Shigella flexneri ERR042796 Sh02-1115 3 Xv 2002 Gabon 
Shigella flexneri ERR042799 Sh02-3648 3 2a 2002 Mayotte 
Shigella flexneri ERR042801 Sh02-8484 3 2a 2002 Haiti 
Shigella flexneri ERR042802 Sh03-0850 3 2a 2003 Haiti 
Shigella flexneri ERR042804 Sh03-2590 3 2a 2003 Madagascar 
Shigella flexneri ERR042806 Sh04-2878 3 2b 2004 Morocco 
Shigella flexneri ERR042807 Sh04-4915 1 1b 2004 Algeria 
Shigella flexneri ERR042810 Sh04-9462 1 1b 2004 Cameroon 
Shigella flexneri ERR042812 Sh05-1382 1 4av 2005 Mali 
Shigella flexneri ERR042813 Sh05-1396 1 1b 2005 Chad 
Shigella flexneri ERR042814 Sh05-1631 3 2a 2005 Dominican Republic 
Shigella flexneri ERR042824 Sh05-9228 3 2a 2005 French Guiana 
Shigella flexneri ERR042827 Sh06-1976 7 4a 2006 Ivory Coast 
Shigella flexneri ERR042828 Sh06-2028 1 1b 2006 Guinea 
Shigella flexneri ERR042829 Sh06-3638 2 3a 2006 Niger 
Shigella flexneri ERR042830 Sh06-7888 3 2a 2006 Algeria 
Shigella flexneri ERR042832 Sh07-0130 6 Y 2007 Madagascar 
Shigella flexneri ERR042836 Sh07-4848 2 3a 2007 Togo 
Shigella flexneri ERR042838 Sh07-5519 7 Yv 2007 Cameroon 
Shigella flexneri ERR042840 Sh07-6497 3 Yv 2007 Ivory Coast 
Shigella flexneri ERR042842 Sh07-7746 3 2a 2007 Guadeloupe 
Shigella flexneri ERR042843 Sh08-0350 4 3a 2008 Dominican Republic 
Shigella flexneri ERR042845 Sh08-1372 3 Xv 2008 Senegal 
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Shigella flexneri ERR042846 Sh08-2354 1 1b 2008 Burkina Faso 
Shigella flexneri ERR042848 Sh08-3483 2 3a 2008 French Guiana 
Shigella flexneri ERR042851 Sh09-0167 1 1b 2009 Senegal 
Shigella flexneri ERR042854 Sh09-2087 3 2a 2009 Mayotte 
Shigella flexneri ERR042855 Sh09-4409 2 3a 2009 Togo 
Shigella flexneri ERR042858 Sh09-5516 7 4av 2009 Congo 
Shigella flexneri ERR042860 Sh09-6787 3 2a 2009 Comores 
Shigella flexneri ERR042863 Sh09-9407 3 Yv 2009 Mali 
Shigella flexneri ERR047372 DE0804 7 4av 2001 Vietnam 
Shigella flexneri ERR047385 DE1461 2 3a 2002 Vietnam 
Shigella flexneri ERR047394 EG0198 2 3a 2008 Vietnam 
Shigella flexneri ERR048288 IB4235 6 Y 2000 India 
Shigella flexneri ERR048291 IB3350 1 1b 2002 Pakistan 
Shigella flexneri ERR048295 IB3391 3 2b 2002 Pakistan 
Shigella flexneri ERR048302 IB0711 3 2a 1999 Korea 
Shigella flexneri ERR048303 IB0712 3 2a 2003 Korea 
Shigella flexneri ERR048319 IB0034 3 1a 2002 China 
Shigella flexneri ERR048321 IB0037 3 2a 2002 China 
Shigella flexneri ERR048322 IB0039 3 2a 2002 Philippines 
Shigella flexneri ERR048323 IB0043 3 2a 2002 Philippines 
Shigella flexneri ERR048324 IB0045 3 2a 2002 Taiwan 
Shigella flexneri ERR048327 IB0068 3 2a 2003 Taiwan 
Shigella flexneri ERR048328 IB1716 7 Yv 2002 Vietnam 
Shigella flexneri ERR048339 IB0064 3 2b 2002 Sri Lanka 
Shigella flexneri ERR126958 370076 3 2a 2009 South Africa (KwaZulu-Natal) 
Shigella flexneri ERR126963 319743 2 3a 2009 South Africa (Eastern Cape) 
Shigella flexneri ERR126966 356458 2 3a 2009 South Africa (Free State) 
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Shigella flexneri ERR126986 441003 3 2a 2010 South Africa (Western Cape) 
Shigella flexneri ERR126987 466310 3 2a 2010 South Africa (KwaZulu-Natal) 
Shigella flexneri ERR126992 428153 2 3a 2010 South Africa (Eastern Cape) 
Shigella flexneri ERR127012 579748 3 2a 2011 South Africa (Gauteng) 
Shigella flexneri ERR127014 527649 3 2a 2011 South Africa (Western Cape) 
Shigella flexneri ERR127015 535661 3 2a 2011 South Africa (Gauteng) 
Shigella flexneri ERR200365 K-9282 3 2a 2009 Bangladesh 
Shigella flexneri ERR200367 K-9324 3 2a 2009 Bangladesh 
Shigella flexneri ERR217024 K-9165 6 Y 2009 Bangladesh 
Shigella flexneri ERR217029 K-8263 6 Yv 2007 Bangladesh 
Shigella sonnei ERR024064 20061758 II NA 2006 Dominican Republic 
Shigella sonnei ERR024068 20041367 III NA 2004 UK 
Shigella sonnei ERR024071 20040880 III NA 2004 Sri Lanka 
Shigella sonnei ERR024077 CS20 III NA 2002 Brazil 
Shigella sonnei ERR024081 20021122 III NA 2002 UK 
Shigella sonnei ERR024083 19984123 III NA 1998 Mexico 
Shigella sonnei ERR024084 20040489 I NA 2004 UK 
Shigella sonnei ERR024087 20011685 III NA 2001 UK 
Shigella sonnei ERR024090 20062087 III NA 2006 Egypt_Tunisia 
Shigella sonnei ERR024096 CS7 III NA 2000 Brazil 
Shigella sonnei ERR024097 CS8 III NA 2000 Brazil 
Shigella sonnei ERR024604 #04 1191 II NA 2004 Tanzania 
Shigella sonnei ERR024605 #06 6470 II NA 2006 Haiti 
Shigella sonnei ERR024606 #07 4369 I NA 2007 France 
Shigella sonnei ERR024607 #05 5623 II NA 2005 Morocco 
Shigella sonnei ERR024608 #06 0108 III NA 2006 French Guiana 
Shigella sonnei ERR024609 #06 2542 III NA 2006 Burkina Faso 
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Shigella sonnei ERR024610 #06 5179 III NA 2006 Senegal 
Shigella sonnei ERR024611 #06 5387 III NA 2006 Morocco 
Shigella sonnei ERR024612 #06 5623 III NA 2006 Morocco 
Shigella sonnei ERR024614 #06 6396 III NA 2006 France  
Shigella sonnei ERR024616 IB1 III NA 2003 Korea 
Shigella sonnei ERR024617 IB690 III NA 2000 Korea 
Shigella sonnei ERR024618 IB691 III NA 1999 Korea 
Shigella sonnei ERR024620 IB2 III NA 2003 Korea 
Shigella sonnei ERR024621 IB3 III NA 2003 Korea 
Shigella sonnei ERR024622 IB10 III NA 2003 Korea 
Shigella sonnei ERR025704 IB2000 III NA 2003 Vietnam 
Shigella sonnei ERR025706 IB2008 III NA 2003 Vietnam 
Shigella sonnei ERR025708 IB2015 III NA 2002 Vietnam 
Shigella sonnei ERR025709 IB3488 III NA 2003 Pakistan 
Shigella sonnei ERR025710 IB3507 III NA 2003 Pakistan 
Shigella sonnei ERR025711 IB3580 III NA 2003 Pakistan 
Shigella sonnei ERR025713 IB2024 III NA 2002 Vietnam 
Shigella sonnei ERR025714 IB2026 III NA 2003 Vietnam 
Shigella sonnei ERR025717 IB3277 III NA 2002 Pakistan 
Shigella sonnei ERR025718 IB3300 III NA 2002 Pakistan 
Shigella sonnei ERR025719 IB3374 III NA 2002 Pakistan 
Shigella sonnei ERR025748 #97 0044 III NA 1997 New Caledonia 
Shigella sonnei ERR025758 #98 8743 III NA 1998 French Guiana 
Shigella sonnei ERR025759 #03 6224 III NA 2003 Senegal 
Shigella sonnei ERR025761 #98 9560 III NA 1998 Madagascar 
Shigella sonnei ERR025762 #9810267 II NA 1998 Madagascar 
Shigella sonnei ERR025763 #99 8911 II NA 1999 France 
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Shigella sonnei ERR025764 #00 2225 III NA 2000 French Guiana 
Shigella sonnei ERR025765 #00 5827 I NA 2000 Madagascar 
Shigella sonnei ERR025767 #03 1382 III NA 2003 Israel 
Shigella sonnei ERR025768 #03 2222 III NA 2003 Cuba 
Shigella sonnei ERR028671 20051272 III NA 2005 Egypt 
Shigella sonnei ERR028677 20060018 III NA 2006 Egypt 
Shigella sonnei ERR028681 20051541 III NA 2005 Uzbekistan 
Shigella sonnei ERR028684 20061309 III NA 2006 Egypt 
Shigella sonnei ERR028686 CS6 III NA 2000 Brazil 
Shigella sonnei ERR028687 CS14 III NA 2001 Brazil 
Shigella sonnei ERR028690 20031275 III NA 2003 Iran 
Shigella sonnei ERR028693 20052631 III NA 2005 Peru 
Shigella sonnei ERR028697 20040924 III NA 2004 Kenya 
Shigella sonnei ERR028700 20071599 II NA 2007 UK 
Shigella sonnei ERR028702 20010007 III NA 2001 UK 
Shigella sonnei ERR028703 20062313 III NA 2006 Nepal 
 
 
Supplementary Table 5.1. Global S. sonnei and S. flexenri isolates used in chapter 5 of this thesis. Strain information including date of isolation, 
country of isolation, lineage and run accession number are shown. 
 
. 
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HGC gene 
name 
Function Number of 
S. sonnei 
isolates 
Number of 
S. flexneri 
isolates 
HGC with the same gene name annotation (S. 
sonnei / S. flexneri numbers) 
aaeB_2 p-hydroxybenzoic acid efflux pump subunit 
AaeB 
146 4 aaeB_1 (139/135) 
aarA Rhomboid protease AarA 146 13 - 
abgA p-aminobenzoyl-glutamate hydrolase subunit A 144 10 abgA_1 (1/10) 
abgB p-aminobenzoyl-glutamate hydrolase subunit B 146 10 - 
abgT_1 p-aminobenzoyl-glutamate transport protein 146 10 abgT_2 (146/0) 
abgT_2 p-aminobenzoyl-glutamate transport protein 146 0 abgT_1 (146/10) 
acoR Acetoin dehydrogenase operon transcriptional 
activator AcoR 
0 129 - 
acrF_2 Multidrug export protein AcrF 146 19 acrF_1 (6/19), acrF_3 (146/13) 
acrF_3 Multidrug export protein AcrF 146 13 acrF_1 (6/19), acrF_2 (146/19) 
adhB Alcohol dehydrogenase 2 0 134 - 
adhE_3 Aldehyde-alcohol dehydrogenase 146 0 adhE_1 (145/52), adhE_2 (146/21), adhE_4 (139/15) 
adhE_4 Aldehyde-alcohol dehydrogenase 139 15 adhE_1 (145/52), adhE_2 (146/21), adhE_3 (146/0) 
adhT Alcohol dehydrogenase 0 133 - 
aldA_2 Lactaldehyde dehydrogenase 145 6 aldA (0/1), aldA_1 (145/126) 
aldB Aldehyde dehydrogenase B 0 133 aldB_1 (0/2), aldB_2 (0/2) 
allA Ureidoglycolate lyase 0 135 - 
allB Allantoinase 146 14 - 
allR HTH-type transcriptional repressor AllR 0 134 - 
allS_5 HTH-type transcriptional activator AllS 139 14 allS_1 (94/0), allS_2 (144/122), allS_3 (145/133), allS_4 
(145/134), allS_6 (145/58) 
aplIR Type-2 restriction enzyme AplI 146 0 - 
araC_2 putative histidine kinase sensor domain protein 146 13 araC (146/135) 
arcC1_2 Carbamate kinase 1 146 13 araC1_1 (146/130), araC1_3 (0/1) 
arcC2 Carbamate kinase 2 146 0 - 
argE_1 Acetylornithine deacetylase 145 13 argE (2/114), argE_2 (145/20) 
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argF Ornithine carbamoyltransferase 145 13 - 
aroG_2 Phospho-2-dehydro-3-deoxyheptonate 
aldolase, Phe-sensitive 
146 3 aroG_1 (146/134) 
aroP_2 Aromatic amino acid transport protein AroP 145 13 aroP_1 (146/134) 
astC_1 Succinylornithine transaminase 19 130 astC (108/83), astC_2 (22/25) 
atoA Acetate CoA-transferase subunit beta 145 0 - 
atoD Acetate CoA-transferase subunit alpha 145 0 - 
atoE Short-chain fatty acids transporter 146 0 - 
atzC N-isopropylammelide isopropyl amidohydrolase 146 0 - 
avtA Valine--pyruvate aminotransferase 0 134 - 
bcr_1 Bicyclomycin resistance protein 146 1 bcr (145/133) 
bfd Bacterioferritin-associated ferredoxin 0 135 - 
bfr Bacterioferritin 0 135 - 
bglA_1 6-phospho-beta-glucosidase BglA 146 12 bgl_2 (146/135) 
cadA_1 Lysine decarboxylase, inducible 146 0 cadA_2 (126/0), cadA_3 (144/0) 
cadA_3 Lysine decarboxylase, inducible 144 0 cadA_1 (146/0), cadA_2 ( 
cadC_1 Transcriptional activator CadC 146 0 cadC_2 (145/0)  
cadC_2 Transcriptional activator CadC 145 0 cadC_1 (146/0) 
caiT_2 L-carnitine/gamma-butyrobetaine antiporter 146 13 caiT (146/122) 
casA CRISPR system Cascade subunit CasA 146 13 - 
casC CRISPR system Cascade subunit CasC 146 13 - 
casD CRISPR system Cascade subunit CasD 138 11 - 
casE CRISPR associated protein 144 13 - 
ccmL Carbon dioxide concentrating mechanism 
protein CcmL 
146 0 - 
cdaR_2 Carbohydrate diacid regulator 0 132 cdaR (146/119), cdaR_1 (0/5) 
cdhB Caffeine dehydrogenase subunit beta 143 0 - 
cdsA_2 Phosphatidate cytidylyltransferase 146 1 cdsA_1 (146/135 
chbC N,N'-diacetylchitobiose permease IIC 
component 
138 1 chbC_1 (4/106), chbC_2 (4/106) 
citC_2 [Citrate [pro-3S]-lyase] ligase 146 13 citC_1 (145/122) 
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clpP1 ATP-dependent Clp protease proteolytic 
subunit 1 
145 0 - 
cytR_1 HTH-type transcriptional repressor CytR 145 0 cytR (146/135) 
dacD D-alanyl-D-alanine carboxypeptidase DacD 
precursor 
146 0 - 
ddpA putative D,D-dipeptide-binding periplasmic 
protein DdpA precursor 
143 13 - 
ddpB putative D,D-dipeptide transport system 
permease protein DdpB 
146 13 - 
ddrA Diol dehydratase-reactivating factor alpha 
subunit 
146 19 - 
dgt_1 Deoxyguanosinetriphosphate 
triphosphohydrolase 
146 0 dgt_2 (145/135) 
dhaK PTS-dependent dihydroxyacetone kinase, 
dihydroxyacetone-binding subunit DhaK 
0 131 - 
dhaL PTS-dependent dihydroxyacetone kinase, ADP-
binding subunit DhaL 
0 130 - 
dinB_2 DNA polymerase IV 145 5 dinB_1 (146/134), dinB_3 (140/91) 
dinJ Antitoxin DinJ 146 0 - 
dlgD 2,3-diketo-L-gulonate reductase 0 133 - 
dmlA D-malate dehydrogenase [decarboxylating] 146 13 - 
dmlR_6 HTH-type transcriptional regulator DmlR 138 4 dmlR_1 (146/135), dmlR_2 (139/120), dmlR_3 (145/116), 
dmlR_4 (146/133), dmlR_5 (123/87), dmlR_7 (140/42) 
dnaC_2 DNA replication protein DnaC 146 10 dnaC_1 (146/135), dnaC_3 (146/135), dnaC_4 (0/4), 
dnaC_5 (1/4) 
dnaJ_1 Chaperone protein DnaJ 13 133 dnaJ (142/105), dnaJ_2 (34/19), dnaJ_3 (1/0) 
ecfT Energy-coupling factor transporter 
transmembrane protein EcfT 
0 134 - 
ecpD_1 Chaperone protein EcpD precursor 146 13 ecpD_2 (146/105) 
elfC_1 putative outer membrane usher protein ElfC 
precursor 
146 18 elfC_2 (146/130), elfC_3 (4/88), elfC_4 (1/2), elfC_5 
(140/15), elfC_6 (2/0) 
elfC_5 putative outer membrane usher protein ElfC 
precursor 
140 15 elfC_1 (146/18), elfC_2 (146/130), elfC_3 (4/88), elfC_4 
(1/2), elfC_6 (2/0) 
elfG_1 putative fimbrial-like protein ElfG precursor 145 19 elfG_2 (146/122), elfG_3 (142/109), elfG_4 (146/130) 
envR putative acrEF/envCD operon repressor 146 13 - 
epsJ_2 putative glycosyltransferase EpsJ 146 13 epsJ (0/24), epsj_1 (146/31) 
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etfA_3 Electron transfer flavoprotein subunit alpha 0 132 eftA_1 (146/122), eftA_2 (146/114) 
eutB_1 Ethanolamine ammonia-lyase heavy chain 146 17 eutB_2 (132/36) 
exsA_2 Exoenzyme S synthesis regulatory protein 
ExsA 
145 13 exsA (15/127), exsA_1 (131/29) 
exuT_1 Hexuronate transporter 146 17 exuT_2 (145/133) 
fecA_1 Fe(3 ) dicitrate transport protein FecA precursor 144 14 fecA (83/82), fecA_2 (69/4) 
fhlA_3 Formate hydrogenlyase transcriptional activator 144 0 fhlA_1 (146/135), fhlA_2 (144/34), fhlA_4 (141/129) 
fimA_1 Type-1 fimbrial protein, A chain precursor 146 19 fimA_2 (146/135), fimA_3 (0/113), fim_4 (0/13) 
flgG_2 Flagellar basal-body rod protein FlgG 146 0 flgG_1 (146/135) 
fliD Flagellar hook-associated protein 2 0 131 fliD_1 (145/0), fliD_2 (146/0), fliD_3 (146/0) 
fliD_1 Flagellar hook-associated protein 2 145 0 fliD (0/131), fliD_2 (146/0), fliD_3 (146/0) 
fliD_2 Flagellar hook-associated protein 2 146 0 fliD (0/131), fliD_1 (145/0), fliD_3 (146/0) 
fliD_3 Flagellar hook-associated protein 2 146 0 fliD (0/131), fliD_1 (145/0), fliD_2 (146/0) 
fliZ_1 Regulator of sigma S factor FliZ 143 7 fliZ (0/125), fliZ_2 (133/3) 
flr Flavoredoxin 145 0 - 
frmA S-(hydroxymethyl)glutathione dehydrogenase 144 0 - 
frmB S-formylglutathione hydrolase FrmB 144 0 - 
frmR Transcriptional repressor FrmR 144 0 - 
fucA_1 L-fuculose phosphate aldolase 144 14 fucA (1/2), fucA_2 (146/134) 
gadW_1 HTH-type transcriptional regulator GadW 144 0 gadW_2 (145/135) 
galF UTP--glucose-1-phosphate uridylyltransferase 0 135 - 
garR_3 2-hydroxy-3-oxopropionate reductase 146 13 garR_1 (143/86), garR_2 (146/134) 
gbpR HTH-type transcriptional regulator GbpR 146 10 - 
glmU_1 Bifunctional protein GlmU 144 0 glmU_2 (146/135) 
glpR_3 Glycerol-3-phosphate regulon repressor 146 13 glpR_1 (146/135), glpR_2 (146/135) 
gltD_2 Glutamate synthase [NADPH] small chain 146 16 gltD_1 (145/134), gltD_3 (146/3), gltD_4 (126/91) 
gltD_3 Glutamate synthase [NADPH] small chain 146 3 gltD_1 (145/134), gltD_2 (146/16), gltD_4 (126/91) 
gltR_1 HTH-type transcriptional regulator GltR 146 12 gltR_2 (146/132) 
gno Gluconate 5-dehydrogenase 146 0 - 
gntK_2 Thermoresistant gluconokinase 146 0 gntK (146/135) 
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gntR HTH-type transcriptional regulator GntR 1 134 gntR_1 (145/2), gntR_2 (146/0) 
gntR_1 HTH-type transcriptional regulator GntR 145 2 gntR (1/134), gntR_2 (146/0) 
gntR_2 HTH-type transcriptional regulator GntR 146 0 gntR (1/134), gntR_1 (146/2) 
group_100
24 
Fimbrial protein 146 3 - 
group_100
58 
Transposase IS116/IS110/IS902 family protein 145 13 - 
group_100
59 
alpha-mannosidase 146 13 - 
group_100
61 
Transposase DDE domain protein 143 0 - 
group_100
83 
Phage minor tail protein U 143 10 - 
group_100
84 
Bacteriophage lambda head decoration protein 
D 
144 10 - 
group_100
91 
putative TonB-dependent receptor precursor 145 12 - 
group_104
31 
Phage late control gene D protein (GPD) 145 0 - 
group_107
95 
Fimbrial assembly protein (PilN) 0 132 - 
group_111
03 
Fels-1 Prophage Protein-like protein 146 13 - 
group_111
05 
IS2 transposase TnpB 141 0 - 
group_111
14 
ImpA domain protein 146 0 - 
group_111
44 
Prophage CP4-57 regulatory protein (AlpA) 145 0 - 
group_111
60 
NIF3 (NGG1p interacting factor 3) 146 12 - 
group_111
61 
Phage protein GP46 146 0 - 
group_111
62 
Excisionase-like protein 140 1 - 
group_111
91 
Phage minor tail protein 143 9 - 
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group_111
94 
Phage major capsid protein E 145 10 - 
group_111
95 
Phage DNA packaging protein Nu1 142 10 - 
group_112
12 
Baseplate J-like protein 146 13 - 
group_112
17 
putative racemase 144 0 - 
group_112
40 
IS1 transposase 146 11 - 
group_120
71 
Type-F conjugative transfer system protein 
(TrbI_Ftype) 
145 4 - 
group_123
73 
Stress-induced bacterial acidophilic repeat motif 
protein 
141 18 - 
group_125
12 
putative fimbrial-like adhesin protein 146 0 - 
group_125
14 
putative fimbrial-like adhesin protein 146 0 - 
group_125
16 
putative fimbrial-like adhesin protein 146 0 - 
group_125
19 
Transposase 139 0 - 
group_125
27 
putative metallophosphoesterase 146 13 - 
group_125
39 
Gene 25-like lysozyme 146 0 - 
group_125
41 
Type VI secretion lipoprotein 145 0 - 
group_125
55 
Ankyrin repeat protein 146 0 - 
group_125
62 
N-glycosyltransferase 144 0 - 
group_125
89 
transcriptional repressor DicA 146 0 - 
group_125
96 
Limonene hydroxylase 146 13 - 
group_126
18 
Mu-like prophage major head subunit gpT 144 0 - 
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group_126
21 
secY/secA suppressor protein 146 13 - 
group_126
22 
lipoprotein 146 13 - 
group_126
33 
Phage antitermination protein Q 146 0 - 
group_126
34 
ORF6N domain protein 146 0 - 
group_126
49 
SMP-30/Gluconolaconase/LRE-like region 144 13 - 
group_126
53 
Glycosyltransferase family 9 
(heptosyltransferase) 
146 0 - 
group_126
57 
Phage regulatory protein Rha (Phage_pRha) 146 10 - 
group_126
59 
Caudovirales tail fibre assembly protein 146 0 - 
group_126
79 
Invasin 146 0 - 
group_126
84 
electron transport complex protein RnfC 146 0 - 
group_126
98 
Phage antitermination protein Q 143 0 - 
group_127
02 
prophage protein NinE 144 0 - 
group_127
11 
Minor tail protein T 143 10 - 
group_127
12 
Bacteriophage lambda minor tail protein (GpG) 143 0 - 
group_127
13 
gpW 144 10 - 
group_127
16 
ORF11CD3 domain protein 145 0 - 
group_127
37 
Colicin E1 (microcin) immunity protein 146 0 - 
group_127
39 
Gram-negative bacterial tonB protein 146 12 - 
group_127
53 
CRISPR-associated protein Cse1 
(CRISPR_cse1) 
146 0 - 
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group_189
6 
reactivating factor for ethanolamine ammonia 
lyase 
146 18 - 
group_272
2 
AAA-like domain protein 138 4 - 
group_285
2 
Serine dehydratase alpha chain 142 16 - 
group_382
0 
Phage terminase large subunit 144 6 - 
group_431
1 
Electron transfer flavoprotein-ubiquinone 
oxidoreductase 
0 131 - 
group_467 Phage portal protein 139 9 - 
group_483
8 
Intracellular multiplication and human 
macrophage-killing 
145 0 - 
group_522
9 
putative E3 ubiquitin-protein ligase ipaH7.8 145 4 - 
group_534
8 
putative transposase 2 132 - 
group_559
8 
putative hydrolase 146 4 - 
group_559
9 
putative hydrolase 0 133 - 
group_591
2 
N-glycosyltransferase 142 0 - 
group_593
0 
Poxvirus D5 protein-like protein 141 0 - 
group_627
7 
WGR domain protein 0 129 - 
group_631
7 
colanic acid biosynthesis protein 0 128 - 
group_677
5 
Phage portal protein, lambda family 144 10 - 
group_703 Lipoprotein Rz1 precursor 143 19 - 
group_733
7 
Caudovirales tail fibre assembly protein 145 13 - 
group_745
5 
PrkA AAA domain protein 144 13 - 
group_747
6 
Phage tail sheath protein 146 16 - 
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group_774
7 
SpoVR family protein 144 16 - 
group_829
1 
Phage integrase family protein 144 10 - 
group_834
1 
Bacterial Ig-like domain (group 2) 144 8 - 
group_835
0 
Transposase IS66 family protein 146 0 - 
group_860
3 
TraE protein 146 4 - 
group_863
4 
RNA 2'-phosphotransferase 0 133 - 
group_872
2 
putative autotransporter precursor 0 134 - 
group_872
5 
putative DNA-binding transcriptional regulator 142 9 - 
group_921
3 
Bacteriophage lysis protein 140 18 - 
group_969
3 
PGL/p-HBAD biosynthesis 
glycosyltransferase/MT3031 
146 19 - 
group_995
3 
Ethanolamine utilisation protein, EutH 146 19 - 
gspA_3 General stress protein A 146 13 gspA_1 (146/122), gspA_2 (146/122), gspA_4 (146/13), 
gspA_5 (146/13) 
gspA_4 General stress protein A 146 13 gspA_1 (146/122), gspA_2 (146/122), gspA_3 (146/13), 
gspA_5 (146/13) 
gspA_5 General stress protein A 146 13 gspA_1 (146/122), gspA_2 (146/122), gspA_3 (146/13), 
gspA_4 (146/13) 
gspB Putative general secretion pathway protein B 146 0 - 
gstA_1 Glutathione S-transferase GstA 146 17 gstA_2 (146/118) 
gstB_1 Glutathione S-transferase GST-6.0 145 13 gstB (146/135) 
guaD Guanine deaminase 145 19 - 
hcaR_3 Hca operon transcriptional activator 141 1 hcaR_1 (145/129), hcaR_2 (146/134) 
hcpA_1 Major exported protein 146 0 hcpA (0/7), hcpA_2 (146/0) 
hcpA_2 Major exported protein 146 0 hcpA (0/7), hcpA_1 (146/0) 
hicB Antitoxin HicB 146 8 - 
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hilA Transcriptional regulator HilA 146 0 - 
hipA Serine/threonine-protein kinase HipA 146 0 - 
hipB Antitoxin HipB 146 0 - 
hscC_1 Chaperone protein HscC 2 129 hscC (144/80), hscC_2 (0/4) 
htrE_1 Outer membrane usher protein HtrE precursor 146 14 htrE (146/119), htrE_2 (115/0), htrE_3 (146/0), htrE_4 
(146/13), htrE_5 (146/0), htrE_6 (146/5) 
htrE_3 Outer membrane usher protein HtrE precursor 146 0 htrE (146/119), htrE_1 (146/14), htrE_2 (115/0), htrE_4 
(146/13), htrE_5 (146/0), htrE_6 (146/5) 
htrE_4 Outer membrane usher protein HtrE precursor 146 13 htrE (146/119), htrE_1 (146/14), htrE_2 (115/0), htrE_3 
(146/0), htrE_5 (146/0), htrE_6 (146/5) 
htrE_5 Outer membrane usher protein HtrE precursor 146 0 htrE (146/119), htrE_1 (146/14), htrE_2 (115/0), htrE_3 
(146/0), htrE_4 (146/13), htrE_6 (146/5) 
htrE_6 Outer membrane usher protein HtrE precursor 146 5 htrE (146/119), htrE_1 (146/14), htrE_2 (115/0), htrE_3 
(146/0), htrE_4 (146/13), htrE_5 (146/0) 
hyuA_1 D-phenylhydantoinase 146 1 hyuA_2 (146/13) 
hyuA_2 D-phenylhydantoinase 146 13 hyuA_1 (146/1) 
iadA Isoaspartyl dipeptidase 0 132 iadA_1 (0/2), iadA_2 (0/1) 
idnD L-idonate 5-dehydrogenase (NAD(P)( )) 146 1 - 
idnT Gnt-II system L-idonate transporter 146 0 - 
intA_4 hypothetical protein 0 135 intA (82/1), intA_1 (54/113), intA_2 (83/135), intA_3 (1/7) 
iraD Anti-adapter protein IraD 0 131 - 
lacY_2 Lactose permease 146 0 lacY_1 (125/0) 
leuE Leucine efflux protein 146 13 leuE_1 (0/11), leuE_2 (0/1) 
loiP_2 Metalloprotease LoiP precursor 146 15 loiP_1 (146/135) 
lptF Lipopolysaccharide export system permease 
protein LptF 
145 18 lptF_1 (0/117), lptF_2 (0/120) 
lysU Lysine--tRNA ligase, heat inducible 146 0 - 
malS Alpha-amylase precursor 0 134 malS_1 (0/3), malS (0/1) 
matA HTH-type transcriptional regulator MatA 146 10 - 
mazE Antitoxin MazE 146 13 mazE_1 (0/1) 
mazF mRNA interferase MazF 146 13 mazF_1 (0/1) 
mcbR_1 HTH-type transcriptional regulator McbR 144 0 mcbR (69/101), mcbR_2 (56/0) 
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mdh_1 NAD-dependent methanol dehydrogenase 146 19 mdh (146/135) 
merA Mercuric reductase 146 4 - 
mhpC 2-hydroxy-6-oxononadienedioate/2-hydroxy-6-
oxononatrienedioate hydrolase 
144 0 mhpC_1 (72/0) 
mhpD 2-keto-4-pentenoate hydratase 143 0 - 
mhpF Acetaldehyde dehydrogenase 144 0 - 
mkaC Virulence genes transcriptional activator 146 18 - 
mngB_3 Mannosylglycerate hydrolase 146 0 mngB_1 (143/40), mngB_2 (145/116) 
mocA Molybdenum cofactor cytidylyltransferase 145 13 - 
mshB 1D-myo-inositol 2-acetamido-2-deoxy-alpha-D-
glucopyranoside deacetylase 
144 0 - 
mtaD 5-methylthioadenosine/S-
adenosylhomocysteine deaminase 
145 0 - 
mtlR_1 Mannitol operon repressor 0 135 mtlR (89/72) 
murP_1 PTS system N-acetylmuramic acid-specific 
EIIBC component 
139 10 murP 4/105), murP_2 (145/18) 
murP_2 PTS system N-acetylmuramic acid-specific 
EIIBC component 
145 18 murP 4/105), murP_1 (139/10) 
nadA Quinolinate synthase A 0 135 nadA_1 (146/1), nadA_2 (140/0) 
nadA_1 Quinolinate synthase A 146 1 nadA (0/135), nadA_2 (146/0) 
nadA_2 Quinolinate synthase A 146 0 nadA (0/135), nadA_1 (146/1) 
nanS_1 hypothetical protein 139 18 nanS (146/132), nanS_2 (74/31), nanS_3 (0/104) 
narV Respiratory nitrate reductase 2 gamma chain 144 0 - 
narW putative nitrate reductase molybdenum cofactor 
assembly chaperone NarW 
145 0 - 
nhoA N-hydroxyarylamine O-acetyltransferase 143 0 - 
ompN_3 Outer membrane protein N precursor 146 0 ompN_1 (1/114), ompN_2 (146/56) 
outO Type 4 prepilin-like proteins leader peptide-
processing enzyme 
19 133 - 
pac Penicillin G acylase precursor 145 13 pac_1 (10/8) 
papC_4 Outer membrane usher protein PapC precursor 145 6 papC (0/11), papC_1 (144/99), papC_2 (145/49), papC_3 
(135/121), papC_5 (144/1), papC_6 (146/0) 
papC_5 Outer membrane usher protein PapC precursor 144 1 papC (0/11), papC_1 (144/99), papC_2 (145/49), papC_3 
(135/121), papC_4 (145/13), papC_6 (146/0) 
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papC_6 Outer membrane usher protein PapC precursor 146 0 papC (0/11), papC_1 (144/99), papC_2 (145/49), papC_3 
(135/121), papC_4 (145/13), papC_5 (144/1) 
pbpX Putative penicillin-binding protein PbpX 146 13 - 
pcaK 4-hydroxybenzoate transporter PcaK 144 0 - 
pduA_1 Propanediol utilization protein PduA 146 0 pduA_2 (145/0) 
pduA_2 Propanediol utilization protein PduA 145 0 pduA_1 (146/0) 
pduB Propanediol utilization protein PduB 146 0 - 
pduC Propanediol dehydratase large subunit 146 0 - 
pduD Propanediol dehydratase medium subunit 145 0 - 
pduE Propanediol dehydratase small subunit 146 0 - 
pduF Propanediol diffusion facilitator 146 0 - 
pduL Phosphate propanoyltransferase 146 0 - 
pduU Propanediol utilization protein PduU 146 0 - 
pduV_1 Propanediol utilization protein PduV 146 1 pduV_2 (136/135) 
pemK mRNA interferase PemK 0 135 pemK (1/3) 
pimB GDP-mannose-dependent alpha-(1-6)-
phosphatidylinositol monomannoside 
mannosyltransferase 
0 133 - 
pinR_1 Putative DNA-invertase from lambdoid 
prophage Rac 
146 1 pinR (0/28), pinR_2 (146/0) 
pinR_2 Putative DNA-invertase from lambdoid 
prophage Rac 
146 0 pinR (0/28), pinR_1 (146/1) 
potA_3 Spermidine/putrescine import ATP-binding 
protein PotA 
146 0 potA_1 (146/135), potA_2 (146/135) 
potF_2 Putrescine-binding periplasmic protein 
precursor 
145 0 potF (2/71), potF_1 (145/64) 
pptA Tautomerase PptA 145 0 - 
preT_3 NAD-dependent dihydropyrimidine 
dehydrogenase subunit PreT 
143 0 preT_1 (145/26), preT_2 (146/115) 
pstS1 Phosphate-binding protein PstS 1 precursor 146 12 - 
pucA putative xanthine dehydrogenase subunit A 146 13 - 
putA Bifunctional protein PutA 145 12 putA_2 (1/1) 
putP Sodium/proline symporter 145 13 - 
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puuE_2 4-aminobutyrate aminotransferase PuuE 141 11 puuE (2/37), puuE_1 (144/89) 
racX putative amino-acid racemase 0 134 - 
recQ_1 ATP-dependent DNA helicase RecQ 146 1 recQ (146/135), recQ_2 (0/1) 
relE2 Toxin RelE2 146 1 relE2_1 (18/3) 
rfaL O-antigen ligase 146 13 - 
rfbB dTDP-glucose 4,6-dehydratase 0 132 rfbB_1 (143/118) 
rfbC dTDP-4-dehydrorhamnose 3,5-epimerase 0 134 - 
rfbD dTDP-4-dehydrorhamnose reductase 0 133 - 
rhaR_2 HTH-type transcriptional activator RhaR 146 16 rhaR_1 (146/135), rhaR_3 (141/119) 
rhaT_1 L-rhamnose-proton symporter 2 135 rhaT (144/39), rhaT_2 (0/5) 
rhmD L-rhamnonate dehydratase 146 13 rhmD_1 (1/0) 
rhmR putative HTH-type transcriptional regulator 
RhmR 
145 13 - 
rhsA_1 putative deoxyribonuclease RhsA 145 0 rhsA_2 (143/0), rhsA_3 (6/0), rhsA_4 (5/1) 
rhsA_2 putative deoxyribonuclease RhsA 143 0 rhsA_1 (145/0), rhsA_3 (6/0), rhsA_4 (5/1) 
rhsC_2 hypothetical protein 142 12 rhsC_1 (117/60), rhsC_3 (78/5), rhsC_4 (136/4), rhsC_5 
(75/3), rhsC_6 (138/10) 
rhsC_6 hypothetical protein 138 10 rhsC_1 (117/60), rhsC_2 (142/12), rhsC_3 (78/5), rhsC_4 
(136/4), rhsC_5 (75/3) 
rmlA1 Glucose-1-phosphate thymidylyltransferase 1 0 134 - 
rpiB Ribose-5-phosphate isomerase B 146 13 - 
rutA_2 Pyrimidine monooxygenase RutA 141 1 rutA (116/118), rutA_1 (27/1) 
rutC_1 Putative aminoacrylate peracid reductase RutC 142 0 rutC (3/111), rutC_2 (144/7) 
rutC_2 Putative aminoacrylate peracid reductase RutC 144 7 rutC (3/111), rutC_1 (142/0) 
salL Adenosyl-chloride synthase 146 13 - 
sbmC DNA gyrase inhibitor 146 0 - 
sfaG S-fimbrial protein subunit SfaG precursor 0 131 - 
sfaH_1 S-fimbrial protein subunit SfaH 0 133 sfaH (146/122), sfaH_2 (0/13) 
sfaS S-fimbrial adhesin protein SfaS precursor 0 134 - 
sicA Chaperone protein SicA 146 0 - 
sinR HTH-type transcriptional regulator SinR 145 8 - 
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sorC_1 Sorbitol operon regulator 146 10 sorC (0/23), sorC_2 (145/95) 
sppA_2 Putative signal peptide peptidase SppA 141 10 sppA (0/106), sppA_1 (146/54) 
srlD_2 Sorbitol-6-phosphate 2-dehydrogenase 143 14 srlD_1 (143/120) 
srlR_4 Glucitol operon repressor 138 14 srlR_1 (146/135), srlR_2 (146/135), srlR_3 (146/135) 
ssb_1 Single-stranded DNA-binding protein 146 19 ssb_2 (111/122), ssb_4 (0/1) 
sucD_1 Succinyl-CoA ligase [ADP-forming] subunit 
alpha 
146 0 sucD (146/135), sucD_2 (1/0) 
tabA_3 Toxin-antitoxin biofilm protein TabA 144 0 tabA_1 (146/135), tabA_2 (145/135) 
taqIM Modification methylase TaqI 146 0 - 
tehB_1 putative S-adenosyl-L-methionine-dependent 
methyltransferase TehB 
146 13 tehB_2 (146/128) 
thlA_1 Acetyl-CoA acetyltransferase 143 0 thlA (0/39), thlA_2 (142/111) 
tibA_2 Adhesin/invasin TibA autotransporter precursor 145 13 tibA (0/3), tibA_1 (146/43) 
topB DNA topoisomerase 3 141 13 topB_1 (20/55), topB_2 (6/122) 
torA_2 Trimethylamine-N-oxide reductase 1 precursor 145 11 torA_1 (144/112) 
torI Response regulator inhibitor for tor operon 146 0 - 
treA_2 Periplasmic trehalase precursor 0 128 treA (138/130), treA_1 (0/1) 
virF Virulence regulon transcriptional activator VirF 146 0 virF_1 (65/129), virF_2 (0/122) 
wcaJ UDP-glucose:undecaprenyl-phosphate glucose-
1-phosphate transferase 
0 132 - 
wzxC_1 Lipopolysaccharide biosynthesis protein WzxC 0 134 wzxC_2 (0/134) 
wzxC_2 Lipopolysaccharide biosynthesis protein WzxC 0 134 wzxC_1 (0/134) 
xdhA_2 Xanthine dehydrogenase molybdenum-binding 
subunit 
146 1 xdhA (1/26), xdhA_1 (145/94) 
xylF D-xylose-binding periplasmic protein precursor 0 135 - 
xylG 2-hydroxymuconic semialdehyde 
dehydrogenase 
1 134 - 
xylH Xylose transport system permease protein XylH 0 132 - 
xylR_1 Xylose operon regulatory protein 0 134 xylR_2 (0/108) 
yafQ mRNA interferase YafQ 146 0 - 
yagU Inner membrane protein YagU 146 13 - 
yahK Aldehyde reductase YahK 145 0 - 
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ybbY Putative purine permease YbbY 146 14 - 
ybdO_1 putative HTH-type transcriptional regulator 
YbdO 
0 135 ybdO (146/135) 
ybhA Pyridoxal phosphate phosphatase YbhA 0 135 - 
ybhN_2 Inner membrane protein YbhN 143 19 ybhN (3/79), ybhN_1 (145/41) 
ycgF_1 Blue light- and temperature-regulated 
antirepressor YcgF 
145 4 ycgF (0/13), ycgF_2 (146/21) 
ycjP_1 Inner membrane ABC transporter permease 
protein YcjP 
144 2 ycjP (0/1), ycjP_2 (145/117) 
ydcR putative HTH-type transcriptional regulator 
YdcR 
146 0 - 
ydcU_1 Inner membrane ABC transporter permease 
protein YdcU 
144 0 ydcU_2 (144/101) 
yddE putative isomerase YddE 145 0 - 
ydeH_2 Diguanylate cyclase YdeH 146 12 ydeH (0/5), ydeH_1 (146/128) 
ydeO_2 transcriptional regulator YdeO 144 0 ydeO (146/135) 
yecD_2 Isochorismatase family protein YecD 1 132 yecD (145/122) 
yedA_2 putative inner membrane transporter YedA 145 0 yedA (146/134), yedA_1 (12/14) 
yedQ putative diguanylate cyclase YedQ 143 10 yedQ_1 (0/1), yedQ_2 (4/134), yedQ_3 (0/2) 
yedQ_2 putative diguanylate cyclase YedQ 4 134 yedQ (143/10), yedQ_1 (0/1), yedQ_3 (0/2) 
yedR Inner membrane protein YedR 146 13 - 
ygbF CRISPR-associated endoribonuclease Cas2 146 13 - 
ygbT_1 CRISPR-associated endonuclease Cas1 146 0 ygbT_2 (145/13) 
ygbT_2 CRISPR-associated endonuclease Cas1 145 13 ygbT_1 (146/0) 
ygcS_1 Inner membrane metabolite transport protein 
YgcS 
146 13 ygcS (0/2), ygcS_2 (146/123), ygcS_3 (145/103), ygcS_4 
(146/0) 
ygcS_4 Inner membrane metabolite transport protein 
YgcS 
146 0 ygcS (0/2), ygcS_1 (146/13), ygcS_2 (146/123), ygcS_3 
(145/103) 
ygeX Diaminopropionate ammonia-lyase 146 13 - 
yggF Fructose-1,6-bisphosphatase 2 class 2 0 134 - 
ygjH_2 tRNA-binding protein YgjH 7 129 ygiH (137/12), ygjH_1 (2/84) 
ygjI_3 Inner membrane transporter YgjI 146 0 ygiI (12/95), ygiI_1 (133/14), ygiI_2 (146/22), ygiI_4 (0/22) 
yhaI Inner membrane protein YhaI 145 13 - 
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yhbU_1 Peptidase family U32 145 10 yhbU_2 (146/132), yhbU_3 (146/134), yhbU_4 (0/1) 
yhdN General stress protein 69 139 19 yhdN_2 (0/120), yhdN_3 (4/115) 
yiaO_2 2,3-diketo-L-gulonate-binding periplasmic 
protein YiaO precursor 
146 0 yiaO_1 (144/107) 
yicJ Inner membrane symporter YicJ 143 12 yicJ_1 (0/122), yicJ_2 (0/56) 
yjcD Putative permease YjcD 18 133 yjcD_1 (145/19), yjcD_2 (128/2), yjcD_3 (0/1) 
yjcD_1 Putative permease YjcD 145 19 yjcD (18/133), yjcD_2 (128/2), yjcD_3 (0/1) 
yjdF Inner membrane protein YjdF 0 132 - 
yjdL putative dipeptide and tripeptide permease YjdL 146 0 - 
yjiE HTH-type transcriptional regulator YjiE 0 133 yjiE_1 (1/78) 
yjiG Inner membrane protein YjiG 0 132 - 
yjmD putative zinc-type alcohol dehydrogenase-like 
protein YjmD 
146 3 - 
ymfD Bacillibactin exporter 146 13 - 
ynaI_1 Low conductance mechanosensitive channel 
YnaI 
144 15 ynaI (0/119), ynaI_2 (86/12) 
ynjC_1 Inner membrane ABC transporter permease 
protein YnjC 
138 2 ynjC_2 (133/123), ynjC_3 (142/134) 
ynjF_1 Inner membrane protein YnjF 146 1 ynjF (2/61), ynjF_2 (144/71) 
yqiJ Inner membrane protein YqiJ 146 19 yqiJ_1 (19/1) 
ytbE putative oxidoreductase YtbE 146 1 - 
yvqK Cob(I)yrinic acid a,c-diamide 
adenosyltransferase 
146 0 - 
zraR_1 Transcriptional regulatory protein ZraR 146 0 zraR (145/134), zraR_2 (1/0) 
zraS_1 Sensor protein ZraS 146 0 zraS (140/134), zraS_2 (6/3) 
 
Supplementary table 5.2. Homologous gene clusters (HGCs) that were found in significantly higher in either S. sonnei or S. flexneri pan genomes. 
Also shown are other HGCs given the same gene name annotation from the BLASTp hit, likely due to different variants of the same gene.  
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Supplementary material – vcfProcess 
 
vcfProcess is a function written in R v3.1.2 that takes VCF files (.vcf) from variant caller 
software, including Samtools and GATK, and processes these files for use with population 
genetics tools, primarily for use with haploid organisms. This function can filter indels 
(insertions/deletions), variants in low coverage regions, variants with low genotype quality, 
and variants problematic repeat regions. The output files will be a concatenated sequence of 
high likelihood SNPs in the common FASTA format for downstream analysis such as 
phylogenetic programs, as well as comma delimited files that can be read in Microsoft Excel. 
 
R Script: 
 
vcfProcess<-
function(inputfile,repeatfile.present=FALSE,repeatfile,outputfile,DP_low=5,lowqual=20,low.qua
lity.file=TRUE,repeat.output.file=TRUE,indel.file=TRUE,var.SNPs.only=FALSE){ 
   
  ######################################   VCF FILE POST PROCESSING  
################################## 
   
  if (!require(stringr)){ 
    install.packages("stringr") 
    library(stringr) 
  } 
  if (!require(seqinr)){ 
    install.packages("seqinr") 
    library(seqinr) 
  } 
   
  ######READ IN VCF FILE, REPEAT REGION FILE AND RETAIN 
HEADER############################################################ 
   
  input<-read.table(inputfile) 
  header_input<-as.matrix(read.table(inputfile,comment.char=" ",sep="\n")) 
  end_head<-which(grepl("#CHROM",header_input)==TRUE) 
  header<-as.data.frame(header_input[1:end_head]) 
  names<-unlist(strsplit(header_input[end_head],"\t")) 
  format<-which(names=='FORMAT') 
  names<-names[10:length(names)] 
  rm(header_input,end_head) 
   
  #######SPLIT GT:PL:DP:GQ... SECTION AND MAKE NEW MATRICES OF THESE 
VALUES################################ 
   
  geno<-input[,10:ncol(input)] 
  s<-unlist(str_split(geno[1,1], ":")) 
  no_of_columns<-length(s)      
  GT<-matrix(0,nrow(geno),ncol(geno)*no_of_columns) 
  l<-seq(1,ncol(GT),no_of_columns) 
  for (i in 1:nrow(geno)){ 
    for (j in 1:ncol(geno)){ 
      s<-unlist(str_split(geno[i,j], ":")) 
      for (k in 1:no_of_columns){  
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        GT[i,l[j]+k-1]<-s[k] 
      }  
    } 
  } 
   
  sep_geno<-cbind(input[,1:9],GT)  
 
   
   
  ##################REMOVE UNWANTED SNPS 
############################################################ 
   
  ######### REMOVE LOW QUAL SNPS 
   
  qual<-as.integer(sep_geno[,6]) 
  b<-qual < lowqual 
  d<-which(b=='TRUE') 
  lowqual<-sep_geno[d,] 
  c<-which(b == 'FALSE') 
  sep_geno<-sep_geno[c,] 
  vcf<-input[c,] 
  if (low.quality.file==TRUE){ 
    if (nrow(lowqual)!=0){ 
      write.csv(lowqual,file="lowqualsnps.csv") 
    } else {print("No low quality SNPs") 
    } 
  } 
 
  ######## MAKE INDEL FILE (if applicable)  
   
  desc<-sep_geno[,8] 
  new_desc<-grepl('INDEL',desc) 
  indel<-which(new_desc=='TRUE') 
  indels<-sep_geno[indel,] 
  if (indel.file==TRUE){ 
    if (nrow(indels)!=0){ 
      write.csv(indels,file="indels.csv") 
    } else {print("No indels") 
    } 
  } 
  f<-which(new_desc=='FALSE') 
  sep_geno<-sep_geno[f,] 
  vcf<-vcf[f,] 
   
  ####### REMOVE REPEAT AND MOBILE ELEMENT REGIONS 
   
  if (repeatfile.present==TRUE){ 
    rep<-as.data.frame(read.csv(repeatfile,header=TRUE)) 
    pos<-sep_geno[,2] 
    res=vector() 
    for (i in 1:nrow(rep)){ 
      y<-c(rep[i,1]:rep[i,2]) 
      res<-c(res,y)    
    } 
    q<-is.element(pos,res) 
    a<-which(q == 'FALSE') 
    sep_geno<-sep_geno[a,] 
    vcf<-vcf[a,] 
    b<-which(q=='TRUE') 
    rep<-sep_geno[b,] 
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    if (repeat.output.file==TRUE){ 
      if (nrow(rep!=0)){ 
        write.csv(rep, file="SNPsinrepregions.csv") 
      } else {print("No repeat or mobile element SNPs") 
      } 
    } 
  } 
   
   
  #### DETERMINE ORDER OF FORMAT FIELDS #### 
   
  s<-unlist(str_split(vcf[1,format], ":")) 
  GT<-which(s=='GT') 
  DP<-which(s=='DP') 
  PL<-which(s=='PL') 
  DP4<-which(s=='DP4') 
   
  ####### SPLIT DATA INTO 1,2 AND 3 ALT ALLELES 
######################################################### 
   
  alt<-sep_geno[,5] 
  b<-which(grepl(",",alt)==TRUE) 
  sep_geno2<-sep_geno[b,] 
  vcf2<-vcf[b,] 
  a<-which(grepl(",",alt)==FALSE) 
  sep_geno<-sep_geno[a,] 
  vcf<-vcf[a,] 
   
  ####### 1 ALT ALLELE ASSIGNING 
####################################################################### 
   
  ref<-sep_geno[,4] 
  alt<-sep_geno[,5] 
  geno<-sep_geno[,seq(GT+9,ncol(sep_geno),no_of_columns)] 
  genotype<-as.matrix(cbind(ref,alt,geno)) 
   
  output=matrix(0,nrow(genotype),ncol(genotype)) 
  rownames(output)=rownames(genotype) 
  colnames(output)=colnames(genotype) 
   
  ####### ASSIGN NUCLEOTIDE TO GENOTYPE  
   
  for (i in 1:nrow(genotype)){ 
    for (j in 3:ncol(genotype)){ 
      if (genotype[i,j]=='0/0'){ 
        output[i,j]=genotype[i,1]} 
      else  {if (genotype[i,j]=='1/1'){ 
        output[i,j]=genotype[i,2] 
      } 
        else { 
          output[i,j]='N'} 
      } 
    } 
  } 
   
  output<-output[,3:ncol(output)]  
   
  ######## low read for all mark as '?'  
  if (length(DP)!=0){ 
    read<-data.matrix(as.matrix(sep_geno[,seq(DP+9,ncol(sep_geno),no_of_columns)])) 
Supplementary materials  
 
 194 
    class(read)<-"numeric" 
    snprd<-read<DP_low 
    lowread<-which(snprd == 'TRUE')  
    output[lowread]<-'?' 
  } else if (length(DP4)!=0){ 
    read<-data.matrix(as.matrix(sep_geno[,seq(DP4+9,ncol(sep_geno),no_of_columns)])) 
    read2<-matrix(0,nrow(read),ncol(read)) 
    for (i in 1:nrow(read)){ 
      for (j in 1:ncol(read)){ 
        read2[i,j]<-sum(as.numeric(unlist(str_split(read[i,j], ",")))) 
      } 
    } 
    class(read2)<-"numeric" 
    snprd<-read2<DP_low 
    lowread<-which(snprd == 'TRUE')  
    output[lowread]<-'?' 
  } 
   
  ###########REMOVE snps that have no alt allele (may have been included due to hetero call) 
   
  alt1<-as.vector(alt) 
  new21<-as.matrix(cbind(alt1,output)) 
  new22<-matrix(0,nrow(new21),ncol(new21)) 
   
  for (i in 1:nrow(new21)){ 
    for (j in 2:ncol(new21)){ 
      if (new21[i,j]==new21[i,1]){ 
        new22[i,j]='FALSE'} 
      else  {if (new21[i,j]!=new21[i,1]){ 
        new22[i,j]='TRUE' 
      } 
      } 
    } 
  } 
   
  new23<-new22[,2:ncol(new22)] 
   
  d<- lapply(1:nrow(new23), function(i){ 
    all(as.logical(new23[i,])) 
  } 
  ) 
  g<-do.call(rbind,d) 
   
  alt_present<-which(g=='FALSE') 
  output<-output[alt_present,]  
  vcf<-vcf[alt_present,] 
   
  ################ 2nd AND 3rd ALLELE ASSIGNING 
###################################################### 
   
  if (nrow(sep_geno2)!=0){ 
     
    ###SPLIT 2 and 3 ALT ALLELE DATA 
     
    twoalt<-which(nchar(as.matrix(sep_geno2[,5]))!=5) 
    threealt<-which(nchar(as.matrix(sep_geno2[,5]))==5) 
    sep_geno3<-sep_geno2[threealt,] 
    sep_geno2<-sep_geno2[twoalt,] 
    vcf3<-vcf2[threealt,] 
    vcf2<-vcf2[twoalt,] 
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    ####2 ALT ALLELE ASSIGNING 
     
    ref<-sep_geno2[,4] 
    alt_split<-t(as.data.frame(strsplit(as.character(sep_geno2[,5]),","))) 
    alt1<-as.vector(alt_split[,1]) 
    alt2<-as.vector(alt_split[,2]) 
     
    geno2<-sep_geno2[,seq(PL+9,ncol(sep_geno2),no_of_columns)] 
    genotype2<-as.matrix(cbind(ref,alt1,alt2,geno2)) 
     
    output2=matrix(0,nrow(genotype2),ncol(genotype2)) 
    rownames(output2)=rownames(genotype2) 
    colnames(output2)=colnames(genotype2) 
     
    for (i in 1:nrow(genotype2)){ 
      for (j in 4:ncol(genotype2)){ 
        s<-unlist(str_split(genotype2[i,j], ",")) 
        if (max(s)==min(s)){ 
          output2[i,j]='N'} 
        else if (length(which(s==min(s))==1)==TRUE){ 
          if (which(s==min(s))==3){ 
            output2[i,j]=genotype2[i,2] 
          } else if (which(s==min(s))==6){ 
            output2[i,j]=genotype2[i,3] 
          } else if (which(s==min(s))==1|which(s==min(s))==4){ 
            output2[i,j]=genotype2[i,1] 
          } else { 
            output2[i,j]='N' 
          } 
        } else { 
          output2[i,j]='N' 
        } 
      } 
    } 
     
    output2<-as.matrix(output2[,4:ncol(output2)]) 
    if (ncol(output2)==1){ 
      output2<-t(output2) 
    } 
     
    ######## low read for all mark as '?' 
     
    if (length(DP)!=0){ 
      read<-data.matrix(as.matrix(sep_geno2[,seq(DP+9,ncol(sep_geno2),no_of_columns)])) 
      class(read)<-"numeric" 
      snprd<-read<DP_low 
      lowread<-which(snprd == 'TRUE')  
      output2[lowread]<-'?' 
    } else if (length(DP4)!=0){ 
      read<-data.matrix(as.matrix(sep_geno2[,seq(DP4+9,ncol(sep_geno2),no_of_columns)])) 
      read2<-matrix(0,nrow(read),ncol(read)) 
      for (i in 1:nrow(read)){ 
        for (j in 1:ncol(read)){ 
          read2[i,j]<-sum(as.numeric(unlist(str_split(read[i,j], ",")))) 
        } 
      } 
      class(read2)<-"numeric" 
      snprd<-read2<DP_low 
      lowread<-which(snprd == 'TRUE')  
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      output2[lowread]<-'?' 
    } 
     
    ###########REMOVE snps that have no alt allele (may have been included due to hetero 
call) 
     
    new21<-as.matrix(cbind(alt1,alt2,output2)) 
    new22<-matrix(0,nrow(new21),ncol(new21)) 
     
    for (i in 1:nrow(new21)){ 
      for (j in 3:ncol(new21)){ 
        if (new21[i,j]==new21[i,1]|new21[i,j]==new21[i,2]){ 
          new22[i,j]='FALSE'} 
        else  { 
          new22[i,j]='TRUE' 
        } 
      } 
    } 
     
    new22<-as.matrix(new22[,3:ncol(new22)]) 
    if (ncol(new22)==1){ 
      new22<-t(new22) 
    } 
     
    d<- lapply(1:nrow(new22), function(i){ 
      all(as.logical(new22[i,])) 
    } 
    ) 
    g<-do.call(rbind,d) 
     
    alt_present<-which(g=='FALSE') 
    output2<-as.matrix(output2[alt_present,])  
    if (ncol(output2)==1){ 
      output2<-t(output2) 
    } 
    vcf2<-vcf2[alt_present,] 
     
    ########## THREE ALT ASSIGN ########## 
     
    if (nrow(sep_geno3)!=0){ 
       
      ref<-sep_geno3[,4] 
      alt_split<-t(as.data.frame(strsplit(as.character(sep_geno3[,5]),","))) 
      alt1<-as.vector(alt_split[,1]) 
      alt2<-as.vector(alt_split[,2]) 
      alt3<-as.vector(alt_split[,3]) 
       
      geno3<-sep_geno3[,seq(PL+9,ncol(sep_geno3),no_of_columns)] 
      genotype3<-as.matrix(cbind(ref,alt1,alt2,alt3,geno3)) 
       
      output3=matrix(0,nrow(genotype3),ncol(genotype3)) 
      rownames(output3)=rownames(genotype3) 
      colnames(output3)=colnames(genotype3) 
       
      for (i in 1:nrow(genotype3)){ 
        for (j in 4:ncol(genotype3)){ 
          s<-unlist(str_split(genotype3[i,j], ",")) 
          if (max(s)==min(s)){ 
            output3[i,j]='N'} 
          else if (length(which(s==min(s))==1)==TRUE){ 
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            if (which(s==min(s))==3){ 
              output3[i,j]=genotype3[i,2] 
            } else if (which(s==min(s))==6){ 
              output3[i,j]=genotype3[i,3] 
            } else if (which(s==min(s))==9|which(s==min(s))==10){ 
              output3[i,j]=genotype3[i,4] 
            } else if (which(s==min(s))==1|which(s==min(s))==4|which(s==min(s))==7){ 
              output3[i,j]=genotype3[i,1] 
            } else { 
              output3[i,j]='N' 
            } 
          } else { 
            output3[i,j]='N' 
          } 
        } 
      } 
       
      output3<-as.matrix(output3[,5:ncol(output3)]) 
      if (ncol(output3)==1){ 
        output3<-t(output3) 
      } 
       
      ######## low read for all mark as '?'  
       
      if (length(DP)!=0){ 
        read<-data.matrix(as.matrix(sep_geno3[,seq(DP+9,ncol(sep_geno3),no_of_columns)])) 
        class(read)<-"numeric" 
        snprd<-read<DP_low 
        lowread<-which(snprd == 'TRUE')  
        output3[lowread]<-'?' 
      } else if (length(DP4)!=0){ 
        read<-data.matrix(as.matrix(sep_geno3[,seq(DP4+9,ncol(sep_geno3),no_of_columns)])) 
        read2<-matrix(0,nrow(read),ncol(read)) 
        for (i in 1:nrow(read)){ 
          for (j in 1:ncol(read)){ 
            read2[i,j]<-sum(as.numeric(unlist(str_split(read[i,j], ",")))) 
          } 
        } 
        class(read2)<-"numeric" 
        snprd<-read2<DP_low 
        lowread<-which(snprd == 'TRUE')  
        output3[lowread]<-'?' 
      } 
       
      ###########REMOVE snps that have no alt allele (may have been included due to hetero 
call) 
       
      new21<-as.matrix(cbind(alt1,alt2,alt3,output3)) 
      new22<-matrix(0,nrow(new21),ncol(new21)) 
       
      for (i in 1:nrow(new21)){ 
        for (j in 4:ncol(new21)){ 
          if (new21[i,j]==new21[i,1]|new21[i,j]==new21[i,2]|new21[i,j]==new21[i,3]){ 
            new22[i,j]='FALSE'} 
          else  { 
            new22[i,j]='TRUE' 
          } 
        } 
      } 
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      new22<-as.matrix(new22[,4:ncol(new22)]) 
      if (ncol(new22)==1){ 
        new22<-t(new22) 
      } 
       
      d<- lapply(1:nrow(new22), function(i){ 
        all(as.logical(new22[i,])) 
      } 
      ) 
      g<-do.call(rbind,d) 
       
      alt_present<-which(g=='FALSE') 
      output3<-as.matrix(output3[alt_present,]) 
      if (ncol(output3)==1){ 
        output3<-t(output3) 
      } 
      vcf3<-vcf3[alt_present,] 
       
      ###### combine output2&3 and vcf2&3 
       
      pos2<-as.numeric(vcf2[,2]) 
      pos3<-as.numeric(vcf3[,2]) 
      output2<-cbind(pos2,output2) 
      output3<-cbind(pos3,output3) 
      output2<-rbind(output2,output3) 
      output2<-output2[order(as.numeric(output2[,1])),] 
      vcf2<-rbind(vcf2,vcf3) 
      vcf2<-vcf2[order(as.numeric(vcf2[,2])),] 
      output2<-output2[,2:ncol(output2)] 
       
    }  
     
    ###### combine output&output2 and vcf&vcf2 
     
    pos<-as.numeric(vcf[,2]) 
    pos2<-as.numeric(vcf2[,2]) 
    output<-cbind(pos,output) 
    output2<-cbind(pos2,output2) 
    output<-rbind(output,output2) 
    output<-output[order(as.numeric(output[,1])),] 
    output<-output[,2:ncol(output)] 
    vcf<-rbind(vcf,vcf2) 
    vcf<-vcf[order(as.numeric(vcf[,2])),] 
  }  
   
  ################ Remove SNPS that are shared by all isolates (i.e. no variation in isolates, 
only from reference) 
   
  if (var.SNPs.only==TRUE){ 
    ref<-as.character(vcf[,4]) 
    mat<-cbind(ref,output) 
    new22<-matrix(0,nrow(mat),ncol(mat)) 
     
    for (i in 1:nrow(mat)){ 
      for (j in 2:ncol(mat)){ 
        if (mat[i,j]==mat[i,1]){ 
          new22[i,j]='FALSE'} 
        else  { 
          new22[i,j]='TRUE' 
        } 
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      } 
    } 
     
    new22<-new22[,2:ncol(new22)] 
     
    d<- lapply(1:nrow(new22), function(i){ 
      all(as.logical(new22[i,])) 
    } 
    ) 
    g<-do.call(rbind,d) 
     
    var_present<-which(g=='FALSE') 
    output<-output[var_present,]  
    vcf<-vcf[var_present,] 
  } 
   
  ################# writing different file 
types############################################## 
   
  ########## Write VCF file of processed SNPs 
   
  v<-as.data.frame(apply(vcf, 1, paste, collapse="\t")) 
  rownames(v)<-NULL 
  names(header)<-names(v) 
  u<-rbind(header,v) 
  write.table(u, file= paste(outputfile,".vcf",sep = ""),row.names 
=FALSE,sep="\t",quote=FALSE,col.names=FALSE) 
   
  ########### CSV file with SNP genotypes only with reference sequence and SNP position  
   
  colnames(output)<-names 
  Reference<-as.character(vcf[,4])# makes single row of ref alleles (from reference sequence) 
  Position<-vcf[,2] 
  forcsv<-cbind(Position,Reference,output) 
  write.csv(forcsv,file=paste(outputfile,".csv",sep = ""),row.names=FALSE) 
   
  ########### Fasta file of all isolates (without ref) 
  output_fast<-t(output) 
  forfasta<-as.list(apply(output_fast, 1, paste, collapse=" ")) 
  write.fasta(forfasta,names,nbchar=60,file.out=paste(outputfile,".fasta",sep = ""),open="w") 
   
  ########### Fasta file of all isolates (with ref) 
   
  namesfasta<-c("Reference",names) 
  forfastaref<-rbind(Reference,output_fast) 
  forfastaref<-as.list(apply(forfastaref, 1, paste, collapse=" ")) 
  write.fasta(forfastaref,namesfasta,nbchar=60,file.out=paste(outputfile,"_with_ref.fasta",sep = 
""),open="w")} 
